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Abstract 
The standard approach of tissue engineering is to develop a cell-seeded scaffold 
which has morphology and mechanical properties similar to those of the target tissue. 
The scaffold material should possess surface properties so that the seeded cells can 
maintain proper activity, function and morphology. In terms of engineering of 
pulmonary epithelial tissue, a major challenge is to obtain sufficient cells because of 
the difficulty in isolating and culturing primary pulmonary epithelial cells in vitro, 
especially type II pneumocytes. To overcome this problem, a method to differentiate 
pulmonary progenitors, which possessed most of the features of type II pulmonary 
epithelial cells, from murine embryonic stem cells (mESCs) was investigated in this 
study. The first aim of this project was to increase the differentiation efficiency of type 
II pneumocyte progenitors from mESCs by enhancing the efficiency of an established 
differentiation protocol using extracellular matrix (ECM), growth factors and 
bioactive peptides. In the first study, mESCs were differentiated on tissue culture 
plastic (TCP) and poly(D,L-lactide) (PDLLA) films coated with ECM proteins, 
including collagen, laminin, fibronectin and Matrigel. The results demonstrated that 
all protein coatings can enhance the wettability of the TCP and PDLLA films and, 
moreover, laminin and Matrigel can enhance the differentiation of mESCs into 
pulmonary progenitors. In the second study, growth factors that are commonly 
thought to affect the development of embryonic lung, including fibroblast growth 
factors (FGFs) 1, 2, 7 and 10, were added to the differentiation culture at various 
concentrations and the subsequent expression of surfactant protein C, a marker of type 
II pneumocytes and their progenitors, was measured. It was found that FGF1 alone 
and FGF10 in combination with Matrigel coating enhanced the differentiation of 
mESCs into pulmonary progenitors. In another study, mESCs were differentiated on 
PDLLA films grafted with the bioactive peptides RGD and YIGSR. Preliminary result 
showed that YIGSR enhanced the differentiation of mESCs into pulmonary 
progenitors. 
 
The second aim of this project was to develop 2D environments and 3D scaffolds 
made of PDLLA suitable for the culture of human pulmonary epithelial cells (A549 
line). PDLLA has advantages of biocompatibility and biodegradability, but a major 
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drawback is its hydrophobic nature. To make the surface of PDLLA films hydrophilic, 
it was modified using a variety of methods, i.e. by grafting the bioactive peptides 
RGD and YIGSR, by introducing amines using aminolysis and by creating 
amine-terminated and carboxylic acid-terminated tree-like branched architectures on 
to the surface. The surface properties of modified PDLLA films were evaluated using 
various techniques. The culture of A549 cells on PDLLA films demonstrated that 
surface modifications can affect the attachment, focal adhesion point formation, 
activity and population size, depending on the type and the concentration of the 
bioactive peptides or functional groups presented on the surface of PDLLA films. 
 
The challenge of culturing pulmonary epithelial cells in 3D is to generate scaffolds 
with proper porous structures which allow sufficient medium diffusion in and waste 
disposal out of the scaffolds. The influence of the preparation conditions, i.e. 
coarsening time and coarsening period of a liquid-liquid phase separation system and 
freezing temperature of a solid-liquid phase separation system, on the porous 
morphology and the subsequent pulmonary epithelial cell culture were examined. 
Scaffolds that possessed alveolus-like round pores and ladder-like pores were 
prepared using liquid-liquid phase separation and solid-liquid phase separation, 
respectively. Culture of A549 cells on the PDLLA scaffolds demonstrated that cell 
penetration into and activity on the scaffolds are influenced by the pore size and the 
pore throat size of the scaffolds. 
 
In conclusion, the results of this project demonstrated that the differentiation of 
mESCs into pulmonary epithelial progenitors can be enhanced by external signals i.e. 
from ECM proteins, FGFs and bioactive peptides. The responses of pulmonary 
epithelial cells to the PDLLA scaffolds can be enhanced by surface modifications 
using bioactive peptides and functional groups and scaffolds that can serve as a 
culture environment for pulmonary epithelial cells were prepared accordingly. Taken 
together, the results of these studies provide a basis for future engineering of 
pulmonary epithelial tissue, an area of tissue engineering that lags behind that of other 
major organs. 
 
 
 5
Table of Contents 
ACKNOWLEDGEMENTS ...............................................................................1 
DECLARATION ...............................................................................................2 
ABSTRACT .....................................................................................................3 
TABLE OF CONTENTS...................................................................................5 
LIST OF FIGURES ........................................................................................10 
LIST OF TABLES ..........................................................................................22 
ABBREVIATIONS .........................................................................................23 
CHAPTER 1. INTRODUCTION ..................................................................28 
1.1. Objective and scope of this thesis .................................................................28 
1.2. Biology of lung and extracellular matrix .....................................................32 
1.2.1. Cells of lung alveolar epithelium: anatomy and physiology ...............32 
1.2.2. Type II pulmonary cells: characteristics, derivation and culture .........33 
1.2.3. Lung development ...............................................................................35 
1.2.4. Role of fibroblast growth factors (FGFs) in lung development...........37 
1.2.5. Extracellular matrix and integrins: an introduction .............................37 
1.2.6. Role of extracellular matrix in lung epithelium and lung development
 ………………………………………………………………………..40 
1.2.7. Extracellular matrix in in vitro lung biology .......................................42 
1.3. Embryonic stem cells and their differentiation...........................................44 
1.4. Composition, preparation and modification of 2D environments and 3D 
scaffolds.......................................................................................................................47 
1.4.1. Lactic acid-based polyesters ................................................................47 
1.4.2. Surface modification of lactic acid-based polyesters...........................50 
1.4.3. Extracellular matrix coating on biomaterials .......................................52 
1.4.4. Scaffolds prepared by Thermally-Induced Phase Separation (TIPS) ..53 
1.4.5. Cell seeding and infiltration of porous scaffolds .................................58 
1.5. Surface characterization of modified biodegradable polymer scaffolds...58 
1.5.1. Wettability of surfaces: contact angle measurements ..........................58 
1.5.2. Information about the surface chemistry obtained from ζ-potential 
measurements...........................................................................................................60 
1.5.3. X-ray photoelectron spectroscopy (XPS) ............................................62 
CHAPTER 2. MATERIALS AND METHODS..............................................64 
 6
2.1. Introduction....................................................................................................64 
2.2. Cell culture and A549 cell transfection ........................................................64 
2.2.1. Cell culture medium.............................................................................64 
2.2.1.1. Medium for the maintenance of mESCs in the undifferentiated state
 ……………………………………………………………………..64 
2.2.1.2. Medium for the differentiation of mESCs into pulmonary 
progenitors ……………………………………………………………………..64 
2.2.1.3. Medium for the culture of A549 cells ..............................................65 
2.2.1.4. Medium for the culture of 804G cells..............................................65 
2.2.2. Culture of murine embryonic stem cells ..............................................65 
2.2.2.1. Culture of undifferentiated mESCs..................................................65 
2.2.2.2. Formation of embryoid bodies (EBs) ..............................................66 
2.2.2.3. Original three-step differentiation of mESCs into pulmonary 
progenitors ……………………………………………………………………..67 
2.2.2.3.1. Differentiation of mESCs into pulmonary progenitors on ECM 
protein-coated TCP and PDLLA films.............................................................68 
2.2.2.3.2. Differentiation of mESCs into pulmonary progenitors by the 
addition of growth factors ................................................................................69 
2.2.2.3.3. Differentiation of mESCs into pulmonary progenitors on 
peptide-grafted PDLLA films ..........................................................................70 
2.2.3. Culture of A549 and 804G cell lines....................................................71 
2.2.4. Transfection of CMV-EGFP construct to A549 cells...........................71 
2.3. Characterization of cell culture ....................................................................73 
2.3.1. Microscopy ..........................................................................................73 
2.3.2. Conventional and realtime PCR for mRNA expression analysis.........73 
2.3.2.1. RNA isolation ..................................................................................74 
2.3.2.2. Reverse transcription .......................................................................74 
2.3.2.3. Conventional PCR amplification .....................................................75 
2.3.2.4. Realtime PCR amplification ............................................................75 
2.3.2.5. Agarose gel electrophoresis .............................................................77 
2.3.3. Immunocytochemistry .........................................................................78 
2.3.4. Flow cytometry ....................................................................................79 
2.4. Preparation of Polymer Constructs..............................................................81 
2.4.1. Preparation of polymer films ...............................................................81 
2.4.2. Preparation of scaffolds using liquid-liquid phase separation and 
solid-liquid phase separation....................................................................................82 
2.4.2.1. Preparation of scaffolds by thermally-induced liquid-liquid phase 
separation of the dioxane-water-PDLLA ternary system.....................................82 
2.4.2.2. Preparation of scaffolds by thermally-induced solid-liquid phase 
separation using the DMC-PDLLA binary system ..............................................83 
2.4.2.3. Freeze-drying of polymer solution using a custom-made freeze-dryer
 ……………………………………………………………………..83 
2.5. Surface modification of polymer constructs................................................84 
2.5.1. Protein adsorption ................................................................................84 
2.5.2. Introduction of primary amines to PDLLA using aminolysis..............86 
2.5.3. Preparation of amine-terminated and carboxylic acid-terminated 
branched architectures .............................................................................................87 
 7
2.5.4. Grafting of laminin peptides onto surface amines of amiolyzed PDLLA 
films ………………………………………………………………………..92 
2.6. Characterization of polymer films and scaffolds ........................................93 
2.6.1. Surface character of polymer films: ζ potential Measurements...........93 
2.6.2. Dynamic contact angle measurements.................................................94 
2.6.3. Morphological analysis of the scaffolds using scanning electron 
microscopy ………………………………………………………………………..95 
2.6.4. Fluorescamine assay for quantification of primary amine functional 
groups ………………………………………………………………………..95 
2.6.5. Surface topography and roughness of modified PDLLA: Atomic Force 
Microscopy (AFM) ..................................................................................................96 
2.6.6. Surface composition of modified PDLLA: X-ray photoelectron 
spectroscopy (XPS)..................................................................................................96 
2.7. Culture and evaluate cells on biomaterials..................................................97 
2.7.1. Seeding A549 cells onto scaffolds .......................................................97 
2.7.2. The penetration of A549 cells into scaffolds evaluated using 
fluorescence and scanning electron microscopy......................................................98 
2.7.3. Evaluation of attachment and population size of A549 cells by 
measurement of DNA content using Hoechst dye ...................................................98 
2.7.4. Evaluation of cell activity using WST-1 assay ....................................99 
2.8. Statistical analysis ........................................................................................100 
CHAPTER 3. THE EFFECT OF CULTURE SUBSTRATUM ON THE 
DERIVATION OF PULMONARY EPITHELIAL PROGENITORS FROM 
MURINE EMBRYONIC STEM CELLS ........................................................102 
3.1. Introduction..................................................................................................102 
3.2. Methodology .................................................................................................104 
3.3. Results ...........................................................................................................104 
3.3.1. Transmitted light and fluorescence microscopy ................................104 
3.3.2. Evaluation of the mRNA expression of differentiated cells using 
RT-PCR ………………………………………………………………………109 
3.3.3. EBs attachment, cell population and cell spreading from EBs.......... 110 
3.3.4. Determination of eGFP-positive cells by flow cytometry ................. 114 
3.3.5. Surface properties of the ECM-coated TCP and PDLLA films......... 116 
3.4. Discussion...................................................................................................... 118 
3.5. Conclusion ....................................................................................................124 
CHAPTER 4. THE EFFECT OF FIBROBLAST GROWTH FACTORS ON 
THE DERIVATION OF PULMONARY PROGENITORS FROM MURINE 
EMBRYONIC STEM CELLS .......................................................................125 
4.1. Introduction..................................................................................................125 
 8
4.2. Methodology .................................................................................................126 
4.3. Results ...........................................................................................................127 
4.3.1. Conventional and realtime PCR.........................................................127 
4.3.2. TTF-1-positive cells and SPC-GFP-expressing cells ........................131 
4.4. Discussion......................................................................................................136 
4.5. Conclusion ....................................................................................................139 
CHAPTER 5. PEPTIDE-GRAFTED POLY(D,L-LACTIDE) AND ITS 
APPLICATION IN A549 CELL CULTURE AND DIFFERENTIATION OF 
MURINE EMBRYONIC STEM CELLS INTO PULMONARY EPITHELIAL 
PROGENITOR CELLS ................................................................................141 
5.1. Introduction..................................................................................................141 
5.2. Methodology .................................................................................................143 
5.3. Results ...........................................................................................................143 
5.3.1. Surface characterization of peptide-grafted PDLLA .........................143 
5.3.2. Attachment of A549 cells to peptide-grafted PDLLA .......................146 
5.3.3. Cell activity and population of A549 cells on days 2 and 4...............147 
5.3.4. Visualization of cell focal adhesion points and cytoskeleton ............149 
5.3.5. Differentiation of pulmonary epithelial progenitors from murine 
embryonic stem cells on peptide-grafted PDLLA .................................................154 
5.4. Discussion......................................................................................................156 
5.5. Conclusion ....................................................................................................159 
CHAPTER 6. FUNCTIONALIZED POLY(D,L-LACTIDE) FOR PULMONARY 
EPITHELIAL CELL CULTURE....................................................................160 
6.1. Introduction..................................................................................................160 
6.2. Methodology .................................................................................................162 
6.3. Results ...........................................................................................................163 
6.3.1. Quantification of primary amine functional groups using fluorescamine 
assay ………………………………………………………………………163 
6.3.2. Surface composition of modified PDLLA: X-ray photoelectron 
spectroscopy (XPS)................................................................................................164 
6.3.3. Wettability of wet PDLLA surfaces: dynamic contact angles ...........164 
6.3.4. Surface topography and roughness of modified PDLLA: Atomic Force 
Microscopy (AFM) ................................................................................................165 
6.3.5. Surface character of modified PDLLA: ζ-potential measurements...167 
6.3.6. Determination of cell attachment using the Hoechst 33258 dye .......168 
6.3.7. Visualization of cell focal adhesion and cytoskeleton .......................169 
6.3.8. A549 cell activity and number on days 2 and 4.................................174 
 9
6.4. Discussion......................................................................................................176 
6.5. Conclusion ....................................................................................................181 
CHAPTER 7. PREPARATION AND MODIFICATION OF 
POLY(D,L-LACTIDE) SCAFFOLDS FOR PULMONARY EPITHELIAL CELL 
CULTURE…………………………………......................................................183 
7.1. Introduction..................................................................................................183 
7.2. Methodology .................................................................................................186 
7.3. Results ...........................................................................................................186 
7.3.1. Morphological analysis of the scaffolds ............................................186 
7.3.2. Penetration of A549 cells cultured on unmodified PDLLA scaffolds 
evaluated using fluorescence microscopy..............................................................193 
7.3.3. Penetration of A549 cells cultured on unmodified PDLLA scaffolds 
evaluated using scanning electron microscopy (SEM)..........................................194 
7.3.4. A549 cell activity on the unmodified PDLLA scaffolds....................195 
7.3.5. A549 activity on the modified PDLLA scaffolds ..............................197 
7.4. Discussion......................................................................................................197 
7.5. Conclusion ....................................................................................................202 
CHAPTER 8. CONCLUSIONS AND FUTURE WORK.............................203 
8.1. Summary and conclusions...........................................................................203 
8.2. Suggestions for future work ........................................................................206 
REFERENCES ............................................................................................210 
Appendix A Step by Step experimental protocol…………………………………230 
A1. Protocols for immunostaining..................................................230 
Appendix B Supplementary results ........................................................................231 
B1. Determination of optimal cycle number for conventional PCR
 ………………………………………………………………..231 
B2. Optimization of reaction concentration of murine SPC primers 
for real-time PCR...............................................................................233 
B3. Standard curve for fluorescamine assay...................................234 
B4. Standard curve for DNA quantity determination using Hoechst 
33258..................................................................................................235 
 
 10
List of Figures 
Figure 1-1 Molecular structure of laminins 1 (Laminin 111) and 5 (Laminin 332), 
adapted from [97]. All laminins are composed of variations of α,β and γ 
chains. ........................................................................................................39 
Figure 1-2 Molecular structure of fibronectin, adapted from [101].............................40 
Figure 1-3 Stereoforms of lactide. Adapted from [146]...............................................48 
Figure 1-4 Critical thickness of degradable polymers above which polymers 
undergo surface erosion [161]....................................................................50 
Figure 1-5 Gibbs free energy of mixing mixGΔ  as the function of 1X . Adapted 
from [184]. .................................................................................................55 
Figure 1-6 Thermal-induced phase separation with various polymer concentrations. 
Modified from [186]. .................................................................................57 
Figure 1-7 Graphical representation of Young’s equation ...........................................59 
Figure 1-8 Schematic representation of the electrochemical double layer model 
according to the Gouy, Chapman, Stern and Grahame model (redrawn 
from [202]). The adsorbed ions in the inner Helmhotz plane are partially 
dehydrated..................................................................................................61 
Figure 1-9 Schematic representation of the measurement cell of the streaming 
potential......................................................................................................61 
Figure 2-1 Light microscopic image of undifferentiated mESCs captured using an 
inverted microscopy (IX70, Olympus, Southall, UK). Scale bar 
indicates 200 μm. A bright rim is indicative of an undifferentiated cell. 
Cells with processes are either starting to differentiate or have already 
differentiated. .............................................................................................66 
Figure 2-2 Light microscopic image of EBs three days after their formation 
captured using an inverted microscope (IX70, Olympus, Southall, UK). 
Scale bar indicates 500 μm. Variations in the sizes of the EBs can be 
observed. ....................................................................................................67 
Figure 2-3 The original 3 step differentiation of mESCs to pulmonary progenitors ...68 
Figure 2-4 The differentiation protocol. Three differentiation media were used 
during pulmonary epithelial differentiation. ..............................................69 
Figure 2-5 Transient and stable EGFP expression of A549 cells captured using an 
inverted microscope (IX70, Olympus, Southall, UK) equipped with a 
 11
fluorescence source (excitement wavelength 395nm). ..............................72 
Figure 2-6 Applied gates for the flow cytometry of the SPC-eGFP positive cells. 
Left: debris was excluded through gate 1. Middle: a gate was applied to 
select PI negative cells in FL3 channel (red). Right: a gate was applied in 
the FL1 channel (green) to make 0.05% of the negative control scores 
positive. ......................................................................................................80 
Figure 2-7 Applied gates for the flow cytometry of the TTF-1 positive cells. Left: 
debris was excluded to gate 1. Right: a gate applied in the FL1 channel 
(green) to make 0.1% of the negative control scores positive ...................81 
Figure 2-8 The setup of the custom-made freeze-dryer. (1) lyophilization flask, (2) 
cold trap, (3) liquid nitrogen tank, (4) connection to the pump, (5) 
ethylene glycol antifreeze agent bath, (6) ethylene glycol pumped to the 
thermostat to maintain the temperature (7) ethylene glycol pumped from 
the thermostat.............................................................................................84 
Figure 2-9 Aminolysis reaction scheme of polyesters. Primary amines can break the 
ester bonds to form amide groups. .............................................................87 
Figure 2-10 Chemicals used to introduce branched architectures to the surface of 
PDLLA films and scaffolds........................................................................88 
Figure 2-11 Schematic of the reaction of EDC and NHS. EDC can react with 
carboxylic acid to form an unstable amine-reactive O-acylisourea 
intermediate which can reactive with amine to form a stable amide bond, 
or hydrolysed by water to regenerative the carboxylic acid, or reactive 
with NHS to form a semi-stable amine-reactive NHS-ester. Comparing 
to O-acylisourea which has a life time of only a few minutes, NHS-ester 
have a life time for several hours in aquous solution and for several 
months when samples are stored in a dry environment, therefore it is 
more suitable to further react with primary amines to form an amide 
bond ([213]). ..............................................................................................89 
Figure 2-12 Reaction scheme used to prepare the 2 branched architectures (bTREN 
and bADA). Reaction 1: succinic acid activated by EDC and NHS was 
grafted to 4%EDiamine. Carboxylic acid (circled by dashed line) 
indicates a site of possible reaction to the adjacent surface amine. Then 
TREN (reaction 2) or ADA (reaction 3) was grafted to the grafted 
succinic acid. Amines (circled by dashed line) in reaction 2 indicate 
 12
possible reaction sites to adjacent carboxylic acid of grafted succinic 
acid. Reaction 4: GABA was grafted to ADA. Reaction 5: ADA was 
grafted to GABA........................................................................................91 
Figure 2-13 Structures of peptides RGD and YIGSR. Amines circled by dashed 
lines are the locations where conjugations occur. ......................................93 
Figure 2-14 Schematic of the peptide grafting reactions. The primary amines on the 
PDLLA were introduced by aminolysis using 4% ethylenediamine in 
isopropanol for 5 min prior to the grafting reaction. .................................93 
Figure 2-15 Fluorescamine reacts with primary amine groups to form primary 
amine adducts which absorb light at 390 nm, and emit light at 475 nm....96 
Figure 2-16 Removal of the air trapped within the scaffolds by negative pressure 
applied to the vacuum desiccator...............................................................98 
Figure 3-1 A-C: left: immunostaining of cryosectioned EBs at the end of day 10, 
right: the negative control of each antibody. (A) Foxa2-immunoreactive 
cells (red) lying around the border of the cell cluster. (B) 
TTF1-immunoreactive cells (red). Positive cells are also seen at the 
periphery of the EB but in lower numbers than those expressing Foxa2. 
(C) Immunoreactiovity for laminin (red) appears to form a layer under 
the outermost ring of cells. Nuclei (blue) stained with DAPI in all cases. 
D-K: left: SPC-eGFP positive cells at the end of day 21; middle: 
transmitted light photograph of the same field; right: the overlay of 
fluorescence images and transmitted light photograph. Transcription of 
the SPC gene, and therefore differentiation of pulmonary progenitors, 
was demonstrated by SPC-eGFP fluorescence (green) in differentiating 
EBs grown on (D) TCP-GN; (E) TCP-CO; (F) TCP-LN; (G) TCP-FN; 
(H) TCP-ML; (I) PDLLA-GN; (J) PDLLA-LN; (K) PDLLA-ML. More 
than 4 images of independent samples from the same conditions were 
analyzed. ..................................................................................................108 
Figure 3-2 Microscopic images taken at the end of day 28 differentiaiton. (A) Left: 
transmitted light photograph of TCP-GN. Right: Green fluorescence 
channel from the same sample. (B) Left: transmitted light photograph of 
PDLLA-LN. Right: Green fluorescence channel from the same sample. 
Strong autofluorescence was observed from the green fluorescence 
channel, obscuring the SPC-eGFP positive cells. ....................................109 
 13
Figure 3-3 Results of RT-PCR analysis of mRNA expression profiles of 
differentiated cells grown on coated (A) TCP and (B) PDLLA at the end 
of day 28 differentiation. Expression of markers for type I (aquaporin 5) 
and type II (SPC, SPD) pneumocytes was seen in EBs grown on TCP 
coated with GN, CO or LN but the strongest expression occurred in EBs 
grown on LN-coated PDLLA. The symbol – stands for negative control. 
The symbol + stands for positive control, which used cDNA from 
MLE-12 cells, an immortalized murine lung epithelial cell line. ............ 110 
Figure 3-4 (A-B) Results of WST-1 assay of cell activity. The activity of cells on 
ECM-coated TCP or PDLLA were found to increase slightly from day 
11 to day 20. A different pattern was noted after day 20 when the overall 
cell activities on ECM-coated TCP stayed at the same level (day 20-24) 
then fell (day 24-28) while those on ECM-coated PDLLA stayed or fell 
(day 20-24), and recovered (day 24-28). 5 independent samples in each 
condition were evaluated. The WST-1 experiments were repeated for 3 
times. C-J: Light microscopy of cells growing on ECM-coated TCP and 
PDLLA at the end of day 12. Cells are shown growing on (C) TCP-GN; 
(D) TCP-CO; (E) TCP-LN; (F) TCP-FN; (G) TCP-ML; (H) 
PDLLA-GN; (I) PDLLA-LN and (J) PDLLA-ML. On PDLLA, cells 
were seen to extend from EBs to the greatest extent when grown on 
Matrigel-coated PDLLA film (J). Scale bar corresponds to 500µm........ 113 
Figure 3-5 Light (A) and fluorescence (B) microscopic images of mESCs 
differentiated on TCP-LN at the end of day 28. Many vacuolated cells 
(arrows) can be observed under light microscopy (A). The vacuolated 
cells are either dying or dead. Strong auto-fluorescence from the cells 
could be observed on fluorescence microscopy....................................... 114 
Figure 3-6 Flow cytometry of SPC-EGFP-expressing cells performed at the end of 
day 28. (A) Gating was done to exclude small cell debris in the low 
forward scattering region. (B) Propidium iodide was used to rule out 
necrotic cells which have around 100 times higher fluorescence level in 
the FL3 channel. Necrotic cells were often found in the terminal 
differentiation culture, especially in the middle of adherent EBs. The 
peak in the high FL3-H region stood for the PI that binded to the DNA of 
dead cells (C) A threshold was set in the green fluorescence channel FL1 
 14
of the negative control of flow cytometry (non-SPC-eGFP-transfected 
mESCs differentiated in parallel with the transfected mESCs). (D) The 
percentage of SPC-eGFP-positive cells cultured on protein-coated TCP 
was compared with cells grown on the control (TCP-GN). (E) The 
percentage of SPC-eGFP-positive cells cultured on protein-coated 
PDLLA was compared with cells grown on the control (PDLLA-GN). 
The numbers shown in each column stand for the percentage of 
SPC-eGFP positive cells of the whole population. Asterisks specify 
statistically significant difference from value of control (TCP-GN and 
PDLLA-GN) (P<0.05). 4 independent samples in each condition were 
evaluated. The flow cytometry were performed for 3 times.................... 115 
Figure 3-7 ζ-potentials of TCP and protein-coated TCP (A) as well as PDLLA and 
protein-coated PDLLA (B) measured as function of pH in 0.1 mM KCl 
supporting electrolyte. All protein-coatings on both TCP and PDLLA, 
except TCP-FN, were found to reduce surface acidity as shown by the 
IEP for each (pH at zero potential [0mV]). 2 independent samples in 
each condition were evaluated. The ζ-potential measurements were 
repeated for 3 times.................................................................................. 118 
Figure 4-1 Expression of mRNAs of the endoderm markers, SOX17 and Foxa2, as 
well as the mesoderm marker, Brachyury, of differentiating mESCs at 
the end of day 14. Sample A was supplemented with 500 ng/ml FGF-1, 
B with1000 ng/ml FGF-1, C 100 ng/ml FGF-2, D 500 ng/ml FGF-2 and 
E 500 ng/ml FGF-1+100 ng/ml FGF-2. All of the FGFs were added 
between days 11-14. 4 independent samples in each condition were 
evaluated. The quantitative PCR measurements were repeated twice.....127 
Figure 4-2 (A) Results of conventional PCR of cells in group 1 and (B) quantitative 
PCR of SPC mRNA of sample 1-1 (control), 1-2 (500 ng/ml FGF-1) and 
1-3 (1000 ng/ml FGF-1) at the end of day 28. * Indicates significant 
difference from control values (P<0.05). More than 3 independent 
samples in each condition were evaluated. The quantitative PCR 
measurements were repeated 3 times.......................................................128 
Figure 4-3 (A)SPC mRNA expression of FGF-10 treated cells measured by 
conventional PCR using GAPDH as the housekeeping gene (B)Relative 
 15
SPC mRNA expression of the same cells measured by realtime PCR. 
Both measurements were performed at the end of day 28 differentiation. 
FGF-10 at 20 ng/ml to 200 ng/ml was added to the culture medium 
during either days 11-14 or days 15-18. No treated samples 
demonstrated a SPC expression level different from that of the control. 4 
independent samples in each condition were evaluated. Both 
conventional PCR and quantitative PCR measurements were repeated 
twice. ........................................................................................................130 
Figure 4-4 (A) Conventional PCR measurement of mRNAs in FGF-10 treated cells 
cultured on gelatin-coated or Matrigel-coated tissue culture plates (B) 
SPC mRNA expression of the FGF-10 treated cells cultured on gelatin 
coating measured by realtime PCR (C) SPC expression of the FGF-10 
treated cells cultured on Matrigel coating measured by realtime PCR (D) 
Relative SPC expression of the FGF-7 treated cells cultured on Matrigel 
coating measured by realtime PCR. All measurements were performed 
at the end of day 28 differentiation. In (B), (C) and (D), 4 independent 
samples in each condition were evaluated. The quantitative PCR 
measurements were repeated 3 times.......................................................131 
Figure 4-5 (A1) TTF-1-immunoreactive cells (green) at the end of day 14 
differentiation culture. (A2) The same field showing the DAPI-stained 
cell nuclei. The overlay of (A1) and (A2) was shown in (A3). (B) The 
negative control of TTF-1 staining. (C1) SPC-eGFP positive cells of day 
21 differentiation culture. (C2) The same field as C1 combined with 
light microscopy image. (D) SPC-eGFP-positive cells of adherent EBs 
prepared by cryosection at the end of day 21. (E) Confocal laser 
microscopy image of SPC-eGFP cells at the end day 21.........................133 
Figure 4-6 Flow cytometry of TTF-1-immunoreactive cells performed at the end of 
day 14. Figures (A) and (B) showed negative controls for flow 
cytometry ( experimental control stained without 1st layer antibodies). 
In (A), a size gate was applied exclude the cell debris. (B) A threshold 
was defined to score 0.1% of cells positive. The gating of both (A) and 
(B) were applied to all other samples. Figures (C) to (H) represented 
samples stained with TTF-1 antibodies. (C) sample 1-1, the 
experimental control (no FGF supplement was added during 
 16
differentiation). The outline of the histogram of the experimental control, 
as demonstrated in (C), were illustrated in (D-H) for better 
understanding of the peak shift. (D)  sample 1-2 (500 ng/ml FGF-1) (E) 
sample 1-3 (1000 ng/ml FGF-1) (F) sample 1-4 (100 ng/ml FGF-2) (G) 
sample 1-5 (500 ng/ml FGF-2) (H) sample 1-6 (500 ng/ml FGF-1+100 
ng/ml FGF-2). Four independent samples in each condition were 
evaluated. .................................................................................................135 
Figure 5-1 Structures of RGD and YIGSR peptides. Amines circled by dashed lines 
are the locations where anchoring to PDLLA by EDC occured. .............142 
Figure 5-2 Dynamic (advancing and receding) captive bubble water contact angles 
on PDLLA, TCP and surface-treated PDLLA films (n=6). The 
advancing and receding contact angles of all surface-modified PDLLA 
samples were significantly lower than PDLLA (P<0.005). + and ++ 
stand for significant difference between peptide-grafted surfaces and 
TCP (+ for P<0.05; ++ for P<0.005). The water contact angle 
measurements were repeated 3 times.......................................................145 
Figure 5-3 Cell attachment 2 h after seeding was evaluated by determining the total 
DNA content of the attached cells using Hoechst dye (n = 6 for all 
samples). * and ** stand for significant difference bewtween 
peptide-grafted surfaces and PDLLA (* for P<0.05; ** for P<0.005). + 
and ++ stand for significant difference between peptide-grafted surfaces 
and TCP (+ for P<0.05; ++ for P<0.005). The cell attachment 
experiments were repeated 3 times. .........................................................147 
Figure 5-4 WST-1 assay of A549 cell activity at day 2 and day 4 (n = 6 for all 
samples). * and ** stand for significant difference bewtween 
peptide-grafted surfaces and PDLLA (* for P<0.05; ** for P<0.005). + 
and ++ stand for significant difference between peptide-grafted surfaces 
and TCP (+ for P<0.05; ++ for P<0.005). The WST-1 assay was repeated 
3 times. .....................................................................................................148 
Figure 5-5 Population of A549 cells at day 2 and day 4 was evaluated by the total 
DNA content using Hoechst dye (n = 6 for all samples). * and ** stand 
for significant difference bewtween peptide-grafted surfaces and 
PDLLA (* for P<0.05; ** for P<0.005). + and ++ stand for significant 
difference between peptide-grafted surfaces and TCP (+ for P<0.05; ++ 
 17
for P<0.005). The evaluation of cell population using Hoschst dye was 
repeated 3 times. ......................................................................................149 
Figure 5-6 Immunostaining of vinculin and labelling of F-actin in A549 cells 
cultured on TCP, PDLLA and peptide-grafted surfaces for 24 h. The left 
panel shows vinculin, and the right column shows F-actin. In the left 
panel, arrows indicate vinculin with “spindle” shape. In the right panel, 
arrows indicated strong F-actin within the cytoplasm. Image (A) to (H) 
stood for: (A) TCP,  (B) PDLLA, (C) Negative control for vinculin 
staining,  (D) 100RGD-0YIGSR, (E) 75RGD-25YIGSR, (F) 
50RGD-50YIGSR, (G) 25RGD-75YIGSR, (H) 0RGD-100YIGSR. ......153 
Figure 5-7  SPC-eGFP-positive pulmonary epithelial progenitors were 
differentiated from mESCs for 28 days on (A) gelatin-coated PDLLA 
film, (B) 100RGD-0YIGSR, (C) 50RGD-100YIGSR and (D) 
0RGD-100YIGSR. (E) The relative levels of SPC mRNA expression of 
the mEScs differentiated on peptide-grafted PDLLA films compared 
with the SPC mRNA expression of cells differentiated on the 
experimental control, gelatin-coated PDLLA films (* P<0.05; ** 
P<0.005). 4 independent samples in each condition were evaluated. The 
quantitative PCR were repeated twice due to the time limit....................155 
Figure 6-1 Schematic diagram showing aminolysis of polyesters by 
transesterification using ethylenediamine................................................162 
Figure 6-2 Effect of ethylenediamine concentration in isopropanol on fluorescence 
intensity and the corresponding quantitiy of primary amine introduced 
to PDLLA films. 4 independent samples in each condition were 
evaluated. The fluorescamine assay were repeated 3 times.....................163 
Figure 6-3 Dynamic water contact angles on PDLLA, TCP and modified PDLLA 
films measured using the captive bubble technique. The advancing and 
receding contact angles of all modified PDLLA were significantly lower 
than PDLLA (P<0.005, n = 4). The water contact angle measurements 
were repeated 3 times...............................................................................165 
Figure 6-4 AFM scans of unmodified and modified PDLLA films. An area of 1μm x 
1μm was imaged. (A) unmodified PDLLA film and aminolysed PDLLA 
films, (B) PDLLA films grafted with branched architectures..................166 
Figure 6-5 ζ-potential of PDLLA films, 4%EDiamine, bTREN3 and bADA3 films 
 18
measured as a function of pH in a 1mM KCl supporting electrolyte. 4 
independent samples in each condition were evaluated. The ζ-potential 
measurements were repeated 3 times.......................................................168 
Figure 6-6 A549 cell attachment was evaluated by measuring the total DNA 
content of the attached cells 2 h after being seeded using Hoechst dye (n 
= 6 for all samples). * and ** stand for significant difference bewtween 
functionalized surfaces and PDLLA (* for P<0.05; ** for P<0.005). + 
and ++ stand for significant difference between functionalized surfaces 
and TCP (+ for P<0.05; ++ for P<0.005). The cell attachment 
experiments were repeated 3 times. .........................................................169 
Figure 6-7 Immunostaining of vinculin (left panel) and F-actin (right panel) in 
A549 cells cultured on PDLLA, TCP and aminolysed PDLLA films 
after 24 h in culture. Four independent samples of each condition were 
recorded. Vinculin immunoreactivity can be seen at the end of some cell 
processes, but no immunoreactive “spindle-like” structures were seen. 
F-actins stained by phalloidin were not distinct in the most cells cultured 
on these surfaces for 24h..........................................................................172 
Figure 6-8 Immunostaining of vinculin (left panel) and F-actin (right panel) in 
A549 cells cultured on PDLLA films with branched architectures after 
24 h in culture. In the left panel, arrows indicate 
vinculin-immunostained structures with spindle shape. Weak 
vinculin-immunoreactive spindle-like structures were seen in the cells 
cultured on bTREN samples. ...................................................................174 
Figure 6-9 Activity of A549 cells on day 2 and day 4 as determined using WST-1 
assay (n = 6 for all samples). * and ** stand for significant difference 
bewtween functionalized surfaces and PDLLA (* for P<0.05; ** for 
P<0.005). + and ++ stand for significant difference between 
functionalized surfaces and TCP (+ for P<0.05; ++ for P<0.005). The 
WST-1 assay were repeated 3 times. .......................................................175 
Figure 6-10 Population of A549 cells on day 2 and day 4 evaluated by total DNA 
content using Hoechst dye (n = 6 for all samples). * and ** stand for 
significant difference bewtween functionalized surfaces and PDLLA (* 
for P<0.05; ** for P<0.005). + and ++ stand for significant difference 
between functionalized surfaces and TCP (+ for P<0.05; ++ for 
 19
P<0.005). The evaluation of cell population using Hoschst dye was 
repeated 3 times. ......................................................................................176 
Figure 7-1 Scanning electron micrographs of PDLLA scaffolds prepared by 
liquid-liquid phase separation using a coarsening temperature of 24℃ 
and increasing coarsening times (group1): (A) no coarsening was 
performed (LL0M); (B) coarsening for 10 min (LL10M); (C) coarsening 
for 20 min (LL20M); (D) coarsening for 30 min (LL30M); (E) 
coarsening for 60 min (LL60M). All figures are at 50x magnification. ..187 
Figure 7-2 The effect of coarsening time on the mean pore size. The error bar 
indicates the standard deviation. The pore sizes of scaffolds prepared 
using different coarsening time are significantly different to each other 
(In each condition, 6 independent samples were imaged. More than 80 
pores in each image were measured. SEM probing was repeated twice).188 
Figure 7-3 Scaffolds prepared by liquid-liquid phase separation using a coarsening 
temperature of 24℃ and increasing coarsening times (0 min, 10 min, 20 
min and 30 min). From left to right: LL0M, LL10M, LL20M, LL30M, 
LL60M. ....................................................................................................188 
Figure 7-4 Scanning electron micrographs of scaffolds prepared by liquid-liquid 
phase separation using a temperature of 24℃. A1: LL20M at x200 
magnification. A2 is an enlargement of the white square shown in A1 at 
x500 magnification. A3 is an enlargement of the white square in A2 at 
x1000 magnification. B: LL30M at x200 magnification. The arrows 
indicate small pore throats at 10 μm to 20 μm scale. The dotted line 
indicates a large pore throat more than 50 μm in diameter. .....................189 
Figure 7-5 Scanning electron micrographs of scaffolds prepared by liquid-liquid 
phase separation using different coarsening temperatures (group 2): (A) 
coarsening at 27 ℃ for 30 min; (B) coarsening at 24 ℃ for 30 min; (C) 
coarsening at 21 ℃ for 30 min; (D) coarsening at 18 ℃ for 30 min (E); 
coarsening at 15 ℃ for 30 min; (F) coarsening at 12 ℃ for 30 min.. ...191 
Figure 7-6 The effect of coarsening temperature on pore size. The error bar 
indicates standard deviation from the mean (In each condition, 6 
independent samples were imaged. More than 40 pores in each image 
were measured. SEM probing was repeated twice). ................................192 
 20
Figure 7-7 Scanning electron micrographs of scaffolds prepared by solid-liquid 
phase separation (Group 3): 5% (w/v) PDLLA was dissolved in DMC 
and frozen at -25℃ (SL-25C) or snap-frozen -196℃ (SL-196C) for 2 h 
(A) scaffold SL-25C sectioned along the direction of the laminated 
pores (B) scaffold SL-25C sectioned transverse to the direction of the 
laminated pores, (C) scaffold SL-196C, sectioned along the direction of 
the laminated pores, (D) scaffold SL-196C sectioned transverse to the 
direction of the laminated pores...............................................................193 
Figure 7-8 Fluorescent microscope images of A549 cells cultured on scaffolds 
prepared using liquid-liquid phase separation with coarsening 
temperature from 27℃ to 12℃ for 30 min (A-F) and solid-liquid phase 
separation with freezing temperature of -196℃ (G) and -25℃ (H), 
including (A) LL27C, (B) LL24C, (C) LL21C, (D) LL18C, (E) LL15C, 
(F) LL12C, (G) SL-196C and (H) SL-25C, after 16 d of culture. The 
scaffolds were sectioned along the direction of A549 seeding. (A), (B) 
and (H) showed the border of sectioned scaffolds, because cells were not 
found in the middle area of the sections. (C-G) showed the middle area 
of the sectioned scaffolds. (I) The LL27C without cells did not emit 
detectable fluorescence, but they scattered the fluorescence emitted by 
the A549 cells as shown in (C-G), resulting the obscurity of the some 
images. .....................................................................................................194 
Figure 7-9 Scanning electron micrographs of A549 cells (arrows) cultured for 16 d 
on the surface of scaffolds A: LL27C, B: LL24C, C: LL21C, D: LL18C, 
E: LL15C, F: LL12C, G: SL-196C, H: SL-25C. .....................................195 
Figure 7-10 Activity of A549 cells cultured on scaffolds prepared by liquid-liquid 
and solid-liquid phase separation at day 4, 8, 12, 16. Statistical analysis 
of A549 cell activity on different scaffolds on day 16 was performed (n 
= 6). The WST-1 assay was repeated 3 times. The absorbance of the 
WST-1 reagent presented in this figure was the absorbance of each 
sample minus the background absorbance (WST-1 reagent added to 
empty wells containing no cells)..............................................................196 
Figure 7-11 Activities of A549 cells cultured on surface-modified scaffold SL-25C 
at day 4, 8, 12 and 16. Asterisks * indicates for P<0.05 and ** for 
 21
P<0.005 (n = 6). The WST-1 assay was repeated 3 times........................197 
Figure A-1 Saturation curve of albumin primer.........................................................231 
Figure A-2 Saturation curve of aquaporin 5 primer...................................................231 
Figure A-3 Saturation curve of β-actin primer...........................................................232 
Figure A-4 Saturation curve of CC10 primer ............................................................232 
Figure A-5 Saturation curve of GAPDH primer ........................................................232 
Figure A-6 Saturation curve of SPC primer...............................................................233 
Figure A-7 Saturation curve of SPD primer ..............................................................233 
Figure A-8 Standard curve of ethylenediamine solution diluted in acetone at 
different concentrations............................................................................235 
Figure A-9 Standard curve of DNA quantity determination using Hoechst 33258 ...235 
 
 22
List of Tables 
Table 1-1 Characteristics of type II pneumocytes (adapted and modified from [56])
......................................................................................................................34 
Table 1-2 Characteristics and molecular control of lung development, adapted and 
modified from [68].......................................................................................36 
Table 1-3 Composition effects of ECM on morphology and metabolic activities of 
type II pneumocytes, adapted from [94]. ND, no significant difference; ↑, 
increase with time in culture; ↓, decrease with time in culture; + increase 
compared to tissue culture plastic; -, decrease compared with TCP............44 
Table 2-1 The polymer substrate and coating of the 6 well-plate used for 
differentiation culture...................................................................................69 
Table 2-2 Conditions used for periods A and B. The differentiation medium C in this 
table is that shown in Figure 2-4..................................................................70 
Table 2-3 The primers and the corresponding reaction conditions of conventional 
PCR reactions...............................................................................................75 
Table 2-4 The primers and conditions of realtime PCR reactions ...............................77 
Table 2-5 Details of antibodies ....................................................................................79 
Table 2-6 Scaffolds prepared by various methods .......................................................82 
Table 2-7 The sequence of reactions (for Figure 2-12) for the preparation of 
branched architectures .................................................................................92 
Table 3-1 Water contact angles of TCP- and PDLLA-coated with/without ECM 
proteins....................................................................................................... 118 
Table 5-1 Roughness parameter (Ra) of PDLLA and surface-modified samples. All 
samples have Ra larger than PDLLA with P<0.005...................................146 
Table 6-1 Surface composition of modified PDLLA as determined by XPS ............164 
Table 6-2 Roughness parameter (Ra) of original PDLLA and modified samples 
(units: nm)..................................................................................................167 
Table A-1 Optimzation of the reaction concentration of four differnt pairs of murine 
SPC primer.................................................................................................234 
Table A-2 Four pairs of primers designed using primer 3 software...........................234 
 
 23
Abbreviations 
ADA N-(2-acetamido) iminodiacetic acid 
bADA 
PDLLA film (Chapter 6) or PDLLA scaffold (Chapter 7) 
that possessed carboxylic acid-terminated branched 
architectures 
bADAn bADA that have up to n generations of branched 
architectures, n can be 1, 2, or 3  
bTREN PDLLA film (Chapter 6) or PDLLA scaffold (Chapter 7) 
that possessed amine-terminated branched architectures 
bTRENn bTREN that have up to n generations of branched 
architectures, n can be 1, 2, or 3 
BSA Bovine serum albumin 
CC-10 Clara cell-associated protein 10 
CCD Charge-coupled device 
cDNA Complementary DNA 
CO Collagen 
DCC N,N'-dicyclohexylcarbodiimide 
DIC N,N'-diisopropylcarbodiimide 
DMC Dimethyl carbonate 
DMEM Dulbecco’s Modified Eagle’s Medium 
DMSO Dimethyl sulfoxide 
EB Embryoid body 
ECM Extracellular matrix 
EDC 1-Ethyl-3-[3-dimethylaminopropyl]carbodiimide 
EGF Epidermal growth factor 
EHS Engelbreth-Holm-Swarm (sarcoma) 
ESC Embryonic stem cell 
ESCA Electron spectroscopy for chemical analysis 
FBS Fetal bovine serum 
FGF Fibroblast growth factor 
FGF-1 Fibroblast growth factor 1 (also known as acidic FGF) 
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coarsening temperature at 24℃ for 0 min 
LL10M 
Scaffolds prepared using liquid-liquid phase separation at 
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LL20M Scaffolds prepared using liquid-liquid phase separation 
with coarsening temperature at 24℃ for 20 min 
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XPS X-ray photoelectron spectroscopy  
YIGSR Peptide composed of 
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25RGD-75YIGSR 
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50RGD-50YIGSR 
PDLLA film grafted with bioactive peptide using peptide 
solution composed of 50 % RGD and 50 % YIGSR 
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PDLLA film grafted with bioactive peptide using peptide 
solution composed of 75 % RGD and 25 % YIGSR 
100RGD-0YIGSR 
PDLLA film grafted with bioactive peptide using peptide 
solution composed of 100 % RGD and 0 % YIGSR 
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Chapter 1. Introduction 
1.1. Objective and scope of this thesis 
Pulmonary disease is a major cause of morbidity and mortality in the world. For end 
stage pulmonary diseases, such as chronic obstructive pulmonary disease (COPD), 
emphysema, idiopathic pulmonary fibrosis, cystic fibrosis and primary pulmonary 
arterial hypertension, there is no effective medical treatment except lung 
transplantation. In 2005, the global reported number of lung transplants reached an all 
time high of 2169 [2], even so the availability of donor lungs is very limited. In 2006, 
patients with severe pulmonary disease had to wait an average of 132 days for a 
suitable lung [3]. For transplanted patients, a big challenge to their long-term survival 
is immune rejection of the transplant. From 1992 to 2006, approximately 10 % of 
transplanted patients died due to acute rejection of the transplanted organ, despite 
receiving immunosuppressive treatments [2].  
 
Tissue engineering is a multidisciplinary science which aims to overcome the 
limitations of conventional therapies by the ‘application of the principles and methods 
of engineering and life sciences towards the fundamental understanding of 
structure-function relationships in normal and pathological mammalian tissues and 
the development of biological substitutes that restore, maintain or improve tissue 
function’ [4]. In addition to the general understanding of delivery of immunologically 
tolerant tissue substitutes into the human body, tissue engineering also involves the 
understanding of in vitro, in vivo and ex vivo cell-environment behaviour in an 
engineered and biological manner. A large number of review papers [5-7] and 
textbooks [8, 9] has been published in recent years, covering the basis and principles 
of tissue engineering. In a nutshell, three approaches are commonly used in tissue 
engineering:  
1. Growth of human tissues in vitro for later implantation into the body to restore 
injured tissues.  
2. Implantation of cell-loaded or cell-free biodegradable constructs to enhance the 
regeneration and repair of human tissues. The former is a scaffold loaded with target 
cells whilst the latter is a bioactive material that can enhance the tissue repair.  
3. Design of external or internal cell-containing devices that can augment the 
physiological function of the impaired organs. 
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In terms of engineering lung tissue, restoration of the gas-exchange function would be 
critical. The units of the lung where gas-exchange occurs, the alveoli, are lined by two 
types of endoderm-derived epithelial cells termed pneumocytes; gas exchange occurs 
across type I pneumocytes while type II cells secrete surfactant that maintains the 
patency of the distal airways. In addition, when type I cells are injured, type II cells 
proliferate and transdifferentiate into type I cells to restore the type I population. At 
present, it is very difficult to obtain pure populations of primary type II pneumocytes 
and it is not possible to maintain their phenotype for a long time in vitro [10]. This 
makes the scale-up of type II pneumocytes in vitro for potential therapeutic 
applications very difficult. 
 
Stem cells hold the promise as cell sources for many of the approaches of tissue 
engineering and regenerative medicine in general. Stem cells are defined as 
clonogenic cells capable of self-renewal and multilineage differentiation [11]. Since 
the derivation of human embryonic stem cells (hESCs) in 1998 [12], stem cell 
research has attracted a lot of attention from various research institutes and funding 
bodies [13-15]. Many cell types, such as osteoblasts, cardiomyocytes and hepatocytes, 
have been successfully differentiated from ESCs. Colleagues in the Stem Cells and 
Regenerative Medicine group at Imperial College have successfully differentiated 
type II pulmonary epithelial cells and their progenitors from murine embryonic stem 
cells (mESCs) using soluble factors [16], reprogramming of mESCs with cell extracts 
[17] or co-culture with pulmonary mesenchyme [18], although only 2 - 10 % of type 
II cells could be acquired. The first aim of this project, therefore, was to increase 
the differentiation efficiency of type II pneumocyte progenitors from mESCs by 
enhancing the established differentiation protocol. To achieve this, extracellular 
matrix (ECM) proteins and fibroblast growth factors (FGFs) were introduced to the 
culture system during the differentiation of mESCs. ECM is the extracellular part of 
the animal tissue and can provide structure support and other physiological functions. 
FGFs are a family of growth factors that are heavily involved in the development of 
the vertebrate embryonic development. Both extracellular matrix (ECM) proteins and 
FGFs are important factors in the development of embryonic lung. 
 
Cells can not be delivered as a whole into the host body with sufficient mechanical 
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integrity and adequate physiological activity if they are not cultured on a biomaterial 
support [19]. The biomaterial supports, which should fulfil several very stringent 
requirements [5], are called scaffolds. Throughout this thesis, PDLLA, a widely-used 
biocompatible and biodegradable polymer, was used to construct 2D environments 
and 3D scaffolds. The mechanical properties of porous PDLLA scaffolds can be 
tailored to meet the requirements of various tissue engineering applications [20]. Once 
the cells are seeded onto a scaffold, factors such as surface topography, surface 
chemistry and the porous structure of the scaffold affect cell attachment, growth and 
differentiation [21]. Thus, the second aim of this project was to develop 2D 
environments and 3D scaffolds made of poly(D,L-lactide) (PDLLA) suitable for the 
culture of pulmonary epithelial cells.  
 
It is possible to modify the surface of a scaffold to improve its interaction with a 
specific cell type. Strategies to achieve this goal include the introduction of cell 
recognition ligands for a specific cell type or the introduction functional groups [10, 
22-41]. Cell recognition ligands can be found in the ECM. Coating the scaffold 
surface with a thin layer of ECM protein(s) thus can introduce cell recognition ligands 
to the biomaterial surface. Furthermore, given the problems associated with the high 
cost and immunogenicity of ECM proteins, peptides that contain the sequence of cell 
recognition ligands of ECM have been grafted to the surface of scaffolds [23-30]. 
Surface modification of PDLLA scaffolds has been carried out to provide appropriate 
functional groups for various cell types [31, 34-36, 40, 41], e.g. attachment of 
MC3T3-E1 osteoblast–like cells was 2.5 fold greater on thiol-functionalised surfaces 
compared with amine-functionalised surfaces. Both strategies were applied in the 
present study for the culture of pulmonary epithelial cells. 
 
To achieve the two main aims of thesis, the following three questions were addressed: 
Question 1: Can the differentiation of murine embryonic stem cells into type II 
pneumocyte progenitor cells be enhanced by 
- coating the culture vessel with ECM protein(s)?  
- grafting bioactive peptides to the culture vessel?  
- adding fibroblast growth factors to the cell culture medium? 
 
Question 2: How do the pulmonary epithelial cells respond to the surface of PDLLA 
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scaffolds grafted with RGD and YIGSR peptides or modified with amines or 
carboxylic acids and how do the surface-modified PDLLA scaffolds differ from 
unmodified PDLLA scaffolds? 
 
Question 3: What are the parameters needed to prepare synthetic scaffolds with a 
pore structure that is suitable for the culture of pulmonary epithelial cells? 
 
These questions are addressed in the experimental chapters of this thesis. This thesis 
is composed of following chapters: Chapter 1 provides the background information 
related to the engineering of pulmonary epithelial tissue. In Chapter 2, the materials 
and methods used for culture and characterization of the pulmonary progenitors and 
A549 cells, as well as for the preparation and characterization of the 2D environments 
and 3D scaffolds, are described in detail. Chapter 3 describes how ECM proteins 
were coated on to tissue culture plastic (TCP) and PDLLA. The ECM coatings on 
TCP and PDLLA were characterized using water contact angle and ζ-potential 
measurements, and their effects on the differentiation of mESCs into progenitors of 
pulmonary epithelial cells studied. In Chapter 4, the effect of fibroblast growth 
factors (FGFs) on the differentiation of mESCs into pulmonary epithelial progenitors 
was investigated. The work described in Chapter 5 is an extension of the study in 
presented in Chapter 3 i.e. the bioactive peptides RGD and YIGSR, mimicking the 
functions of ECM, were grafted to the surface of PDLLA films. The effect of 
peptide-grafted PDLLA on the culture of a standard pulmonary epithelial cell (A549) 
line and the differentiation of progenitors of pulmonary epithelial cells from mESCs 
were studied. In Chapter 6, PDLLA films were modified by introducing various 
functional groups on to their surfaces; primary amines were introduced using 
aminolysis and, in addition, amine-terminated and carboxylic acid-terminated, 
tree-like branched architectures were created on the surface of the PDLLA films. The 
surface properties of all surface modified PDLLA films were characterized and the 
responses of A549 cells to the surface-modified PDLLA films were recorded. 
Chapter 7 describes the preparation of porous 3D scaffolds using thermally induced 
phase separation (TIPS). The prepared scaffolds were further modified using the 
techniques described in Chapter 6. A549 cells were subsequently cultured on the 
prepared scaffolds and their metabolic activity was investigated. In Chapter 8, the 
main conclusions and possible future work following on from the findings of this 
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thesis are described. 
 
1.2. Biology of lung and extracellular matrix 
1.2.1. Cells of lung alveolar epithelium: anatomy and 
physiology 
The human lung alveolus, around 200 μm in diameter, consists of several types of 
cells, including type I pneumocytes, type II pneumocytes, macrophages, fibroblasts 
and others. Among these cells, type I and type II pneumocytes play major roles in the 
physiological functions of lung. Only 8% of the total lung alveolar epithelial cells are 
type I pneumocytes. Despite this low percentage, they cover 92% of the alveolar 
surface which reflects their physiological function: gas exchange [42]. Thus, the 
diameter of the type I cell ranges from 50-100 μm [43]. In contrast, type II 
pneumocytes comprise 15% of total lung epithelial cell numbers and 2-5% of the 
alveolar surface [44]. The diameter of type II cells is around 10 μm [43]. Type II 
pneumocytes secrete surfactant [45] which decreases the surface tension in the alveoli 
and, thus, maintains their shape during respiration. Furthermore, type II cells also 
serve as type I cell progenitors during development [46] and in the injury repair 
process [47]. The most distinct characteristic of the type II cell is its cytoplasmic 
inclusions: lamella bodies. Lamellar bodies contain surfactant phospholipids, 
surfactant proteins A, B, C and D, and lysozyme [48]. Type II cells also synthesise 
type IV collagen [49], laminin [50], fibronectin [51], thromobospondin, heparin 
sulfate proteoglycans and chondroitin sulfate proteoglycans [52]. The synthesis of 
these molecules is enhanced by transforming growth factor-α, transferrin, epidermal 
growth factor and retinoic acid. 
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1.2.2. Type II pulmonary cells: characteristics, derivation and 
culture 
Isolation of type II pneumocytes and maintenance of their phenotype had been a 
challenge in the 1970s. They were not successfully isolated until the first 
breakthrough made by Kikkawa et al. [53] in 1974. After that, several techniques, 
such as IgG-coated plate isolation [54] and isolation using laser flow cytometry with 
monoclonal antibodies against type II cells [55], were developed to provide a 
reproducible method for type II cell isolation.  
 
As Table 1-1 shows, type II cells possess a range of morphological and biochemical 
characteristics, many of which are also expressed by other cells but some are specific; 
these latter are of importance since they can be used as assessment of type II cell 
phenotype and condition. Lamellar bodies are the most obvious morphological 
characteristics of type II cells under phase contrast microscopy or interference 
contrast microscopy, although it can be difficult to differentiate lamellar bodies from 
intracellular inclusions of other cell types. Type II pneumocytes also secrete 
pulmonary surfactant proteins A, B, C and D. Among these four types of surfactant 
proteins, only surfactant protein C is solely expressed by type II pneumocytes. As a 
result, the expression of surfactant protein C was frequently used to evaluate the 
presence of type II pneumocytes in the experimental sections of this thesis. 
Aquaporins are the water channels existing on the surface of various lung epithelial 
cells. Type I pneumocytes express aquaporin 4 and 5, whereas aquaporin 3 is only 
expressed by type II pneumocytes. 
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Table 1-1 Characteristics of type II pneumocytes (adapted and modified from [56]) 
Morphological characteristic  
Lamellar bodies 
Microvilli 
Biochemical characteristics 
Synthesized molecules 
Lipid (phosphatidylglycerol and phosphatidylcholine) 
Surfactant proteins A, B, C and D 
TTF1 (Thyroid transcription factor-1) 
Surface marker 
Heymann nephritis antigen 
Aquaporin 3 [57] 
Cytokeratins 
Cytokeratins 7, 8, 18, 19 
 
Despite success in their isolation, prolonged maintenance of the type II phenotype is 
still to be achieved; type II cells lose their characteristics within days of being 
cultured. The synthesis of surfactant protein by primary type II pneumocytes 
decreases with time [58]. Expression of surfactant protein mRNA decreases within 
several hours of culture [59]. In addition, the number of lamellar bodies in cultured 
primary type II cell pneumocytes decreases with time [56]. Evidence indicates that 
type II cells turn into type I cells in vitro with the increased expression of the type I 
pneumocyte marker aquaporin-5 [60]. Rice et al. reported the longest period, 7 days, 
of functional type II pneumocyte culture to date [10]. They used BEGM (bronchial 
epithelial cell basal medium) with the addition of carbon-stripped FBS (fetal bovine 
serum) and human KGF (keratinocyte growth factor) as the culture medium for the 
type II cells grown on 30:70 rat-tail collagen-Matrigel mixture-coated wells. These 
culture conditions may provide information for stem cell differentiation into type II 
cells.  
 
In view of the difficulty in culturing pneumocytes, several cell lines, including A549 
[61], L2 [62], MLE-12 [63] and MLE-15 [63] cells, have been developed for in vitro 
study. The intrinsic weaknesses of these cell lines include the deficiency of certain cell 
markers; carcinoma-origin and virus-transformation mean that these cells do not 
correspond fully to the primary cell phenotype. 
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1.2.3. Lung development 
Furthering the understanding of the mechanisms of lung development is not an 
objective of this study. However, factors that are involved in lung development may 
also have effects on the in vitro differentiation of pulmonary progenitors from ESCs, 
and so the development of human lung is briefly reviewed in this section.  
 
Human lung maturation can be divided into several phases [64, 65]. In the embryonic 
stage, the foregut endoderm develops into a lung bud, which then invades into the 
splanchnic mesoderm and starts to branch, generating five saccules. Two saccules lie 
on the left side and three on the right. The five saccules correspond to the future lung 
lobes. During the pseudoglandular stage, the hierarchical patterns of the blood 
vessels and preacinar airways develop. The whole bronchial tree is formed, and the 
airway epithelial cells are presented in the airway earlier than 10 weeks after 
fertilization. All major elements of the lung have formed at this stage except for the 
gas exchange unit. Thus, respiration is impossible for those fetuses born during this 
period. The most distinct characteristic of the canalicular stage is the advent of the 
terminal saccules (primordial alveoli), the development of vascularization and 
differentiation of pulmonary epithelium. The terminal bronchioles divide into two or 
more respiratory bronchioles, which further give rise to three to six alveolar ducts by 
24 weeks of gestation. Various transcription factors are known to play important roles 
in differentiation at this stage; Foxa-2, Gata-6 and TTF-1 are expressed by the 
alveolar and airway epithelial cells. (Table 1-2). During the final saccular stage, the 
alveolar epithelium becomes thinner and, thus, the air space becomes larger. 
Capillaries bulge into the developing lung, forming the so-called blood-air barrier [66]. 
The blood-air barrier, where gas exchange happens, is the intimate contact between 
the vascular endothelium and alveolar epithelium. Type I alveolar cells line most of 
the surfaces of the terminal saccules surface by 26 weeks, whereas type II cells are 
scattered among the squamous type I cells [67]. Secretion of surfactant protein by 
type II cells and the presence of lamellar bodies can be identified at this stage. The 
surfactant counteracts the surface tension forces in the terminal saccules during this 
stage, thus with intensive care, premature infants may survive if born 24-26 weeks 
after fertilization. During the alveolar stage, type I pneumocytes attenuate into very 
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thin cells, so that the surrounding capillaries bulge into the alveolus. The 
alveolocapillary membrane becomes thin enough to facilitate gas exchange. The 
increase in number and complexity of alveoli continues until the age of 8. 
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1.2.4. Role of fibroblast growth factors (FGFs) in lung 
development 
Fibroblast growth factors (FGFs) play important roles in the development of lung. 
Among all FGFs expressed, FGF-1 (also called acidic FGF), FGF-2 (also called basic 
FGF), FGF-7 (also called keratinocyte growth factor) and FGF-10 are the most 
studied ones [69-91]. In the early development of the embryo, cells in the foregut 
endoderm require signals from the cardiac mesoderm to commit the differentiation 
into liver or lung [92]. This intermesenchymal interaction was found to be necessary 
because the isolated foregut endoderm alone can not enter the pulmonary lineage in 
the absence of cardiac mesoderm. Interestingly, when FGF-1 and FGF-2 were added 
to isolated foregut endoderm, the explants could activate either liver- or lung-specific 
genes, depending on the concentrations of added FGF-1 and 2 [85].  
 
An important mechanism, called epithelial-mesenchymal interaction, governs 
embryonic lung development. FGFs are released by the lung mesenchyme and 
selectively bind to the FGF receptors with different levels of affinity. In the initial 
stages of lung bud formation and bronchial tree formation, FGF-10 is absolutely 
necessary; FGF-10 knockout mice fail to develop a lung [83]. The FGF-10 receptor, 
FGFR2IIIb, can be found throughout the embryonic respiratory epithelium [93] and 
FGFR2IIIb knock-out mice also fail to develop lung. In vitro culture of pulmonary 
epithelium explants demonstrated that FGF-1 can stimulate the proliferation of 
pulmonary epithelium and result in lung bud formation, while FGF-7 promotes the 
proliferation of pulmonary epithelium and results in the formation of cyst-like 
structures [69]. FGF-7 also can enhance the secretion of surfactant protein C (SPC) by 
primary type II pneumocyte cultured in vitro [74, 75]. 
 
1.2.5. Extracellular matrix and integrins: an introduction 
Extracellular matrix (ECM) is a component of the basement membrane and interstitial 
connective tissue. The basement membrane of the lung consists of type IV collagen, 
laminin, entactin, heparin sulfate proteoglycans, fibronectin, nidogen and other 
proteoglycans. Interstitial connective tissue is composed of fibrillar collagen, elastic 
fibres and proteoglycans. It has been established that ECM can provide structural 
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support, affect cell shape and function, alter gene expression, stimulate cell 
proliferation and induce cell polarity [94]. Cell-ECM interactions are mainly mediated 
by heterodimeric transmembrane glycoproteins called integrins.  
 
Collagen is the most abundant protein in the body. It provides the tensile strength of 
tissues. Collagen is mainly made up of left-handed triple-helix chains which consist of 
Glycine-X-Y. X and Y could be any amino acids, but are most frequently proline and 
hydroxyproline, respectively. Other amino acids presented in X and Y positions do not 
follow any repeating pattern. Among all the amino acids in collagen, lysines which 
participate in the covalent cross-linking between molecules are the site for sugar 
attachment. Collagens can be divided into fibrillar and non-fibrillar ones. Fibrillar 
collagens, type I, II, III, V and type XI, comprise most of connective tissues. Type I 
collagen is the prototype of fibrillar collagen, forming most of the skin, bone and 
tendon. In contrast to fibrillar collagens, non-fibrillar collagens can be categorised 
into basement membrane collagens, short-chain collagen and others. Type IV collagen 
is the major collagen in the basement membrane. Type IV collagen therefore a major 
component of Matrigel, a commercially-available ECM replacement extracted from 
Engelbreth-Holm-Swarm (EHS) sarcoma [95]. 
 
Laminin is a heterotrimer composed of three polypeptide chains, namely α chain, β 
chain and γ chain (Figure 1-1), linked together by disulfide bonds [96]. Currently, 
there five variations of α chains (α1 - α5), three variations of β chains (β1 - β3) and 
three variations of γ chains (γ1 -γ3) have been identified in either mouse or human [1, 
97]. The first laminin identified was from an EHS tumour, laminin 1, which has α1, 
β1 and γ1 chains [98]. The molecular structure of laminin comprises 4 arms: three 
short and one long arm. N-terminal regions of α1, β1 and γ1 chains contribute to the 
short arm, whereas the long arm is formed by three chains in a triple-stranded manner. 
In the presence of +2Ca , laminin self-assembles into oligomers or a large polymer 
network in vivo. This self-assembly property is thought to be the basis of the structure 
of the basement membrane. One of the most important functions of laminin is to 
mediate cell adhesion by interacting with cells on one hand and the ECM on the other. 
Laminin molecules contain a domain which is similar to that of epidermal growth 
factor (EGF) molecules. This domain is reported to possess mitogenic activity [99].  
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Figure 1-1 Molecular structure of laminins 1 (Laminin 111) and 5 (Laminin 332), adapted from [97]. 
All laminins are composed of variations of α, β and γ chains. 
 
Fibronectin (FN) is a heterodimeric glycoprotein with a molecular weight of 500 kDa 
[100] (Figure 1-2). The two FN monomers are linked by two disulfide bonds at the 
C-terminus (Figure 1-2). Two major forms of FN are present in vertebrates, including 
soluble plasma FN and insoluble cellular FN. Plasma FN, synthesised mainly in the 
liver, is a major component of blood plasma. Cellular FN, secreted by various cell 
types, is a major component of the ECM. FN is encoded by only one gene, however, 
alternative splicing of the FN precursor mRNA gives rise to more than 20 forms of FN. 
Several functional domains can be found along the two FN monomers. The 
self-association domain is located near the end of the N-terminus of the FN monomer. 
It is necessary for the initiation of the FN matrix assembly. Another important domain, 
the cell binding domain, contains the RGD sequence and the synergy sequence. Both 
the RGD sequence and the synergy sequence form part of the cell binding sites [101]. 
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Figure 1-2 Molecular structure of fibronectin, adapted from [101]. 
 
Cells bind to ECM mainly via integrins. Integrins are cell surface receptors containing 
two distinct subunits, namely α and β subunits. The different combinations of α and β 
subunits result in a number of distinct integrins. At the present time, 25 different 
integrins are identified in mammals. Integrins for collagen binding include integrin 
α1β1, α2β1 and α3β1. Integrin α6β1 binds to laminin-1, whereas α2β1, α3β1, α6β1and 
α6β4 integrins bind to laminin-5 [102]. For the integrin binding to FN, integrin α5β1 
and α3β1 bind to RGD sites of FN whereas α4β1 integrin binds to IIICS site of the 
molecules [100]. 
 
1.2.6. Role of extracellular matrix in lung epithelium and lung 
development 
The maturation and development of the lung involves several forces, including 
transcriptional factors, growth factors, cell-cell as well as cell-matrix interactions. The 
cell-matrix interaction affects the airway branching, epithelium differentiation, 
vascularization and other processes during lung development. The most distinct 
phenomenon of the ECM in alveolar differentiation is the discontinuity of the 
basement membrane (BM) which coincides with the differentiation of type II 
pneumocytes [103]. The discontinuity of the BM allows the extension of cytoplasmic 
processes from differentiating type II cells into interstitial spaces where they associate 
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closely with fibroblasts [104]. This physical arrangement reaches a peak after birth 
and decreases in adult age. As no discontinuity is reported beneath type I cells, the 
phenomenon is considered as an inseparable process of type II cell differentiation and 
proliferation. Type IV collagenase expression is also reported to be higher in 
fibroblasts and alveolar epithelium during discontinuity formation [105].  
 
During lung development, laminin is involved in mesenchymal-epithelial interaction 
as well as cell adhesion and cell polarization [106]. It is crucial to the development of 
many solid and glandular organs, such as lung, liver and kidney. During lung 
development, laminin mRNA levels increase as organogenesis progresses. Three 
chains of laminin-1 are strongly expressed during lung development, even in the 
basement membrane of early organogenesis [107]. When the antibody AL-1 was used 
to block the crossing region of the α chain of laminin, lung epithelial cells were found 
to be unable to attach to mesenchymal cell populations, and the proliferation of lung 
epithelial cells was inhibited [106].   
 
Fibronectin (FN) is synthesised by many embryonic tissues and several adult tissues 
[108]. Fibronectin-deficient mice die even before the embryonic stage of lung 
development [109]. As integrin α5β1 can bind to FN, mice that are deficient in the α5 
integrin subunit also die at an early embryonic stage [110]. Increased expression of 
FN between 9-18 days of the pseudoglandular stage is followed by subsequent decline 
at the beginning of alveolar stage in chick lung development [111]. It is also worth 
noting that FN expression in mesenchyme always increases prior to the appearance of 
differentiated type II epithelial cells [112]. A similar finding was made by 
immunostaining FN and integrin α5β1 in developing murine lung. Fibronectin 
expression was detected in the early pseudoglandular stage in mesenchyme and 
parabronchial cells, it then increased until the early canalicular stage [113]. To sum up 
the findings, it seems that an increase in FN expression coincides with branching 
morphogenesis, thus FN may be related more to branching than alveolarization. 
However, there is also a parallel between vascular endothelial marker expression and 
FN expression, suggesting a role of FN in vascularization. The possible role of FN in 
the differentiation of type II cells has been less addressed. In vitro, type II cells, 
cultured on FN-coated tissue culture plates exhibit better organized, polarized and 
tightened morphology [114]. An increase in FN expression after birth implies its role 
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in lung maturation [115]. 
 
1.2.7. Extracellular matrix in in vitro lung biology 
As mentioned previously (1.2.2), it is well known that type II pneumocytes lose their 
phenotype soon after being placed in culture. The effects of the ECM on the 
morphology and physiological function of type II pneumocytes are summarized in 
Table 1.3. The morphology of type II pneumocytes can be preserved by culturing 
them on Matrigel-coated tissue culture plastic [116], floating collagen membrane [117] 
and inactivated fibroblast feeder layers [70].  
 
Matrigel is a solubilized basement membrane extract prepared from 
Engelbreth-Holm-Swarm (EHS) mouse sarcoma which is rich in extracellular matrix. 
Matrigel consists of collagen IV, laminin [118], heparin sulfate proteoglycans, entactin 
as well as nidogen [95, 119]. The original Matrigel also contains some 
naturally-occurring growth factors, including 0-0.1 pg/ml bFGF, 0.5-1.3 ng/ml EGF, 
15.6 ng/ml IGF-1, 12 pg/ml PDGF, <0.2 ng/ml NGF, 2.3 ng/ml TGF-beta and others. 
For experiments that require highly defined base membrane, growth factor-reduced 
Matrigel, which contains 0-0.1 pg/ml of bFGF, <0.5 ng/ml EGF, 5 ng/ml IGF-1, <5 
pg/ml PDGF, <0.2 ng/ml NGF, 1.7 ng/ml TGF-beta, was developed in order to reduce 
the effect of the growth factors. Despite so, tract amounts of growth factors still exist 
in the commercially-available Matrigel. 
 
Individual components of ECM, such as collagen [50] and laminin [120], can also 
help transient phenotype preservation. With different proportions of ECM, type II 
pneumocytes exhibit different morphologies. Type II pneumocytes cultured on a layer 
of protein composed of 90:10 of Matrigel to collagen with the supplement of 
keratinocyte growth factor (KGF) in the cell culture medium aggregate into colonies 
whereas they formed a monolayer of cells when cultured on a layer of protein 
composed of 70:30 of Matrigel to collagen ratio. Under serum-free conditions, 
primary type II cells form an organoid structure, which is characterised by a lumen 
and epithelium, within collagen gel [121] and spherical aggregates within Matrigel 
[116]. Laminin is also reported to contribute to the alveolar-like structure [122]. In 
terms of surfactant secretion, type II cells cultured on Matrigel-coated plastic and 
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feeder layers on floating collagen gels synthesized more surfactant phospholipids and 
proteins than cells grown on TCP alone [123]. The role of ECM in the expression of 
cell markers, DNA synthesis and cell proliferation is listed in Table 1.3. Among the 
cell markers, intercellular adhesion molecule-1 (ICAM-1) is expressed in type I rather 
than type II cells. Increased ICAM-1 expression represents transdifferentiation of type 
II to type I cells [124]. 
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Table 1-3 Composition effects of ECM on morphology and metabolic activities of type II pneumocytes, 
adapted from [94]. ND, no significant difference; ↑, increase with time in culture; ↓, decrease with time 
in culture; + increase compared to tissue culture plastic; -, decrease compared with TCP 
Culture condition Morphology 
Surfactant 
phospholipid 
expression 
Surfactant protein 
expression 
C
ytokeratin expression 
IC
A
M
-1 
D
N
A
 synthesis 
R
adiolabeled nuclei 
C
ell division 
TCP Attenuated ↓ ↓ ↑ ↑ ↑ 5% None 
Matrigel Cuboidal + + - N/A - ND N/A 
Type I collagen Cuboidal ND N/A N/A N/A N/A ND N/A 
Type IV collagen Attenuated ND N/A N/A + N/A ND 
or + 
N/A 
Type I with type IV 
Collagen 
Attenuated ND N/A N/A N/A N/A ND N/A 
Laminin Cuboidal ND ND - + N/A + Serum - 
free 
medium 
Fibronectin Attenuated N/A N/A + + N/A + N/A 
Type II cell matrix Attenuated N/A N/A N/A N/A N/A N/A N/A 
Floating collagen gel Cuboidal N/A N/A N/A - N/A N/A N/A 
Feeder+floating 
collagen gel 
Cuboidal + + N/A N/A N/A N/A N/A 
Feeder 
layers+attached 
collagen gel 
Attenuated ND ND N/A N/A N/A N/A N/A 
 
1.3. Embryonic stem cells and their differentiation 
The first derivation of murine (mESCs) and human embryonic stem cells (hESCs) 
was achieved in 1981 [125] and 1998 [12], respectively, by isolation of cells from the 
inner cell mass (ICM) of blastocysts. Both types of ESCs are characterized by their 
pluripotency, which is the capacity to differentiate into every cell types of endoderm, 
mesoderm and ectoderm. Recently, hESCs were found to be able to differentiate into 
cells of the trophoblast [126].  
 
Both types of ESC showed high alkaline phosphatase activity, high telomerase 
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activity and high nucleus/cytoplasma ratio [127]. Furthermore, both mESCs and 
hESCs express characteristic surface markers and transcriptional factors. The 
commonly-used surface markers of mESCs include stage-specific embryonic antigens 
1 (SSEA-1) and CD9, while the commonly-used surface markers of hESCs include 
SSEA-3, SSEA-4, TRA-1-60, TRA-1-81, GCTM2 and CD9. Active transcriptional 
factors expressed by both mESCs and hESCs include POU domain transcriptional 
factor Oct 3/4 (POU5F1), homeodomain protein Nanog, homeobox domain 
transcriptional factor SOX-2 and zinc finger transcriptional factor REX-1.  
 
To maintain the undifferentiated state of ESCs, most lines of mESCs require leukemia 
inhibitory factor (LIF) and many hESCs require the bFGF and the support of a MEF 
feeder layer. The MEF feeder layer secretes the factors that worked in conjugation 
with bFGF to support the undifferentiated state of hESCs. LIF can bind to the 
heterodimeric LIF receptor and subsequently activate the STAT3 transcription factor 
via a complicated pathway to control the gene of self-renewal [128]. For the 
maintenance of hESC pluripotency, feeders layers other than MEF feeder layers, 
including human skin fibroblasts [129] and immortalized hESCs-derived fibroblasts 
[130] have been reported. In other studies, KGF, noggin [131] and activin A [132] 
were also applied to maintain the undifferentiated state of hESCs in a feeder-free 
culture environment. 
 
Once implanted into Severe Combined Immunodeficiency (SCID) mice, both mESCs 
hESCs form teratomas which comprise cells from the three germ layers [125, 133]. In 
vitro, a similar phenomenon can also be observed; upon removal of LIF (for mESCs) 
or the feeder layer (for hESCs), ESCs start to differentiate into 3D structures known 
as embryoid bodies (EBs) that are spheroid colonies of ESCs usually grown in 
suspension culture on bacterial-grade Petri dishes. Markers for endoderm, mesoderm 
and ectoderm are localised to specific regions of the EBs [134, 135]. This observation 
led to the hypothesis that EBs may recapitulate the development of the embryo to a 
certain extent. This is why the relevance of lung development to the current study was 
highlighted in the previous section. 
 
Most reported research on ESC differentiation starts with EB formation. In contrast, 
some studies indicate that ESCs can also differentiate into specific lineages on a layer 
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of ECM protein or on a feeder layer in a 2D manner, that is, without EB formation 
[136, 137]. Both lines of research involved ECM coating of the culture vessels during 
stem cell differentiation. Coraux et al. [137] reported the differentiation of mESCs 
into airway epithelium without the EB formation at an air-liquid interface. This 
air-liquid interface suggests the importance of the extracellular environment of both in 
vitro differentiation and natural development processes.  
 
Strategies that have been employed to try to upregulate the differentiation of ESCs 
into a specific lineage include addition of growth factors to the culture medium [16], 
reprogramming of ESCs using cytoplasmic or nuclear extracts from the target cells 
[17], genetic manipulation of ESCs [138] and co-culture of ESCs with the target cells 
[18]. By adding various growth factors or interleukins to EBs, ESCs can be 
encouraged to differentiate into specific lineages. For example, retinoic acid induces 
neuronal formation [139]. Combining IL-3 and other factors stimulates ESCs to turn 
into macrophages, mast cells or neutrophils [140]. TGF-β guides the ESCs into 
forming muscle cells [141]. The addition of the growth factors does not exclusively 
direct ESCs differentiation into a single specific cell type, rather it changes the 
relative proportion of each cell type [142]. 
 
Whether or not the in vitro differentiation of ESCs to a particular lineage has to 
recapitulate the in vivo development process has yet to be determined but simulation 
of the natural developmental process and environment may give a good guideline. 
During embryonic development, embryonic ectoderm of the epiblast forms 
neuroectoderm and bi-potential mesendoderm, the latter then undergoes 
epithelial-mesenchymal transition, bringing about mesoderm and endoderm formation. 
Using soluble factors for stem cell differentiation is stage-specific. For an endodermal 
lineage, one can increase the relative endoderm population by adding certain factors 
to culture medium at an early stage of the differentiation of ESCs, then other factors 
can be added to the culture medium after the endoderm phase to maximise the 
differentiation of cells of that lineage, such as type II epithelial cells, in the later stage. 
Activin A is reported to increase mESC differentiation into the endodermal lineage 
when added to EB culture medium [143]. However, addition of activin A to 
monolayer cultures of differentiated ESCs dissociated from human EBs increases 
mesoderm differentiation [142]. Furthermore, adding activin A to hESCs is reported to 
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help maintain pluripotency of the undifferentiated hESCs in the absence of a feeder 
layer [132]. These results indicate the time-, species- and quantity-dependent effects 
of soluble factors.  
 
1.4. Composition, preparation and modification of 2D 
environments and 3D scaffolds 
1.4.1. Lactic acid-based polyesters 
Lactic acid-based polymers have been used for medical applications for more than 2 
decades [144]. Being one of the smallest optically active materials, lactic acid, also 
called 2-hydroxypropanoic acid, can be either a L(+) or D(-) stereoisomer. Both of the 
optically active configurations are produced by the Lactobacilli bacterial systems 
through the Embden-Meyerhof pathway which converts 1 mole of hexose into as 
much as 1.8 mole of lactic acid [145]. In contrast, mammalian systems can only 
produce L-lactic acid. Catalysed by lactic acid dehydrogenase, lactic acid can be 
synthesised from pyruvate under oxygen-limiting conditions using lactic acid 
fermentation [145], then the synthesised lactic acid can be neutralised with base 
followed by filtration, concentration and acidification to obtain pure lactic acid for 
polymerization [146]. 
 
In spite of a large number of publications on lactic acid-based polymers, there are lots 
of contradictions in their nomenclature. It is known that polymers derived from lactic 
acid can be prepared by polycondensation or ring-opening polymerization (ROP). In 
order to differentiate the way they are synthesised, polymers prepared by the former 
method are generally referred to as poly(lactic acid) whereas the ones prepared by the 
latter are called poly(lactide) [146]. As the material used in this project is synthesised 
by ROP, it is proper to refer to the material as poly(D,L-lactide) instead of 
poly(D,L-lactic acid), which is used extensively in the literature [147, 148]. 
Furthermore, poly(D,L-lactide) is also generally referred to as PDLLA. 
 
Polycondensation usually generates polymers with a lower molecular weight. An 
additional chain coupling agent, such as hexamethylene diisocyanate, is usually 
required to overcome this effect [149]. The low molecular weight of the condensation 
polymer is due to the viscous polymer melt, the statistical absence of the reactive end 
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group and the formation of the six-member lactide ring during reaction [150]. 
Recently, the preparation of poly(lactic acid) by condensation polymerization with a 
molecular weight of 510  Da was reported [151]. In contrast, PDLLA prepared by 
ROP has a higher molecular weight ( wM  > 
510  Da). The route of ROP includes 
condensation polymerization of lactic acid into low molecular weight prepolymer 
followed by the depolymerization of the low molecular weight prepolymer into a 
dehydrated cyclic dimer (3,6-dimethyl-1,4-dioxane-2,5-dione) (Figure 1-3). The 
depolymerization is processed by elevating the polycondensation temperature and 
lowering pressure followed by distilling off the depolymerized cyclic dimer [146]. 
The cyclic dimer then undergoes ROP to yield a high molar mass polymer. The 
stereoregularity of the polylactide is therefore dependent on the proportion of lactide 
of different stereoforms prepared. Among all the metal catalysts commonly used in 
ROP, tin(II) 2-ethylhexanoante, which later converts into tin(II) alkoxide in reaction 
with alcohol in ROP, is the most frequently used catalyst despite concerns over its 
potential toxicity [152]. The use of supercritical 2CO  to remove the catalyst and 
residual solvent is therefore promising for the synthesis of polymer used in 
biomedical applications [153, 154]. 
 
D,D(R,R)-lactide  
(A and C: H ; B and D: 3CH ) 
L,L(S,S)-lactide  
(B and D: H ; A and C: 3CH )
D,D(R,R)-lactide+ L,L(S,S)-lactide 
(rac-lactide) C
C
O
C
C
O O
O
D
B
C
A
 
D,L(R,S)-lactide 
(meso-lactide) 
(A and D: H ; B and C: 3CH )
 
Figure 1-3 Stereoforms of lactide. Adapted from [146]  
 
Two configurationally distinct polymers are commonly used in tissue engineering 
applications, PLLA (poly(L-lactide)) and poly(D,L-lactide) (PDLLA ). PLLA is 
semicrystalline, stereoregular, highly resistant to hydrolysis and possesses high 
mechanical strength. In contrast, PDLLA is amorphous, racemic and, therefore, more 
susceptible to hydrolysis. PDLLA undergoes degradation by hydrolysis in an aqueous 
environment. In an acidic environment, the introduction of water and protons causes 
the cleavage of the ester bonding. One may see this reaction as the reverse reaction of 
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the polycondensation. The acidic degradation product of the polylactide further 
increases the degradation rate by lowering the pH. In a basic environment, the 
polyester bond breaks because of the attack of the ester bond by hydroxyl ions.  
 
Lactic acid-based polymers usually undergo bulk degradation instead of surface 
erosion. Bulk degradation occurs by random scission of molecular chains followed by 
the onset of weight loss and a decrease of chain scission rate [155, 156]. The weight 
loss becomes significant when the molar mass of the degraded polymer is 
considerably below the entanglement molar mass, which is around 5170 Da (for 
number average molecular weight) or 3330 Da (for weight average molecular weight) 
[157]. Similar results obtained from a dielectric spectroscopy study of PDLLA have 
also been reported [158]. However, the GPC elution profile of water soluble 
oligomers diluted from the PDLLA microspheres demonstrates a peak wM  ranging 
from 1050 to 1150 Da [159]. It may suggest that polymer chains smaller than the 
entanglement molar mass undergo further degradation before they can freely diffuse 
out of the polymer. 
 
PLA features higher autocatalytic effects in the interior than that near the surface. This 
is because oligomeric degradation products, which possess carboxyl end groups that 
can catalyse further hydrolysis, can diffuse out of the sample easier from a volume 
near the surface than those at the centre, resulting in an acidity gradient across the 
sample from the centre to the surface. As the degradation progresses, the inner part 
turns into a highly viscous oligomer core followed by further degradation which 
renders the oligomers small enough to diffuse through to the outer layer of the sample. 
A hollow structure is therefore formed. However, this process is not applicable to 
polylactides in any dimension [148]. Lactic acid-based polymer samples smaller than 
300 μm in diameter undergo homogeneous degradation, which means the surface 
material degrades as fast as the material at the core [160]. Furthermore, when the 
dimensions of the lactic acid-based polymer parts are larger than the so-called 
“critical thickness”, the degradation mode alters. Figure 1-4 demonstrates the critical 
thickness of most degradable degradable materials [161]. When the dimension of the 
polymers is above the critical thickness, polymers undergo surface erosion instead of 
bulk erosion. PDLLA, which belongs to the polyester group, has a critical thickness of 
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around 7.4 cm. 
 
Figure 1-4 Critical thickness of degradable polymers above which polymers undergo surface erosion 
[161]. 
 
The auto-catalytic effect of PDLLA degradation can be lowered by the introduction of 
basic particles, such as hydroxyapatite and Bioglass®, into the polymer to neutralize 
the released lactic acid [162]. The porosity of a porous polymer also plays a role in 
this degradation behaviour. 75:25 poly(DL-lactide-co-glycolide) porous microspheres 
incorporated with bone morphological protein degraded in three weeks in vivo 
whereas the non-porous counterpart took more than 20 weeks to degrade [163]. 
 
1.4.2. Surface modification of lactic acid-based polyesters 
The hydrophobicity of lactic acid-based polyesters, such as PDLLA and PLLA, may 
inhibit cell responses, e.g. cell attachment and cell proliferation. The easiest way to 
enhance the PDLLA surface wettability is to apply a protein coating to the polymer 
surface. This coating process is simply the adsorption and the unfolding of proteins to 
the materials; no chemical reaction occurs in the coating process. Modifications of 
polyesters that involve the breakdown of covalent bonds can be classified as either 
physical or chemical modifications. The former include plasma treatments [41, 164, 
165], electron beam [166] and UV irradiation [167]. The latter include hydrolysis [33], 
aminolysis [33-35, 40, 168] and surface grafting of bioactive molecules [31, 165, 
169].  
 
Plasma treatments are the most frequently-used physical surface treatments using 
oxygen, nitrogen and ammonia plasmas, which have been found to be effective for 
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lactic acid-based polymer films. Traditional plasma treatments, however, are unable to 
penetrate into the porous structures of scaffolds for more than a few millimetres [33]. 
Chemical modification of polymer scaffolds, such as hydrolysis and aminolysis, can 
be cheap and easier than surface modification of scaffolds using plasma treatment. 
Hydrolysis introduces carboxylic acid and hydroxyl groups to the surface of 
polyesters, while aminolysis introduces amines. Hydrolysis can occur under either 
acidic or basic conditions. Under acidic conditions, hydrolysis occurs when hydrogen 
ions attack the carbonyl oxygen due to electrophilic attack. Under basic conditions, 
hydrolysis occurs when hydroxide ions attack the carbonyl carbon due to the 
nucleophilic attack. Surface modification using hydrolysis is strongly dependent on 
the reaction pH and temperature, furthermore, it is difficult to restrict the hydrolysis to 
the polymer surface alone [33, 170]. In contrast, aminolysis has been reported to be 
more controllable [33]. Aminolysis is commonly used in the textile industry to 
increase the wettability of synthetic fibres. Its application in biomaterial modification 
has only recently been investigated [33-35, 40, 168]. The basic mechanism of 
aminolysis is the nucleophilic attack of the carbonyl carbon in the polymer backbone 
by amines, generating a tetrahedral intermediate, which then further deprotonates to 
generate amide bonds in basic aqueous solution or in a polar solvent with high π 
basicity, such as isopropanol. In this thesis, aminolysis was used to introduce amines 
to the PDLLA surfaces used as substrates for cell culture and for further surface 
modification of these pre-treated PDLLA surfaces by grafting bioactive peptides and 
molecules that possessed multiple functional groups. 
 
A variety of studies has reported the coupling of peptides [25, 26, 28], proteins [35], 
hydrophilic molecules [168], or molecules possessing multiple functional groups [171] 
to the biomaterial surfaces using linker molecules. The choice of these linkers is 
critical to the final product of the grafting reaction. Zero-length linkers, such as 
1-Ethyl-3-[3-dimethylaminopropyl] carbodiimide hydrochloride (EDC), N,N'-Dicyc-
lohexylcarbodiimide (DCC) and N,N'-diisopropylcarbodiimide (DIC), mediate the 
formation of covalent bonds between the surface and the molecule to be coupled 
without adding spacers or linkers in between. Other linkers mediate the grafting 
reaction by adding a spacer of several atoms in between the surface and the grafted 
species. 
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1.4.3. Extracellular matrix coating on biomaterials 
Extracellular matrix (ECM) proteins have been used as biomaterial coatings for 
decades [172-174]. Cells cultured on protein-coated biomaterials experience more 
cell-matrix interaction than on TCP. To maintain the bioactivity of the protein coating 
on the biomaterial surface, it must be appropriately conformed during the coating 
process.  
 
In water solution, the interactions between the side chains of a protein cause the 
folding of protein molecules, with hydrophobic residuals preferentially located in the 
hydrophobic core of the protein molecules [175]. Once a protein is exposed to a 
polymer surface, adsorption to the material surface occurs [175-177]. This process is 
driven by electrostatic forces, hydrogen bonds and van der Waals forces between the 
polymer surface and the protein in solution. When the protein adsorbs, the protein and 
the material surface should be at least partially dehydrated. Thus, the water molecules 
associated with the protein are released when the proteins unfolds, consequently, the 
thermodynamics favours the hydrophobic materials as a better adherent than materials 
of a more hydrophilic nature. The entropy of the whole system increases when 
proteins unfold and adsorb to the polymer surfaces. 
 
Fibronectin (FN) is a good model to elucidate the changes in surface properties of a 
biomaterial after coating. Adsorption of FN on biomaterials can modulate cell 
behaviour. At low FN concentration, the bioactivity of the FN is substrate-dependent. 
This is because when FN is at low concentration, the conformation of the unfolded FN 
on the substrate determines the exposure of bioactive sites of the FN. Once the FN 
concentration increases, the bioactivity of FN exhibits no differences between 
substrates [178]. FN exhibits an extended and condensed morphology when coated 
onto hydrophilic and hydrophobic materials, respectively [179]. The active binding 
site of FN for integrin measured by immunostaining varies as FN is coated on 
different substrates [23].  
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1.4.4. Scaffolds prepared by Thermally-Induced Phase 
Separation (TIPS) 
A tissue engineering scaffold should satisfy the following requirements [5]: The 
scaffolds should (1) exhibit interconnected porosity with an appropriate porous 
structure allowing cell penetration and mass transport, (2) have a biodegradation rate 
that matches the formation rate of the host tissue, (3) possess optimal surface 
properties to enhance cellular attachment, differentiation and/or proliferation, (4) 
possess adequate mechanical properties to bear physiological movement and handling, 
(5) induce no adverse response of the host tissue and (6) be and easy and reproducible 
to manufacture. 
 
Techniques for scaffold fabrication have been reviewed extensively [5, 7, 20, 21, 180, 
181]. Among all the techniques, Thermal-Induced Phase Separation (TIPS), was one 
of the earliest techniques used to prepare porous polymer membranes [20, 181]. It has 
since been applied to make porous polymer scaffolds [20, 181] and for 
polymer/Bioglass® composite scaffolds [182].  
 
The TIPS process can be categorized into solid-liquid phase separation or 
liquid-liquid phase separation. In a solid-liquid phase separation system, the 
liquid-liquid phase separation temperature of the polymer solution is lower than the 
crystallization temperature (freezing point) of the solvent [181]. Therefore, when the 
polymer solution is quenched or cooled down, the solvent starts to crystallize, causing 
the polymer to be repelled from the crystallization front of the solvent. The separation 
of the dissolved polymer from the crystalling solvent therefore is named solid-liquid 
phase separation. The porous structure can be preserved by lyophilising the 
frozen-polymer solution to remove the solvent. The solid-liquid phase separation 
technique typically produces highly porous, sheet-like, anisotropic pore structures, 
with better mechanical properties along the pore orientation than along the transverse 
direction [181]. Scaffolds prepared by solid-liquid phase separation can be used for 
the engineering of tissues with orientated tubular or fibrous bundle architectures, such 
as nerve, bone, muscle, tendon, ligament and dentin. 
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Unlike solid-liquid phase separation, in a liquid-liquid phase separation system, the 
temperature of the polymer solution is much higher than the crystallization 
temperature (freezing point) of the solvent [20]. The bottom half of the Figure 1-5 
illustrates the typical temperature to composition phase diagram of an ideal polymer 
solution. The dashed, spinodal curve divides the two phase regions; the area below the 
binodal region is split into a thermodynamically unstable spinodal decomposition 
region and the metastable nucleation region. The area above the binodal curve is the 
homogeneous solution area. Phase separation happens as the polymer solution is 
cooled down from the homogeneous region to the area below binodal decomposition 
temperature.  
 
Figure 1-5 can also be derived mathematically [183, 184]. Firstly, consider a polymer 
solution “A+B → Mixture of A and B”. Complete miscibility occurs only when the 
Gibbs free energy of mixing is lower than the Gibbs free energy of the components A 
and B. 
 
It is well explained in the literature that the entropy of mixing mixSΔ can be derived as 
[184]:  
1 1 2 2ln lnmixS kN X kN XΔ = − −                                                  (1-1) 
where k is the Boltzmann constant. 1N  and 2N  represent the numbers of the 
molecules of A and B, and 1X  and 2X  the mole fraction of A and B, respectively. 
Therefore: 
1
1
1 2
NX
N N
= +                                                                  (1-2) 
and 22
1 2
NX
N N
= +                                                              (1-3) 
Upon mixing, there are interactions between the two components A and B. Therefore, 
consider the enthalpy change on mixing mixHΔ  [184]: 
1 2 1 2 1 2( )mixH rN X r N N X XΔ = = +                                               (1-4) 
where r is defined as the energy change per molecule in the mixing process and the 
Gibbs free energy of mixing mixGΔ  is: 
mix mix mixG T S HΔ = − Δ + Δ                                                        (1-5) 
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where T is the temperature. By combining equation (1-1), (1-4) and (1-5) together, the 
following equation is obtained: 
1 1 2 2 1 2 1 2ln ln ( )mixG kTN X kTN X r N N X XΔ = + + +                               (1-6) 
Consider X1+X2=1, equation (1-2) and (1-3), mixGΔ  can be rewritten as: 
1 1 1 1 1 1( ln (1 ) ln(1 )) (1 )mixG kT X X X X rX XΔ = + − − + −                            (1-7) 
where 
1 2
mix
mix
GG
N N
ΔΔ = + , is the Gibbs free energy of mixing per molecule. 
Therefore, the second derivative of the Gibbs free energy of mixing per molecule is: 
2
2
1 1 1
1 1 2
1
mixG kT r
X X X
⎛ ⎞∂ Δ = + −⎜ ⎟∂ −⎝ ⎠
                                               (1-8) 
 
Figure 1-5 Gibbs free energy of mixing mixGΔ  as the function of 1X . Adapted from [184].  
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The top half of Figure 1-5 demonstrates the Gibbs free energy of mixing per molecule 
mixGΔ  as the function of the polymer composition X1. At temperature T5 the polymer 
system is miscible regardless of the solution composition X1. Between temperature TC 
and the crystallization temperature of the solvent, the polymer system is partially 
miscible, and tangent lines that have two contact points with mixGΔ  can be found. 
The binodal curve in the bottom half of Figure 1-5 is the projection of the contact 
points between the mixGΔ  curve and their tangents to the temperature-composition 
plane. Similarly, the spinodal curve is the projection of the inflexion points of the 
2
2
1
0mixG
X
∂ Δ =∂  to the temperature-composition plane. At a certain temperature, say T1, 
the mixGΔ  is higher at composition C2 than at C1 or C3 where two co-existing phases 
exist. As a result, phase separation occurs at composition C2. A special temperature TC, 
also called the critical solution temperature, is the temperature where 
2 3
2 3
1 1 1
0mix mix mixG G G
X X X
∂Δ ∂ Δ ∂ Δ= = =∂ ∂ ∂ . Therefore, a homogeneous phase exists at TC. 
 
When the temperature of an ideal polymer solution is lowered below the binodal 
curve of the temperature-composition phase diagram, the polymer solution phase 
separates into polymer-rich and polymer-poor regions. In both metastable regions, 
phases separate by the nucleation and growth mechanism [185]. In the left metastable 
region, the polymer solution separates into droplet-like polymer-rich regions 
dispersed in polymer-poor matrix. Once the solvent is lyophilized, the final polymer 
product has a beaded structure (Figure 1-6A). In the right metastable region, the final 
polymer product possesses a closed-pore structure (Figure 1-6C). 
 
In contrast, in the unstable region, phases separate by the spinodal decomposition. If 
the status of a polymer solution is brought to the unstable region, foams with 
well-interconnected open-pores can form when the solvent is lyophilized (Figure 
1-6B).  
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Figure 1-6 Thermal-induced phase separation with various polymer concentrations. Modified from 
[186]. 
 
The pore size of scaffolds has a huge effect on the behaviour of cells seeded on them 
[187]. For different cell types, the optimal pore size for cell entry, attachment and 
matrix deposition varies. For the preparation of a porous scaffold using TIPS, the pore 
size and the interconnectivity are influenced by many factors, including polymer type, 
polymer solution concentration, solvent type, cooling rate of the polymer solution and 
coarsening time and temperature [20, 181, 188]. Coarsening, also referred to as aging, 
is a time-dependent phase separation process. When the temperature of a polymer 
solution is brought down to the temperature below the binodal curve, phase separation 
of the polymer solution occurs. Over time, the tendency to reduce the interfacial 
energy between the already-separated two phases results in the increased size of the 
phase-separated droplets and decreased total interfacial area [189]. Therefore, the pore 
size of the future scaffolds is affected by the coarsening time and coarsening 
temperature [185, 189, 190]. Moreover, the rate that a polymer solution is cooled 
down also affects the pore size of the future scaffold. A slow cooling rate of the 
polymer solution generates scaffolds with larger pore sizes and a more uniform pore 
structure than a fast cooling rate [188]. This is because during the cooling process, 
phase separation still progresses. A slow cooling rate, therefore, allows for a longer 
period of phase separation than a fast cooling rate. Practically, a slow cooling rate can 
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be achieved using a freezer and a fast cooling rate using liquid nitrogen. 
 
1.4.5. Cell seeding and infiltration of porous scaffolds 
Cell penetration into scaffolds is dependent on mass transport, such as oxygen 
diffusion, nutrition diffusion into and waste removal from the scaffold interior. For 
those scaffolds with small pore sizes, the ingrowth of cells is limited by the oxygen 
concentration. Cell penetration from the surface into the bulk of the scaffold has been 
reported to be limited to within 180 μm for cardiac-like tissues [191], 500 μm for 
osteoblasts [192] and 5 mm for chondrocytes [193]. These results suggest that cells 
which bear higher physiological activities might have lower scaffold penetration 
ability due to the higher requirement of mass transport. In vivo, capillaries which are 
around 6-8 μm in diameter, cause slow passage of blood through the vessels. The 
resident time of blood within the vessels is longer than the diffusion time of O2, CO2 
and nutrients to the surrounding tissues, thus ensuring adequate mass exchange. In 
addition, all cells except chondrocytes can not survive more than 100 μm away from a 
blood supply in vivo [194]. This finding is also supported by the avascular structure of 
cartilage. As far as lung type II epithelial cells are concerned, their penetration and 
growth on 3D scaffolds were reported in only very few studies [22, 195-199]. 
Consequently, this is one of the focuses in the present research project. 
 
1.5. Surface characterization of modified biodegradable 
polymer scaffolds 
Depending on the information required, a variety of techniques can be used to 
characterise the surface of biomaterials [200]. In this section, background information 
on some characterization techniques used in this thesis is briefly reviewed. 
 
1.5.1. Wettability of surfaces: contact angle measurements 
When a drop of liquid is placed on a surface which has a lower surface energy than 
the liquid, a clear angleθ  will form at the three-phase contact point, as Figure 1-7 
shows. Young’s equation describes this three phase interfacial equilibrium using the 
vectorial sum: 
(1-9) cosLG SG SLγ θ γ γ= −
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where ijγ  is the interfacial energy between the phase i and j. Subscript L, G and S 
refer to the liquid phase, gas in equilibrium with the saturated liquid vapour, and solid 
phase, respectively. Young’s equation is valid only if the following prerequisites can 
be satisfied: the surface is smooth, rigid and homogeneous, and there is no interaction 
between liquid and solid phase.  
 
Figure 1-7 Graphical representation of Young’s equation 
 
In contrast to the static contact angle or Young’s contact angle described by equation 
1-9, commonly two dynamic contact angles can be measured, which are the contact 
angles when gas-liquid front is advancing, i.e. the liquid wets a dry surface, or 
receding, i.e. the liquid dewets a wet surface. Practically, adding liquid to an existing 
water droplet will increase the contact angle of the droplet. The gas-liquid front only 
moves towards the gas phase when enough water is added. The advancing contact 
angle θa stands for the largest observed angle during this gas-liquid front movement 
[200]. Subtracting liquid from the existing water droplet decreases the height and the 
contact angle of the droplet. The gas-liquid front only withdraws over a pre-wetted 
surface when enough water is subtracted. The receding contact angle θr stands for the 
smallest observed angle during this gas-liquid front movement [200]. The movement 
of the liquid-air front can be controlled by increasing or decreasing the liquid drop (or 
air bubble) using a microsyringe connected to a syringe pump. The shape of the liquid 
drop can be recorded using a camera, and the contact angle θ  can be measured by 
drop shape analysis software. As the dynamic contact angle is governed by the 
interfacial driving force and the viscous retarding force, it is rate dependent. 
 
Contact angle hysteresis is defined as the difference between θa and θr. Factors that 
determine contact angle hysteresis include the surface roughness, chemical surface 
hetereogeneity and surface contaminations. In a surface composed of hydrophilic and 
hydrophobic domains, when the water front advances, the hydrophobic domain can 
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pin the movement of the water front thereby increasing the contact angle. Similarly, 
when the water front recedes, the hydrophilic domain can hold the water phase of the 
contact line, decreasing the contact angle. 
 
The dynamic contact angle can be measured in several ways, such as using the 
Wilhelmy plate technique using a tensiometer or using the sessile or captive bubble 
method using a goniometer [200]. The latter approach was used throughout the 
current research. 
 
1.5.2. Information about the surface chemistry obtained from 
ζ-potential measurements 
When an aqueous electrolyte solution is in contact with a solid surface that possesses 
surface charges, ions in the electrolyte accumulate at the solid-liquid interface. 
According to the widely accepted GCSG model on the basis of the studies of Gouy, 
Chapman, Stern and Grahame [201], the ions that accumulate at the solid-liquid 
interface can be defined as belonging to two layers, namely the diffuse layer and the 
immobile layer. The immobile layer, also known as the Stern layer, is made up of the 
inner (IHP) and the outer (OHP) Helmholtz layer or plane. The IHP comprises a 
monolayer of immobile, partially dehydrated ions adsorbed on the solid surface. The 
charge of the adsorbed ions depends on the nature of the solid surface. The OHP, in 
contrast, is composed of immobile, hydrated ions that are opposite in charge to the 
ions adsorbed in the IHP. The number of charged ions in the diffuse layer decreases 
when the distance from the solid-liquid interface increases. When the electrolyte 
solution moves under an applied external force, movement of the ions in the diffuse 
layer generates a shear plane close to the boundary between the Stern layer and the 
diffuse layer. The potential at this shear plane is called the ζ potential.  
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Figure 1-8 Schematic representation of the electrochemical double layer model according to the Gouy, 
Chapman, Stern and Grahame model (redrawn from [202]). The adsorbed ions in the inner Helmhotz 
plane are partially dehydrated. 
 
 
Figure 1-9 Schematic representation of the measurement cell of the streaming potential 
 
Figure 1-9 illustrates the measurement cell used to measure the ζ-potential of flat film 
substrates using the streaming potential method. This method shears off the ions in the 
diffuse layer and, therefore, generates a potential when an electrolyte is driven 
through a channel by a pressure gradient. The polymer samples to be studied line both 
sides of the streaming channel. If the polymer surface is negatively charged, part of 
the positive counter-ions accumulates at the right electrode when the liquid is pumped 
through the streaming channel in the direction of the arrows, generating a potential 
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(ΔU) between the two electrodes. The ζ-potential can be calculated using the 
Helmholtz-Smoluchowski equation: 
0
SU
p
η κζ εε
⋅ ⋅= ⋅ Δ                                                                 (1-10) 
where η is the viscosity of the solution, ε the dielectricity of the electrolyte, ε0 the 
permittivity of vacuum, κ the total specific conductivity of the electrolyte solution in 
the channel in between the samples and Δp the applied pressure difference across the 
channel. The ζ-potential can be measured as a function of pH (ζ=f(pH)). There are two 
important indicators of the ζ=f(pH) curve, the isoelectric point (IEP) and the plateau 
value of ζ=f(pH) curve (ζplateau). IEP is the pH where the measured ζ potential is equal 
to zero. The IEP is mainly determined by the number (i.e. concentration) and pKa of 
the dissociating acidic and basic functional groups present at the surface. The plateau 
value of the ζ=f(pH) is determined by both the ions adsorpted to the solid-liquid 
interface as well as the number of dissociated surface functional groups at the 
corresponding pH. Therefore, it is also affected by the wettability of the solid surface, 
i.e. the more hydrophilic a surface is the more water will be adsorbed to the surface 
and, therefore, fewer adsorption sites for ions will be available. Another advantage of 
ζ-potential measurements is that they provide information about the macroscopic 
properties at the solid-liquid interface in aqueous solution, which resembles the 
biological environment.  
 
1.5.3. X-ray photoelectron spectroscopy (XPS) 
X-ray photoelectron spectroscopy (XPS), also known as electron spectroscopy for 
chemical analysis (ESCA), is a spectroscopic technique that allows to quantify the 
elemental composition of a material surface in an ultra-high vacuum environment 
[200]. It provides compositional information about a material in a volume of 1 to 10 
nm away from the surface. The sensitivity of a standard XPS instrument is in the parts 
per thousand range. The basic principle of XPS is to use an X-ray beam to irradiate 
the material surface and the energy of the X-ray photon is transferred to the core 
electrons of the atoms in the surface material. The kinetic energy (Ek) and the number 
of the escaped core electrons are measured. As the kinetic energy (Ek) of the 
photoelectron is measurable, the binding energy (Eb) of the electron can be calculated 
by:  
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Eb = hν – Ek                                                               (1-11) 
where h is Planck’s constant, ν the X-ray frequency and hν the incident energy of the 
X-ray beam. 
 
Once core electrons escape, the vacancy of the core shell is filled by electrons from a 
shell with higher energy level with energy released in a form of X-ray photons at the 
same time. If the released energy is high enough, it can be conserved by the ejection 
of another electron from higher energy level. The second ejected electron is called an 
Auger electron, which can also be detected by the sensor of the XPS instrument. 
Therefore, the signals detected by the XPS instrument include photoelectron and 
Auger electron lines. Each element present in the materials surface can produce a 
unique set of characteristic peaks that can be used as the “fingerprint” to identify its 
elemental composition. The intensities of the characteristic peaks are proportional to 
the concentration of the detected elements in the surface. If the same atom is bound to 
different chemical species, shifts in the peak positions called chemical shift, ranging 
from 0.1 eV to 10 eV, can occur. This is because the binding energies of electrons in 
an atom are affected by the atom’s chemical, physical environment as well as the 
oxidation state of the atom. For example, C1s binding energy in a hydrocarbon bond is 
285 eV, whilst in an ester bond, the C1s binding energy is 289 eV, shifted by 4 eV to 
higher energy because the presence of the more electronegative oxygen in the vicinity 
of the carbon draws away electron density form the carbon making it harder to 
remove even a core electron [200]. Depending on the locations of these bondings in a 
molecule, the binding energy can vary for a range of ± 0.2 eV. In this way, it is 
possible to evaluate the chemical state of the element in the materials by comparing 
the obtained peaks with the records in the XPS peak database [200]. For an insulating 
material, such as PDLLA that was used in the current project, positive charge can 
build-up on the material surface when the photoelectrons are emitted from of the 
sample surface. Consequently, the sample surface acquires a positive potential and the 
XPS peaks of the core electrons shift to higher binding energies. The surface charge 
can be neutralised by the electrons generated by an accessorised low-energy electron 
flood gun of the XPS instrument. 
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Chapter 2. Materials and Methods 
2.1. Introduction 
This present thesis can be divided into 2 major areas: (1) derivation of type II 
pneumocytes from mESCs and (2) processing of biomaterials for the culture of 
pulmonary epithelial cells. The former focuses more on biological aspects and the 
latter on material aspects. As each area requires sample preparation and 
characterization, this chapter therefore is divided into methods for cell culture and 
characterization of cell culture as well as preparation and surface modification of 
polymer constructs, characterization of polymer constructs, and finally, culture of 
cells on biomaterials.  
 
2.2. Cell culture and A549 cell transfection 
2.2.1. Cell culture medium 
2.2.1.1. Medium for the maintenance of mESCs in the undifferentiated state 
Dubelcco’s Modified Eagle’s Medium (DMEM, Invitrogen, Paisley, UK) was 
supplemented with 10% (v/v) FBS (Invitrogen, Paisley UK), 100 U/mL penicillin and 
streptomycin (Invitrogen, Paisley, UK), 2 mM L-glutamine, (Invitrogen, Paisley UK), 
0.1 mM 2-mercaptoethanol (Sigma-Aldrich, Dorset, UK) and 1000 U/mL Esgro™ 
LIF (Chemicon, Temecula, CA). For the transfected mESC line, SPC-eGFP mESC, an 
additional 200 µg/mL Geneticin sulphate (Invitrogen, Paisley, UK) was added to the 
undifferentiated mES medium. 
 
2.2.1.2. Medium for the differentiation of mESCs into pulmonary progenitors 
Three differentiation media were used during pulmonary epithelium differentiation, 
depending on the time point of the differentiation, including (1) differentiation 
medium A: DMEM supplemented with 10% (v/v) FBS and 2 mM L-glutamine, (2) 
differentiation medium B: DMEM supplemented with 10% (v/v) Knockout-serum 
(KOSR) , 2 mM L-glutamine, plus 10 ng/ml Activin A, (3) differentiation medium C: 
DMEM supplemented with 10% (v/v) KOSR and 2 mM L-glutamine. No antibiotics 
were used in any of the differentiation media. 
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2.2.1.3. Medium for the culture of A549 cells 
The medium for the culture of the untransfected A549 cells was composed of Ham’s 
F12K medium supplemented with 10% (v/v) FBS, 100 U/mL penicillin and 
streptomycin, and 2 mM L-glutamine. For the culture of EGFP-N1 transfected A549 
cells (Chapter 2.2.4), 300 μg/ml of geneticin was added to the A549 medium during 
expansion and subsequent culture in order to maintain the EGFP expression.  
 
2.2.1.4. Medium for the culture of 804G cells 
DMEM was supplemented with 10% (v/v) FBS, 100 U/mL penicillin and 
streptomycin and 2 mM L-glutamine. 
 
2.2.2. Culture of murine embryonic stem cells 
Three important stages in murine embryonic stem cell culture are (1) culture of 
undifferentiated mESCs, (2) formation of embryoid bodies and (3) the three-step 
differentiation into type II pneumocytes. 
 
2.2.2.1. Culture of undifferentiated mESCs 
The murine embryonic stem cell (mESC) line E14-Tg2a (a kind gift from Prof. Austin 
Smith, University of Edinburgh, UK) stably transfected with a 4.8kb murine SPC 
promoter/EGFP construct using LipofectamineTM 2000 (Invitrogen, Paisley, UK), as 
described previously [17], was used through this study. Untransfected E14-Tg2a cells 
were also cultured in parallel as a negative control for the flow cytometry. mESCs 
were maintained and feed everyday in an undifferentiated state on 0.1% 
gelatin-coated tissue culture plates (TCP, Corning Inc., Acton, MA) with fresh mESC 
maintenance medium in a humidified incubator set to 37℃ and 5% CO2. 
Undifferentiated mESCs were passaged every 2-3 days when they reached 30-50% 
confluency. 
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Figure 2-1 Light microscopic image of undifferentiated mESCs captured using an inverted microscopy 
(IX70, Olympus, Southall, UK). Scale bar indicates 200 μm. A bright rim is indicative of an 
undifferentiated cell. Cells with processes are either starting to differentiate or have already 
differentiated. 
 
2.2.2.2. Formation of embryoid bodies (EBs) 
It requires careful manipulation to form EBs from mESCs. Roughly day 2 or 3 after 
passaging, EBs (Figure 2-2) were formed when undifferentiated mESCs reached 
around 50% confluency. In order to obtain a high undifferentiated to differentiated 
cell ratio, cells were used 2 to 3 passages after defrosting from liquid nitrogen.  
 
Briefly, cells were trypsinized for 3 min and mESC maintenance medium was added 
to stop the function of the trypsin/EDTA. Trypsinized cells were centrifuged for 3 min 
at 800 rpm. The supernatant medium was aspirated and cells resuspended from the 
pellet using differentiation medium A with very gentle pipetting to form cell clumps 
comprising around 20 cells. Great care was taken in this step because clumps with too 
or too few cells form larger or smaller EBs, respectively, resulting in variations of the 
experimental results. A T75 flask of mESCs generated three 90 mm bacteriological 
grade Petri dishes (Bibby Sterilin, UK). 10 ml of differentiation medium was used for 
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each 90 mm petri dish. 
 
 
Figure 2-2 Light microscopic image of EBs three days after their formation captured using an inverted 
microscope (IX70, Olympus, Southall, UK). Scale bar indicates 500 μm. Variations in the sizes of the 
EBs can be observed. 
 
2.2.2.3. Original three-step differentiation of mESCs into pulmonary 
progenitors  
The three-step differentiation protocol [203] was used to differentiate mESCs into 
pulmonary progenitors as illustrated in Figure 2-3. Three different media, namely 
differentiation medium A, B and C, were used to feed cells in sequence (Chapter 
2.2.1.2). EB formation is referred to as day 1 in the three-step differentiation protocol. 
On day 1 and 2, EBs were fed with differentiation medium A. On day 3, the medium 
was changed to differentiation medium B with fresh medium being given again on 
day 5. On day 7, differentiation medium C was used to fed EBs. The adherent culture 
period starts on day 11 when EBs were plated on 6 well plates coated with gelatin. 
One Petri dish of EBs generated two 6 well plates (or one 6-well plate and one 24 well 
plate). During day 11 to day 20, the differentiation medium C was used to culture 
adherent EBs with medium changed for every 4 days. From day 21 to day 28, SABM 
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(Cambrex Corporation, East Rutherford, NJ, USA) was used for 8 days with medium 
changed for every 4 days. 
 
Figure 2-3 The original 3 step differentiation of mESCs to pulmonary progenitors 
 
2.2.2.3.1. Differentiation of mESCs into pulmonary progenitors on ECM 
protein-coated TCP and PDLLA films 
The effects of the ECM proteins and ECM replacement Matrigel coating of TCP and 
PDLLA films on the differentiation of the mESCs into pulmonary progenitors were 
investigated in Chapter 3. The experimental protocol was modified from the original 
three-step differentiation protocol [201](Figure 2-3). The only difference between the 
modified and original protocols was that, on day 11 of the modified protocol, EBs 
were seeded and differentiated onto ECM protein-coated polymer substrate. The ECM 
proteins and polymer substrates used are listed in Table 2-1. The control used for this 
experiment was TCP coated with gelatin (TCP-GN), as was used in the original 
three-step differentiation protocol [203]. 
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Table 2-1 The polymer substrate and coating of the 6 well-plate used for differentiation culture 
Sample name Polymer substrate Coating 
TCP-GN 
(the experimental control) 
TCP Gelatin (GN)  
TCP-CO TCP Collagen (CO) 
TCP-LN TCP Laminin 332 (LN) 
TCP-FN TCP Fibronectin (FN) 
TCP-ML TCP Matrigel (ML) 
PDLLA-GN PDLLA GN 
PDLLA-LN PDLLA LN 
PDLLA-ML PDLLA ML 
2.2.2.3.2. Differentiation of mESCs into pulmonary progenitors by the addition 
of growth factors 
The effects of the fibroblast growth factors (FGFs) 1, 2, 7 and 10 added to the 
differentiation medium for the differentiation of mESCs into pulmonary epithelial 
progenitors were investigated in Chapter 4. The experimental protocol was modified 
from the original three-step differentiation protocol [201] (Figure 2-4). The only 
difference between the modified and original protocols was that during day 11-14 
(period A in Figure 2-4) and day 15-18 (period B in Figure 2-4) of the modified 
protocol, FGF-1, 2, 7 and 10 were added to the differentiation medium C. The FGFs 
were added at the beginning of the day 11 or day 15, and the medium was not changed 
for 4 days. The details of the FGF supplementation in periods A and B are listed in 
Table 2-2. 
 
Figure 2-4 The differentiation protocol. Three differentiation media were used during pulmonary 
epithelial differentiation. 
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Table 2-2 Conditions used for periods A and B. The differentiation medium C in this table is that shown 
in Figure 2-4. 
Sample 
number 
Period A (day 11-14) Period B (day 15-18) 
Group 1: Addition of FGF-1 and FGF-2 to cells cultured on gelatin-coated plates 
1-1 Differentiation medium C Differentiation medium C 
1-2 500 ng/ml FGF-1 Differentiation medium C 
1-3 1000 ng/ml FGF-1 Differentiation medium C 
1-4 100 ng/ml FGF-2 Differentiation medium C 
1-5 500 ng/ml FGF-2 Differentiation medium C 
1-6 500 ng/ml FGF-1 + 100 ng/ml FGF-2 Differentiation medium C 
Group 2: Addition of FGF10 to cells cultured on gelatin-coated plates 
2-1 Differentiation medium C Differentiation medium C 
2-2 20 ng/ml FGF-10 Differentiation medium C 
2-3 60 ng/ml FGF-10 Differentiation medium C 
2-4 100 ng/ml FGF-10 Differentiation medium C 
2-5 200 ng/ml FGF-10 Differentiation medium C 
2-6 Differentiation medium C 20 ng/ml FGF-10 
2-7 Differentiation medium C 60 ng/ml FGF-10 
2-8 Differentiation medium C 100 ng/ml FGF-10 
2-9 Differentiation medium C 200 ng/ml FGF-10 
Group 3: Addition of 60 ng/ml FGF10 to cells cultured on Matrigel-coated plates 
3-1 Differentiation medium C Differentiation medium C 
3-2 60 ng/ml FGF-10 Differentiation medium C 
3-3 Differentiation medium C 60 ng/ml FGF-10 
Group 4: Addition of 10 ng/ml FGF-7 to cells cultured on Matrigel-coated plates 
4-1 Differentiation medium C Differentiation medium C 
4-2 10 ng/ml FGF-7 Differentiation medium C 
4-3 Differentiation medium C 10 ng/ml FGF-7 
 
2.2.2.3.3. Differentiation of mESCs into pulmonary progenitors on 
peptide-grafted PDLLA films 
The effects of the bioactive peptide-grafted PDLLA films on the differentiation of the 
mESCs into pulmonary progenitors were investigated in Chapter 5. The experimental 
protocol was modified from the original three-step differentiation protocol (Figure 
2-3). The only difference between the modified and original protocols is that at the 
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beginning of the day 11 of the modified protocol, EBs were seeded and differentiated 
on PDLLA films grafted with bioactive peptides. Three different grafted-peptide 
layers were prepared, i.e. the grafted-peptide layer composed of only RGD, RGD and 
YIGSR, or only of YIGSR. The method of the peptide-grafting was explained in 
Chapter 2.5.4. 
 
2.2.3. Culture of A549 and 804G cell lines 
The A549 cell line A549 (ATCC CCL no. 185, Rockville, MD) was originally isolated 
from a human alveolar cell carcinoma [61]. It possesses the features of type II 
pneumocytes, including cytoplastic inclusion bodies (lamellar bodies) and synthesis 
of lecithin containing a high percentage of disaturated fatty acid. Its migration and 
adhesion repertoire has also been used as a model for lung injury [204].  
 
804G cells (kind gift of Prof. Richard Lubman, University of South California, CA, 
USA), originally isolated from a bladder carcinoma, can secrete matrix containing 
laminin-related components that participate in hemidesmosome assembly formation 
[205]. Medium conditioned by 804G cells contains laminin 332 that can be used as a 
coating for pulmonary epithelium culture [206]. A standard cell culture protocol can 
be applied to both A549 and 804G cells with medium changed every other day using 
A549 medium and 804G medium, respectively. Cultures of either cell type can be 
split once 80% confluency is reached.  
 
2.2.4. Transfection of CMV-EGFP construct to A549 cells 
In order to see A549 cells on fluorescence microscopy, they were transfected with 
pEGFP-1 vector using Lipofectamine 2000 reagent (Invitrogen, Paisley, UK). 
pEGFP-N1 (CMV-promoter, Clontech, Heidelberg, Germany) is a commonly-used 
plasmid that carries cytomegalovirus (CMV) promoter, CMV enhancer and the coding 
sequence for enhanced green fluorescence protein (EGFP). The CMV promoter is 
active in A549 cells [207], therefore pEGFP-N1-transfected A549 cells can stably 
emit green fluorescence when excited at the wavelength of 395 nm using a 
fluorescence microscopy.  
 
First of all, A549 cells at 90% confluency were cultured in 24 well plates using A549 
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culture medium excluding antibiotics. E. coli strand TOP10s carrying pEGFPN-1 in 
glycerol stock was defrosted and expanded in liquid LB broth with kanamycin 
prepared using imMedia™ Kan liquid (Invitrogen, Paisley, UK). Plasmids were 
extracted using Wizard® Plus SV Minipreps DNA Purification System (Promaga, UK) 
according to manufacturer’s protocols. Once plasmid DNA was extracted, a complex 
containing DNA (μl) and Lipofectamine 20000 (μl) at ratio of 1:2.5 was prepared. 
Briefly, pGFPN-1 vector was added to 50 μl DMEM. Lipofectamine™ 2000 was also 
diluted in 50 μl DMEM followed by 5 min incubation at room temperature, then the 
diluted DNA was mixed with the diluted Lipofectamine™ 2000 gently followed by 
20 min incubation at room temperature.  
 
100 μl of complex was added to 24 well plates containing cells and medium, mixed 
thoroughly by rocking the plate back and forth. A549 cells were incubated at 37°C in 
5% CO2 for 24 h. Transient EGFP expression can be observed at this time (Figure 
2-5). The transfection efficiency is 6.8%, determined using manual microscopy. Cells 
were then passaged at a 1:10 ratio into fresh A549 medium. Geneticin (G418) at 1100 
μg/ml was then added to the A549 medium on the following day, with medium and 
geneticin changed every other day for 1 week, after which only cells that stably 
expressed EGFP survived. The best colonies were picked up carefully and expanded 
using the standard A549 cell culture protocol. In order to maintain the EGFP 
expression, 300 μg/ml of geneticin was added to the A549 medium during expansion 
and subsequent culture.  
 
Figure 2-5 Transient and stable EGFP expression of A549 cells captured using an inverted microscope 
(IX70, Olympus, Southall, UK) equipped with a fluorescence source (excitement wavelength 395nm).  
Left: EGFP expression 24 h after transfection of A549 cell line. Right: A stable EGFP-A549 cell line 
after selection with Geneticin 
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2.3. Characterization of cell culture 
2.3.1. Microscopy 
Light and fluorescent microscope images were captured using an IX70 inverted 
microscope (Olympus, Southall, UK) equipped with F-View II, a black and white 
high resolution charge-coupled device (CCD) camera (Soft Imaging Systems GmbH, 
Germany), or a BX60 upright (Olympus Southall, UK) microscope equipped with an 
axiocam (Zeiss, Germany) digital camera. Confocal images were taken using an 
upright Leica SP2 confocal microscope (Leica, Germany) and processed using LCS 
lite software (Leica, Germany). 
 
2.3.2. Conventional and realtime PCR for mRNA expression 
analysis 
For Chapter 3, conventional PCR was performed to evaluate the expression of 
mRNAs for genes coding for the pneumocyte markers SPC, SPD, and aquaporin 5, 
the housekeeping genes GAPDH and beta-actin in the differentiating mESCs on day 
28. For Chapter 4, the expression of mRNAs for these genes plus those coding for 
Clara cell protein 10 (CC10), a marker for distal airway epithelium progenitors and 
mature Clara cells, and the hepatocyte marker, albumin, was analysed on day 28 of 
the differentiation culture using conventional PCR. Furthermore, on day 28, the 
expression of SPC and GAPDH mRNAs by differentiating cells treated with 20 ng/ml, 
60 ng/ml, 100 ng/ml and 200 ng/ml of FGF-10 during day 11-14 or 15-18 in the 
presence of gelatin coating and by differentiating cells treated with 60 ng/ml of 
FGF-10 during day 11-14 or 15-18 in the presence of Matrigel was analysed using 
conventional PCR.  
 
Realtime PCR was performed to quantify the RNAs for the endoderm markers 
SOX17, Foxa2 and the mesoderm marker brachyury at the end of day 14 of the 
differentiation culture, right after addition of FGF-1 and 2 for 4 days, as described in 
Chapter 4. In the same chapter, realtime PCR was also performed to evaluate the 
expression of SPC mRNA by cells of the differentiation cultures treated with (1) 500 
ng/ml and 1000 ng/ml of FGF-1 during day 11-14, (2) 20 ng/ml, 60 ng/ml, 100 ng/ml 
and 200 ng/ml of FGF-10 during day 11-14 or 15-18 in presence of gelatin coating, (3) 
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0 ng/ml of FGF-10 during day 11-14 or 15-18 in presence of matrigel or (4) 10 ng/ml 
of FGF7 during day 11-14 or 15-18 in presence of Matrigel. 
 
2.3.2.1. RNA isolation  
Total RNA was isolated using the RNeasy Mini Kit (Qiagen, UK) according to the 
manufacturer’s instructions. Briefly, a cell monolayer was harvested directly using 
350 µL of buffer RLT pre-added with 1% (v/v) of 14.3 M β-mercaptoethanol. Cell 
lysates were transferred to QIAshredder spin columns placed in 2 mL collection tubes 
and centrifuged for 2 min at 13000 rpm. 350 µL 70% ethanol was added to the 
homogenized lysate and mixed well by pipetting. 700 µL of the sample, including any 
precipitate, was transferred to the RNeasy mini columns placed in 2 mL collection 
tubes and centrifuged for 15 s at 13000 rpm. After discarding the flow-through, 700 
µL Buffer RW1 was added to the RNeasy columns followed by centrifugation for 15 s 
at 13000 rpm. The flow-through and the collection tubes were discarded. RNeasy 
columns were transferred into new 2 mL collection tubes and 500 µL Buffer RPE 
pre-added with 4 volumes of ethanol added onto the RNeasy columns followed by 
centrifugation for 15 s at 13000 rpm and again the flow-through was discarded. 
Another 500 µL buffer RPE was added to the RNeasy columns then centrifugation 
was performed for 2 min at 13000 rpm. The RNeasy columns were transferred to new 
1.5 mL collection tubes and 50 µL RNase-free water was directly pipetted onto the 
RNeasy silica-gel membrane. Samples were centrifuged for 1 min at 13000 rpm to 
collect the total RNA. The concentration and purity of the total RNA were determined 
using a spectrophotometer (Eppendorf BioPhotometer, Germany) at 260/280 nm with 
a dilution rate of 5 μl of sample to 145 μl of RNase and DNase-free water. Samples 
were stored at –80℃ until further use. 
 
2.3.2.2. Reverse transcription  
A thermoscript RT-PCR system (Invitrogen, Paisley, UK) was used to form cDNA 
according to the manufacturer’s protocol. 12 μl mixtures containing 1 μl of primer, 2 
μl of dNTPs, up to 5 μl of RNA and DEPC-treated water together were transferred to 
a to 65˚C pre-heated thermal cycler for 5 min and quenched on ice. The second 8 μl 
mixtures containing 4 μl of 5x buffer, 1 μl of 0.1 M DTT, 1 μl (40U) of RNaseOUT, 
1μl of DEPC-treated water and 1 μl (15U) of reverse transcriptase were mixed with 
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first mixtures and transferred to a thermal cycler at 25˚C for 10 min, 50˚C for 55 min, 
85˚C for 5 min and a hold at 4˚C at the end of the temperature profile. 
 
2.3.2.3. Conventional PCR amplification 
Conventional PCR primers were designed using Primer 3 software (Primer3 (v. 0.4.0) 
Pick primers from a DNA sequence, link in: http://frodo.wi.mit.edu/ accessed on 
06.01.2009). PCR cycles were performed using a thermal cycler (Eppendorf 
Mastercycler, Hamburg, Germany) with cycle conditions as followed: 94℃ for 2 min, 
amplication phase (denaturation at 94℃ for 15 s, annealing for 30 s, elongation for 30 
s at 72℃) for different cycles and final incubation at 72℃ for 7 min. Optimal cycle 
numbers were predetermined (see Appendix B1 for the determination of optimal cycle 
number of various primers). 
 
Table 2-3 The primers and the corresponding reaction conditions of conventional PCR reactions 
Target gene Conventional PCR primer Annealing temp Cycle Product Length
F:AACTGGCTGACTGCTGTAC 
Albumin 
R:GCAAATAGTGTCCCATAAAG 
57 36 162bp 
F:ACTGCCACAGCTCAGACCTCA 
Aquaporin 5 
R:AACGCCCAACCCGAATACC 
58 36 267bp 
F:GTGGGCCGCTCTAGGCACCAA 
β-actin 
R:CTCTTTGATGTCACGCACGATTTC
59 33 540bp 
F:GCCTCCAACCTCTACCATGA 
CC10 
R:CTCTTGTGGGAGGGTATCCA 
55 42 241bp 
F:TGTGTCCGTCGTGGATCTGA 
GAPDH 
R:CCTGCTTCACCACCTTCTTGA 
59 30 76bp 
F:CAGCTCCAGGAACCTACTGC 
SPC 
R:CACAGCAAGGCCTAGGAAAG 
63 36 200bp 
F:GAGGTTGCCTTCTCCCACTA 
SPD 
R:CCACAAGCCTTATCATTCCA 
55 35 374bp 
 
2.3.2.4. Realtime PCR amplification 
Realtime PCR amplification was performed using SYBR Green PCR Core Reagents 
with GeneAmp® 5700 Sequence Detection System (both from AB Applied 
Biosystems, Warrington, UK). Each test was performed in triplicate in 25 μl reaction 
volumes containing 2.5 μl of 10X SYBR green PCR buffer, 3 μl of 25 mM MgCl2, 2 
μl of 2.5 mM dNTP blend, 0.125 μl of 5 U/μl AmpliTaq Gold polymerase, 0.25 μl of 1 
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U AmpErase UNG (uracil-N-glycosylase), 2.5 μl of forward primer, 2.5 μl of reverse 
primer, cDNA template equal to 25 ng of RNA input and water which made up the 
final total volume to 25 μl. A matrix of combinations of different primer 
concentrations ranging between 50-900 nM was tested for SPC mRNA expression 
according to manufacturer’s protocol (See Appendix B2). The concentration and 
sequences of other primers were listed in Table 2-4. The melting temperature of all 
realtime PCR primers were considered to be between 58-60℃.  
It is worth noting that, in realtime PCR reactions, the dNTP mixture does not contain 
dTTP, instead, it contains dUTP, dCTP, dGTP and dATP. The advantages of this 
design is that any carryover from previous realtime PCR product can be degraded 
using AmpErase UNG before the start of any realtime PCR reaction. This 
decontamination process is of special importance because realtime PCR is highly 
sensitive. Therefore, in each realtime PCR reaction, the temperature profile starts at 
50℃ for 2 min, which is optimal for AmpErase UNG activity. 94℃ for 10 min was 
then used to activate the AmpliTaq Gold DNA Polymerase. This was followed by 40 
cycles of template denaturation (95℃ for 15 s) and primer annealing and extension 
(60℃ for 1 min). Melting curve (dissociation curve) analysis was performed at the 
end of all realtime PCR cycles to ensure that the fluorescence light was emitted by the 
SYBR® green dye binding to the amplicon instead of primer dimer. Pure PCR 
product only produces one sharp and narrow peak [208]. If there is primer dimer in 
the reaction mixture, a lower and broader peak can be seen at lower temperature, 
mostly around 80°C, than the main peak [209]. 
 
In addition to the samples to be tested, three No Template Controls (NTCs) and three 
No Amplification Controls (NACs) were also used. The former, also known as a 
negative control in conventional PCR, contains everything except cDNA in order to 
rule out any cDNA contamination in the mastermix or water. NAC control contains 
samples but no enzyme. It is used to rule out any fluorescence contamination present 
in the sample or heating block. 
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Table 2-4 The primers and conditions of realtime PCR reactions 
Primers 
Primer 
concentrations 
Product length 
murine GAPDH primer 
Forward TGTGTCCGTCGTGGATCTGA 300 nM 
Reverse CCTGCTTCACCACCTTCTTGA 300 nM 
77 
murine Brachyury primer 
Forward F: CATTACACACCACTGACGCACA 300 nM  
Reverse R: AGAAGACGAGGACGTGGCAG 300 nM  
51bp 
murine Foxa2 primer 
Forward F: CATCTCGCTCATCACCATGG 900 nM  
Reverse R: CAGCGTCAGCATCTTGTTGG 900 nM  
55 
murine Sox17 primer 
Forward F: AGCTCAGCGGTCTACTATTGCA 300 nM  
Reverse R: GGTCGGCAACCGTCAAAT 300 nM  
51 
murine SPC primer 
Forward CAGCTCCAGGAACCTACTGC 900 nM 
Reverse GCGAAAGCCTCAAGACTAGG 900 nM 
70 
 
The efficiency of the amplification of primer pairs was determined by realtime PCR 
tests of serial dilution of sample cDNAs. After obtaining the amplification curves of 
all diluted cDNAs, a horizontal line was drawn across the linear regions of all the 
amplification curves. The cycle number where the horizontal line crosses the 
amplification curve is called Ct. A linear regression line can be plotted against Ct of 
each diluted sample [208]. The efficiency can be obtained using the equation 
( 1/ )10 1SE −= − , where E is the efficiency of the amplification and S the slope of the 
regression line. The gene expression of the target gene was calculated using Pfaffl’s 
equation: 
arg
arg( )
( )
t et
reference
Ct
t et
Ct
reference
E
ratio
E
Δ
Δ=  where ΔCt is the Ctcontrol –Cttreated [208]. 
 
2.3.2.5. Agarose gel electrophoresis 
Aliquots of 10 μl of amplified cDNA were mixed with 2 μl of 6x loading buffer. Gel 
electrophoresis was performed on 26 well 2% (w/v) agarose gels made up of 2.4 g of 
agarose gel, 120 ml of 1X TBE and 0.001 μg/mL ethidium bromide. 10 L of 1X TBE 
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can be diluted from 1 L of 10X TBE made up of 108 g Trizma® base, 54 g Boric acid, 
40 ml 0.5 M EDTA (pH 8), 960 ml double distilled H2O. When exposed to UV 
illumination, the gel should show a single band in each lane. Multiple bands in a 
single lane imply nonspecific binding or poor PCR primer design. In this case, a 
higher annealing temperature or a new primer should be used. Images of the gel were 
captured digitally using a BioRad Fluor-S multi-imager (BioRad/Zeiss, UK). 
 
2.3.3. Immunocytochemistry 
Immunostaining was performed in Chapters 3, 4, 5 and 6. For Chapter 3, 
immunostaining was performed on EBs differentiated for 10 days. The expression of 
the endodermal marker Foxa2, early lung and thyroid marker thyroid transcription 
factor 1 (TTF1) and basement membrane component laminin was examined in this 
study. For Chapter 4, differentiating cells that were fed with FGF-1 and 2 from day 
11 to day 14 were immunostained for TTF-1 at the end of day 14. For Chapter 5 and 
6, immunostaining was performed to localize focal adhesion points in the A549 cells 
24 h after seeding on various substrate surfaces.  
 
Negative controls were performed for every sample stained and for every method in 
every run. Negative controls were stained using a normal immunostaining procedure 
in which the primary antibody was replaced by the normal serum from the species of 
the first layer antibody. Negative controls were used to test the specificity of the 
antibodies involved in the staining procedure. Positive controls were also performed 
to ensure that all the reagents were in working condition and all the immunostaining 
protocols applied correctly. Positive controls were specific tissue or cells that were 
already proven to contain antigens tested. The positive control tissue or cells used for 
each antibody in the experiments were listed in Table 2-5.  
 
The step by step protocol of immunostaining, modified from the book “Introduction to 
immunocytochemistry” [210], is described in Appendix A1. In addition to staining 
antigens using antibodies, staining of F-actin in A549 cells using Phalloidin-TRITC 
(1:50, P1951, Sigma-Aldrich, Dorset, UK) was also performed in Chapter 5 and 6. 
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Table 2-5 Details of antibodies 
Antigens Primary antibodies Secondary antibodies Positive controls 
SPC 
 
rabbit anti-mouse (diluted 
1:500, kind gift from Professor 
Jeffrey A Whitsett, Cincinnati 
Children's Hospital Medical 
Centre, US) 
goat anti-rabbit conjugated 
with Fluorescein (diluted 
1:100; F9887, Sigma-Aldrich, 
Dorset, UK) 
Sectioned murine lung 
tissue 
TTF-1 
 
mouse anti-mouse (diluted 
1:100, NCL-L-TTF1, 
Novacastra, New castle upon 
Tyne, UK) 
rabbit anti-mouse conjugated 
with TRITC (diluted 1:100; 
R0270, Dako, Copenhagen, 
Denmark) 
Sectioned murine lung 
tissue 
FOXA-2 
 
goat anti-mouse (diluted 1:50; 
SC-9187, Santa Cruz, 
Berkeley, CA) 
rabbit anti-goat conjugated 
with rhodamine (diluted 
1:100; AP106R, Chemicon 
international, Temecula, CA) 
Sectioned murine lung 
tissue 
Laminin 
 
rabbit anti-mouse (1:100; 
L9393, Sigma-Aldrich, Dorset, 
UK) 
goat anti-rabbit conjugated 
with rhodamine (diluted 
1:100; AP132R, Chemicon) 
MLE12 cells 
Vinculin mouse anti-mouse (1:100; 
V4505, Sigma-Aldrich, Dorset, 
UK) 
rabbit anti-mouse conjugated 
with FITC (diluted 1:100; 
F0261, Dako, Copenhagen, 
Denmark) 
MLE12 cells 
 
 
2.3.4. Flow cytometry  
For Chapter 3, flow cytometry was performed on day 28 on the experimental groups 
and negative controls, which are E14-Tg2a mESCs without SPC-eGFP transfection 
cultured on gelatin in parallel with experimental groups. 400 μl of trypsin/EDTA (T/E) 
was added to each well in a six-well plate for 15 min to dissociate the adherent cell 
clumps. In order not to damage the cells during the subsequent pipetting, chicken 
serum was added at a pre-determined dilution ratio of 1:50 to slow down the cytotoxic 
effects of trypsin. Cells were pipetted vigorously more than 60 times after T/E 
dissociation. Dissociated cells were spun down at 800 rpm for 3 min and resuspended 
with 1 ml of PBS with 2μg/ml of propidium iodide (PI). Flow cytometry was 
performed with a FACalibur® flow cytometer and CellQuest™ software (Becton 
Dickinson, CA, USA). Data were analysed with FCS express 3.0 software (De Novo 
Software, Ontario, Canada). Gating was done to exclude dead cells and cell debris 
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(Figure 2-6; Left) in the low forward scattering region. Necrotic cells were also ruled 
out by excluding cells expressing high fluorescence in the FL3 (PI) channel (Figure 
2-6; Middle). A threshold was then applied in the FL1 channel to make 0.05% of the 
negative control scores positive (Figure 2-6; Right) [4]. Relative populations of 
SPC-eGFP-positive cells were compared using one way analysis of variance 
(ANOVA) with LSD post-hoc tests at a significance level of P < 0.05 using SPSS 
software (SPSS Inc., Chicago, USA). 
 
 
Figure 2-6 Applied gates for the flow cytometry of the SPC-eGFP positive cells. Left: debris was 
excluded through gate 1. Middle: a gate was applied to select PI negative cells in FL3 channel (red). 
Right: a gate was applied in the FL1 channel (green) to make 0.05% of the negative control scores 
positive. 
 
Flow cytometry was also performed to evaluate the immediate effects of FGF-1 and 2 
on the number of TTF-1 immunoreactive cells, at the end of day 14, right after the 
addition of FGF-1 and 2 for 4 days as described in Chapter 4. The attached EBs were 
dissociated into single cells using collagenase and further stained for TTF-1 for flow 
cytometry. Briefly, attached EBs were washed thoroughly with PBS and treated with 
0.25% (w/v) collagenase for 60 min in an incubator. Cells were passed through 21G 
needles for 3 times and an equal volume of medium containing 5% (v/v) FBS was 
added to stop the reaction of the collagenase. Dissociated cells were immunostained 
with TTF-1 antibody using the same protocol as described in the immunostaining 
method section (Chapter 2.3.3). The negative control used here was the samples that 
are only stained with the secondary antibodies. The frequencies of 
TTF-1-immunoreactive cells were evaluated using FACScalibur system (BD 
bioscience, Oxford, UK) equipped with CellQuest™ software (Becton Dickinson, CA, 
USA). Collected data were analysed with FCS express 3.0 software (De Novo 
Software, Ontario, Canada). A size gate was applied to the negative control sample to 
exclude the cell debris in the low forward scattering region (Figure 2-7A). A threshold 
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was then applied to the negative control sample (Figure 2-7B) in the FL1 channel to 
make 0.1% of the sample scores positive [203].  
 
Figure 2-7 Applied gates for the flow cytometry of the TTF-1 positive cells. Left: debris was excluded 
to gate 1. Right: a gate applied in the FL1 channel (green) to make 0.1% of the negative control scores 
positive 
 
2.4. Preparation of Polymer Constructs 
2.4.1. Preparation of polymer films 
PDLLA films were prepared for Chapters 3, 5 and 6. The conditions for the 
preparation of PDLLA films were the same for all three chapters. 5% PDLLA (w/v) 
solution was prepared by dissolving PDLLA powder with inherent viscosity of 1.53 
dl/g (Purasorb®; Purac biochem, The Netherlands) completely in dimethyl carbonate 
(DMC) (Sigma-Aldrich, Dorset, UK). 1 ml of the dissolved polymer solution was 
coated onto circular borosilicate glass coverslips (15 mm or 32 mm diameter to fit 
into either 24 or 6 well tissue culture plates, respectively), which have previously been 
washed in acetone and ethanol. The PDLLA solution was allowed to dry slowly for 72 
h under minimal air-flow in order to obtain smooth polymer films. The 
polymer-coated coverslips were fixed on the base of the wells of either 24 or 6 well 
tissue culture plates by adding several drops of 5% PDLLA-DMC solution, then all 
plates containing PDLLA films were dried in a fume hood for 1 week and sterilized 
under UV light for 45 min at 0.120 J and 80 W (BLX-254, Vilber Lourmat, France). 
UV-sterilized plates were further washed several times with 0.1 M phosphate-buffered 
saline solution (PBS; Invitrogen Ltd., Paisley, UK) to ensure complete removal of 
foreign bodies. 
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2.4.2. Preparation of scaffolds using liquid-liquid phase 
separation and solid-liquid phase separation 
Three groups of 3D porous scaffolds were prepared using different conditions for 
Chapter 7. The details of the experimental conditions are provided in Table 2-6. 
Scaffolds prepared were given a sample name for convenience and clarity. The prefix 
LL stands for scaffolds prepared using liquid-liquid phase separation and SL for 
solid-phase separation. The suffixes M and C, the abbreviation of minutes and degrees 
Celsius, stand for coarsening time and coarsening temperature or freezing temperature, 
respectively. 
 
Table 2-6 Scaffolds prepared by various methods  
Group 1: Scaffolds prepared by changing coarsening time 
Polymer solution 5% PDLLA dissolved in 13% water and 87% dioxane and coarsened at 
24℃ for different times 
Coarsening time 0 min 10 min 20 min 30 min 60 min 
Sample name LL0M LL10 M LL20 M LL30 M LL60 M 
Group 2: Scaffolds prepared by changing coarsening temperature  
Polymer solution 5% PDLLA dissolved in 13% water and 87% dioxane and coarsened for 30 
min at different temperatures  
Coarsening temperature 27℃ 24℃ 21℃ 18℃ 15℃ 12℃ 
Sample name LL27C LL24 C LL21 C LL18 C LL15 C LL12 C 
Group 3: Scaffolds prepared by solid-liquid phase separation using two quenching temperatures 
Polymer solution 5% PDLLA solution (in DMC) 
Quenching temperature -25℃ (freezer) -196℃ (liquid nitrogen) 
Sample name SL-25C SL-196C 
 
2.4.2.1. Preparation of scaffolds by thermally-induced liquid-liquid phase 
separation of the dioxane-water-PDLLA ternary system 
5% (w/v) of PDLLA with an inherent viscosity of 1.53 dl/g (Purasorb®; Purac 
biochem, The Netherlands) was dissolved in 100 ml of solution containing 87% 
dioxane and 13% double distilled water under magnetic stirring for 6 h. Two factors, 
coarsening time (Table 2-6, Group 1) and coarsening temperature (Table 2-6, Group 
2), were used to control the morphology of the scaffold by thermally-induced phase 
separation [20, 181]. 10 ml of the polymer solution was transferred into a 30 ml glass 
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bottle prewarmed to 50℃ and held for 1 h, then coarsened in a water bath (Haake K15, 
Germany) for different times or at different temperatures. The chosen temperatures 
were below the cloud point of the PDLLA solution, 30 ± 2℃, which was determined 
in preliminary experiments. The glass bottles were then quenched in a beaker 
pre-cooled in liquid nitrogen. After 2 h, the frozen PDLLA solution in the glass bottles 
was freeze-dried using a custom-made freeze dryer (Chapter 2.4.2.3).  
 
2.4.2.2. Preparation of scaffolds by thermally-induced solid-liquid phase 
separation using the DMC-PDLLA binary system 
Two types of scaffolds were prepared by TIPS using the DMC-PDLLA binary system 
[20, 181] (Table 2-6). 5% (w/v) of PDLLA in DMC was prepared and stirred 
overnight. 80 ml of polymer solution was transferred into a Petri dish and either 
quenched in liquid nitrogen for 2 h or frozen in a freezer kept at -25℃ overnight. The 
petri dishes were then freeze-dried using a custom-made freeze-dryer (Chapter 
2.4.2.3). The exterior temperature was kept at -15℃. 
 
2.4.2.3. Freeze-drying of polymer solution using a custom-made freeze-dryer 
The frozen polymer solution kept in glass bottles or Petri dishes as described in 
sections 2.4.2, 2.4.2.1 and 2.4.2.2 was placed in a vacuum desiccator (Figure 2-8, 1) 
and connected to a vacuum pump (Leyhold Trivac D8) at 10 −2  Torr (Figure 2-8, 4) 
via a cold trap (Figure 2-8, 2). The temperature of the ethylene glycol bath was kept at 
-15℃ (Figure 2-8, 5). The solvent was collected in the cold trap for at least 96 h. The 
residual solvent was then removed at room temperature until the scaffolds reached a 
constant weight. 
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Figure 2-8 The setup of the custom-made freeze-dryer. (1) lyophilization flask, (2) cold trap, (3) liquid 
nitrogen tank, (4) connection to the pump, (5) ethylene glycol antifreeze agent bath, (6) ethylene glycol 
pumped to the thermostat to maintain the temperature (7) ethylene glycol pumped from the thermostat 
 
2.5. Surface modification of polymer constructs 
2.5.1. Protein adsorption 
4 different ECM proteins, type I collagen (Sigma-Aldrich Co., Dorset, UK), laminin 
332 (obtained from a conditioned medium as described below), fibronectin (Roche 
Diagnostics GmbH, Germany) and Matrigel (BD Biosciences, Bedford, USA) and, as 
an experimental control, gelatin (Sigma-Aldrich Co., Dorset, UK) were used as 
protein coatings. 
 
Gelatin 
0.1% (w/v) gelatin was prepared by dilution of 2% (w/v) gelatin stock solution in PBS. 
200 µl of the solution was plated per centimetre square of the culture surface and 
incubated for 20 min at 37℃. Gelatin was then aspirated and the exposed plate was 
allowed to dry in a sterile laminar flow hood for 20 min.  
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Fibronectin 
Fibronectin lyophilizate was first reconstituted in water to yield a stock solution at a 
concentration of 1 mg/ml. Incubation for 30-60 min at 37℃ without agitation was 
necessary for dissolution. The stock solution was further dissolved in PBS to make a 
working solution at concentration of 50 µg/ml. 100 µl of the working solution (50 
µg/ml) was applied per centimetre square of culture surface (final concentration of 5 
µg/cm2) using rubber cell scrapers. The vessel containing fibronectin was incubated at 
RT for 45 min. The plate was used immediately after aspiration of the protein 
solution.  
 
Collagen I 
One vial of lyophilized collagen was dissolved in sterile 0.2% (v/v) acetic acid to 
make the final concentration 2 mg/ml. 2.5 µl of the collagen solution was applied to 
substrate surface at concentrations of 2.5 µl/cm2 (5 µg/cm2) using rubber cell scrapers 
and air-dried at room temperature for 1 h in a fume-cupboard. 
 
Laminin 332 
Laminin 332 was obtained from DMEM conditioned by a laminin 332-producing rat 
bladder cell line (804G) (a kind gift from Prof. Richard Lubman, University of South 
California, USA) [205, 211, 212]. In order to eliminate the competitive adsorption 
effect of serum proteins, especially albumin and vitronectin, the 804G cells were fed 
with DMEM only when they reached 70% confluence, then the conditioned medium 
was collected 24 h after addition followed by 0.22 µm filter sterilization. 200 µl per 
cm2 of 804G cell-conditioned medium was added to substrate surface at 37℃ for 1 h. 
The plates were used immediately for adherent culture after aspiration of conditioned 
medium.  
 
MatrigelTM Basement Membrane Matrix 
Stock solution of growth-factor-reduced Matrigel was first thawed at 4℃ overnight to 
prevent gelation. Pre-cooled pipettes, plates and tubes were used in the preparation of 
coating the culture surface. Thawed Matrigel was diluted 1:30 in serum-free medium 
(DMEM supplemented with 10% (v/v) KOSR, 2 mM L-glutamine and 0.1 mM 
2-mercaptoethanol) and 200 µl/cm2 of the diluted solution was applied to the substrate 
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surface, incubated at RT for 1 h, after which unbound material was aspirated.  
 
2.5.2. Introduction of primary amines to PDLLA using 
aminolysis 
Primary amines were introduced into the surface of PDLLA films (for Chapters 5 and 
6) and PDLLA scaffolds (for Chapter 7) using aminolysis (Figure 2-9). 
Ethylenediamine was diluted in isopropanol to yield a solution with concentrations 
(v/v) ranging from 1% to 20%. PDLLA films and scaffolds were immersed into the 
prepared solutions and continuously agitated for 5 min using an orbital shaker. The 
samples were then rinsed with excess water to remove any free, unreacted solution 
and stored in a vacuum desiccator until use. 
 
PDLLA films prepared in Chapter 5 were treated with only 4% ethylenediamine 
solution. PDLLA films prepared in Chapter 6 were treated with 1%, 2%, 4%, 6%, 8%, 
10%, 15% and 20% of ethylenediamine solution. PDLLA scaffolds prepared in 
Chapter 7 were treated with only 4% ethylenediamine solution. PDLLA films 
(Chapter 6) or scaffolds (Chapter 7) treated with n% ethylenediamine in isopropanol 
were abbreviated as n%EDiamine, where n is the concentration of the 
ethylenediamine used for aminolysis. 
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Figure 2-9 Aminolysis reaction scheme of polyesters. Primary amines can break the ester bonds to form 
amide groups. 
 
2.5.3. Preparation of amine-terminated and carboxylic 
acid-terminated branched architectures 
Amine-terminated and carboxylic acid-terminated branched architectures were 
introduced to the surface of PDLLA films in Chapter 6 and PDLLA scaffolds (SL-25C) 
in Chapter 7 by repetitively grafting spacer and “trifunctional molecule” to the 4% 
ethylenediamine-treated PDLLA surface, which was described in Chapter 2.5.2. 4 % 
ethylenediamine (v/v) was used to treat PDLLA films and scaffolds first because the 
preliminary study suggested that PDLLA films treated with ethylenediamine 
concentrations higher than 4 % were too fragile for further branching modifications. 
Using either tris(2-aminoethyl)amine (TREN) (Figure 2-10) or N-(2-acetamido) 
iminodiacetic acid (ADA) (Figure 2-10) as “trifunctional molecules”, which possess 
three functional groups, it is possible to generate amine-terminated (bTREN) and 
carboxylic acid-terminated (bADA) branched architectures. Branched architectures up 
to three generations were prepared. In the following text, bTRENn and bADAn stands 
for branched architectures that have maximal n generations, where n can be 1, 2 or 3. 
The choice of spacers was not identical for all branched architectures. In brief, 
succinic acid (Figure 2-10) was used as spacer for all generations of bTREN, while 
succinic acid was used as spacer for the first generation only and γ-amino butyric acid 
(GABA) (Figure 2-10) for the subsequent generations of bADA.  
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Figure 2-10 Chemicals used to introduce branched architectures to the surface of PDLLA films and 
scaffolds 
 
The linkers 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC) 
and N-hydroxysuccinimide (NHS) were used to link the carboxylic acid of one 
molecule, i.e. the spacer or the trifunctional molecule, to the primary amine of another 
molecule, i.e. the trifunctional molecule or the spacer. Once mixed with carboxylic 
acid, EDC can react with NHS to form a semi-stable amine-reactive NHS ester with 
life times of several hours, making two step grafting reactions possible. 
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Figure 2-11 Schematic of the reaction of EDC and NHS. EDC can react with carboxylic acid to form an 
unstable amine-reactive O-acylisourea intermediate which can reactive with amine to form a stable 
amide bond, or hydrolysed by water to regenerative the carboxylic acid, or reactive with NHS to form a 
semi-stable amine-reactive NHS-ester. Comparing to O-acylisourea which has a life time of only a few 
minutes, NHS-ester have a life time for several hours in aqueous solution and for several months when 
samples are stored in a dry environment, therefore it is more suitable to further react with primary 
amines to form an amide bond ([213]). 
 
Five different reactions were used to prepare branched architectures (Figure 2-12). 
The choice and the sequence of the reactions for the preparation of certain branched 
architectures were listed in Table 2-7. All reactions composed of 2 steps. The first step 
was the activation of the carboxylic acid of one molecule, and the second was the 
coupling reaction of amine of another molecule to the activated carboxylic acids. Step 
1 and step 2 were performed at pH 5 and pH 8, respectively. In reaction 1 4 mg of 
EDC and 11 mg of NHS were added per ml of 0.1 M 2-(N-morpholino)ethanesulfonic 
acid (MES) buffer containing 20 mM succinic acid at pH 5 and stirred for 15 min at 
RT. The final concentrations of EDC and succinic acid in MES buffer were 20 mM 
and 50 mM, respectively. 10 M NaOH was then added to adjust the solution pH to 8. 
4% ethylenediamine-treated films were then immersed and agitated continuously for 2 
h in 2 ml of the activated succinic acid solution followed by a thorough water rinse. 
For reaction 2 and 3 (Figure 2-12), PDLLA films were immersed and agitated in 2 ml 
of solution containing 20 mM EDC and 50 mM NHS in MES buffer at pH 5 for 15 
min, thoroughly washed with water afterwards, then immersed in 2 ml of 4% (w/v) 
TREN in water at pH 8 (Figure 2-12, reaction 2) or 50 mM ADA in PBS at pH 8 
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(Figure 2-12, reaction 3) for 2 h under continuous agitation and finally rinsed 
thoroughly with water. For reaction 4 and 5, each PDLLA film was activated in the 
same way as for reaction 2 or 3, rinsed and immersed in 2 ml of 50 mM GABA in 
PBS at pH 8 (Figure 2-12, reaction 4) or 50 mM ADA in PBS at pH 8 (Figure 2-12, 
reaction 5) for 2 h under continuous agitation. Samples were washed with large 
quantities of distilled water after each reaction. All grafting reactions were performed 
at RT.
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Figure 2-12 Reaction scheme used to prepare the 2 branched architectures (bTREN and bADA). 
Reaction 1: succinic acid activated by EDC and NHS was grafted to 4%EDiamine. Carboxylic acid 
(circled by dashed line) indicates a site of possible reaction to the adjacent surface amine. Then TREN 
(reaction 2) or ADA (reaction 3) was grafted to the grafted succinic acid. Amines (circled by dashed 
line) in reaction 2 indicate possible reaction sites to adjacent carboxylic acid of grafted succinic acid. 
Reaction 4: GABA was grafted to ADA. Reaction 5: ADA was grafted to GABA.  
 92
 
Table 2-7 The sequence of reactions (for Figure 2-12) for the preparation of branched architectures 
Branched 
architectures 
Sequence of reactions  
bTREN1 1→2 
bTREN2 1→2→1→2 
bTREN3 1→2→1→2→1→2 
bADA1 1→3 
bADA2 1→3→4→5 
bADA3 1→3→4→5→4→5 
 
2.5.4. Grafting of laminin peptides onto surface amines of 
aminolyzed PDLLA films 
Bioactive peptides were grafted to the surface amines of the aminolyzed PDLLA films 
as described in chapter 5. Firstly, PDLLA films were treated with 4% (v/v) 
ethylenediamine solution as described in section 2.5.2. The peptides 
arginine-glycine-aspartic acid (RGD, Sigma-Aldrich, Haverhill, UK) (Figure 2-13) 
and Tyr-Ile-Gly-Srg-Arg (YIGSR, Bachem, St. Helens, UK) (Figure 2-13) were 
dissolved at concentrations of 0.02 mg/ml and 0.034 mg/ml, respectively, in 0.1 M 
PBS. Both peptide solutions were adjusted to pH 8 using 10 M HCl. Cocktails 
consisting of RGD and YIGSR in molar ratios of 100:0 (100RGD-0YIGSR), 75:25 
(75RGD-25YIGSR), 50:50 (50RGD - 50YIGSR), 25:75 (25RGD-75YIGSR) and 
0:100 (0RGD-100YIGSR) were grafted to PDLLA surfaces using a 2 step protocol 
(Figure 2-14). In step 1, 4 mg of 1-ethyl3(3dimethylaminopropyl) carbodiimide 
hydrochloride (EDC, Pierce Biotechnology, Northumberland, UK) and 11 mg of 
N-hydroxysuccinimide (NHS, Acros Organic, Geel, Belgium) were added per ml of 
0.1M 2-(N-morpholino)ethanesulfonic acid (MES) buffer containing 20 mM succinic 
acid at pH 5 and stirred for 15 min at RT. The final concentrations of EDC and 
succinic acid were 20 mM and 50 mM, respectively. 10 M NaOH was then added to 
adjust the solution pH to 8. Films pretreated with 4% (v/v) ethylenediamine in 
isopropanol for 5 min were then immersed and shaken continuously in 2 ml of the 
activated succinic solution for 2 h followed by thoroughly water rinse. In step 2, each 
succinic acid-grafted PDLLA film was immersed and agitated in 2 ml of solution 
containing 20 mM mg EDC and 50 mM of NHS in a MES buffer at pH 5 for 15 min, 
then each activated film was immersed in 2 ml of the peptide cocktail at pH 8 for 2 h 
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under continuous agitation followed by thorough washing using large quantities of 
water. 
 
 
Figure 2-13 Structures of peptides RGD and YIGSR. Amines circled by dashed lines are the locations 
where conjugations occur. 
 
 
Figure 2-14 Schematic of the peptide grafting reactions. The primary amines on the PDLLA were 
introduced by aminolysis using 4% ethylenediamine in isopropanol for 5 min prior to the grafting 
reaction. 
 
2.6. Characterization of polymer films and scaffolds  
2.6.1. Surface character of polymer films: ζ potential 
Measurements 
The ζ-potentials of uncoated TCP, protein-coated TCP, uncoated PDLLA films and 
protein-coated PDLLA films as described in Chapter 3, and surface-modified PDLLA 
films (4%EDiamine, bTREN3 and bADA3) as described in Chapter 6, were measured 
using an Electrokinetic Analyser (EKA, Anton Paar KG, Graz, Austria) based on the 
streaming potential method [214]. To eliminate any errors that could be caused by 
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polymer swelling, the ζ-potential change over time, ζ=f(t), was recorded at constant 
ionic strength (1 mM KCl) prior to conducting the ζ=f(pH). After the ζ-potential 
stabilised with time, it was subsequently recorded as a function of pH (ζ=f(pH)) in a 1 
mM KCl supporting electrolyte solution. The streaming potential was generated by 
applying a steadily increasing pressure difference (Δp) from 30 to 250 mbar across a 
channel which was created by stacking a PTFE film with a preformed channel 
between two sample films. The pH was controlled by adding either 0.1 M HCl or 0.1 
M KOH using a remote titration unit (RTU, Anton Paar KG, Graz, Austria) at a 
constant temperature of 20°C. 
 
2.6.2. Dynamic contact angle measurements 
The relative levels of hydrophilicity displayed by uncoated TCP, uncoated PDLLA 
films, protein-coated TCP and protein-coated PDLLA films as described in Chapter 3 
were assessed by dynamic contact angle measurements using the Drop Shape Analysis 
System (DSA 10 Mk2; Krüss GmbH, Hamburg, Germany) using sessile drop or 
captive bubble methods. The wettability of the modified PDLLA films as described in 
Chapter 5 and Chapter 6 was assessed only by dynamic captive bubble contact angle 
measurements using the same equipment. At least 5 independent measurements of 
advancing and receding contact angles were performed per sample. 
 
For sessile drop method, advancing and receding contact angles were measured from 
digital images of a drop of de-ionised water in direct contact with a dry surface. The 
volume of the droplet was controlled by a motor driven microsyringe. For the captive 
bubble method, the polymer films were immersed in distilled water overnight before 
the measurements, allowing the polymer to equilibrate, i.e. to swell and for the 
reorientation of polymer chains. An air bubble of 60 μl was created at a rate of 20 
μl/min beneath the polymer film immersed in de-ionized water. The volume of the 
bubble was controlled by a motor driven microsyringe. The contact angle θ was 
measured into the water phase. At least 5 independent measurements of advancing 
and receding contact angles were performed per sample. All measurements were 
made in an air-conditioned room at a constant temperature of 20 °C. 
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2.6.3. Morphological analysis of the scaffolds using scanning 
electron microscopy 
For the morphological analysis of scaffolds as described in Chapter 7, scaffolds 
prepared using liquid-liquid phase separation were sectioned along the vertical axis of 
the scaffolds, and scaffolds prepared using solid-liquid phase separation were section 
both along and transverse to the direction of the ladder-like pores using a razor blade. 
The sectioned scaffolds were examined with a Jeol JSM-840A scanning electron 
microscope. Prior to SEM, the samples were coated with an 11 nm thick Au layer 
using a sputter coater (Emitech Ltd., Ashford, UK) in an argon atmosphere. The size 
of the pores was analysed using Image-pro plus software (Media Cybernetics, Silver 
Spring, Maryland, USA). 
 
2.6.4. Fluorescamine assay for quantification of primary amine 
functional groups 
The fluorescamine assay was originally used to quantify proteins by measuring the 
amount of the primary amines in a protein [22, 23] and later applied to quantify the 
amine amount on a polymer surface [28, 215]. A fluorescamine molecule can react 
with a primary amine to generate a fluorescent primary amine adduct (Figure 2-15). 
The fluorescence was measured by dissolving the aminolyzed PDLLA films (Chapter 
6) in the fluorescamine solution. Thus, the fluorescamine assay measured the bulk 
concentration of the primary amines of the modified PDLLA films. However, if the 
amines are located only at the surface, the amine concentration on the surface of 
PDLLA films can be estimated. The fluorescamine working solution was prepared by 
dissolving 30 mg of fluorescamine in 90 ml of acetone. 2 cm2 of aminolysis-treated 
PDLLA films were completely dissolved in 1 ml of fluorescamine solution for 30 min. 
100 μl of the assay solution containing the samples was transferred to a white 96 well 
plate and tested in a fluorescence plate reader using an excitation wavelength of 390 
nm and emission wavelength of 475 nm. In order to determine the concentration of 
amines in the fluorescamine solution containing samples, a calibration curve of the 
fluorescence intensity against primary amine concentration was established by serial 
dilution of ethylene diamine in the fluorescamine assay solution (see Appendix B3). 
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Figure 2-15 Fluorescamine reacts with primary amine groups to form primary amine adducts which 
absorb light at 390 nm, and emit light at 475 nm. 
 
2.6.5. Surface topography and roughness of modified PDLLA: 
Atomic Force Microscopy (AFM) 
1 μm2 of PDLLA films grafted with bioactive peptides, as described in Chapter 5, and 
1 μm2 of functionalized PDLLA films, as described in Chapter 6, were imaged using a 
Multimode V Atomic Force Microscope with Nanoscope 6 software (Veeco, USA) 
operated in the tapping mode. The surface roughness parameter Ra, the average 
deviation of distance between all points of a roughness profile and a mean line, was 
calculated using the open source software Gwydion V2.9 (Link in: 
http://gwyddion.net/ assessed on 06.01.2009) according to ISO 4287/1-1997 standard. 
At least 4 different areas of each sample were imaged to obtain the average Ra of the 
unmodified and modified PDLLA films. 
 
2.6.6. Surface composition of modified PDLLA: X-ray 
photoelectron spectroscopy (XPS) 
The surface composition of the PDLLA films modified with amine-terminated and 
carboxylic acid-terminated branched architectures, as described in Chapter 6, were 
determined using X-ray Photoelectron Spectroscopy (XPS) (Escalab 220iXL, Thermo 
VG Scientific, UK). Measurements of surface elemental composition were performed 
using an Al Kα monochromated X-ray source and quantified in CasaXPS (Casa 
software Ltd). To reduce the charging of the polymer surface, a silver mask was 
placed on top of the polymer sample and the X-ray beam stroke the sample through 
the slot of the silver mask. Furthermore, an electron flood gun was used to 
compensate charging effects of the samples. For all the samples, both survey and high 
resolution spectra were recorded for precise evaluation of the chemical composition. 
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For the quantification of the elemental composition of the modified PDLLA films, a 
frequently-used background subtraction algorithm, Shirley background, was applied 
for the asymmetric background subtraction before the curve fitting was employed. 
 
2.7. Culture and evaluate cells on biomaterials 
2.7.1. Seeding A549 cells onto scaffolds 
Scaffolds with different porous structures, as described in Chapter 7, were cut into 
cubes with the dimensions 2 mm × 2 mm × 4 mm using a razor blade. The scaffolds 
were sterilized under UV light for 45 min at 0.120 J and 80 W (BLX-254, Vilber 
Lourmat, France). 
 
It should be noticed that upon exposure to UV, the surface properties of a biomaterial 
altered. UV radiation could break the polymer chain near the surface of polymer, 
generating free radicals and new chemical groups. The free radicals can induce further 
reaction, such as crosslinking and grafting, if other reactive groups were presented. 
The newly-formed chemical groups can reduce the water contact angle and improve 
the biocompatibility. The scisson of the polymer chains caused by UV lowered the 
molecular weight of the material, thus accelerate the degradation. As a result, the 
surface roughness of the biomaterial can be affected by the UV sterilization. Despite 
so, only extended UV exposure, e.g. more than 5 h as reported by recent studies [216, 
217], can the UV sterilization change the cell responses to a material. 
 
Before cell seeding, the scaffolds were immersed in A549 medium, placed in a 
desiccator and vacuum pumped to remove all air trapped from the scaffolds until no 
apparent bubbles could be seen. Scaffolds sank to the bottom of the flask when most 
bubbles were removed. 2 μl of the medium soaked within the scaffold was removed 
using a pipette, then 2 μl of high density A549 cell suspension (1000 cells/μl) was 
seeded on the scaffolds, which were placed on non-tissue culture-treated 
polycarbonate Petri dishes and incubated in 5% (v/v) CO2 atmosphere at 37℃ for 4 h. 
The scaffolds were then transferred to 24 well plates and 500 μl of culture medium 
added to each well gently in order not to remove the unattached cells from the 
scaffolds. A549 cells were cultured for 16 days with medium changed every other day. 
 
 98
 
Figure 2-16 Removal of the air trapped within the scaffolds by negative pressure applied to the vacuum 
desiccator 
 
2.7.2. The penetration of A549 cells into scaffolds evaluated 
using fluorescence and scanning electron microscopy 
Scaffolds (LL27C to LL12C, SL-25C and SL-196C) cultured with A549 cells for 16 
days, as described in Chapter 7, were examined under an Olympus IX70 inverted 
fluorescence microscope (Olympus, Helperby, UK). Scaffolds were further cut in half 
along the direction of initial cell seeding in order to investigate whether the A549 
cells penetrated into middle of scaffolds. Cells were fixed in situ with 4% (w/v) 
paraformaldehyde in 0.1 M phosphate-buffered saline (PBS) for 40 min at room 
temperature. Serial dehydration of fixed A549 cells was then performed to completely 
remove the water from the cells. Briefly, samples were thoroughly rinsed twice with 
PBS and dehydrated sequentially in 25, 50, 70 and 90% (v/v) ethanol for 5 min once, 
100% ethanol for 5 min twice which was followed by incubation in 
hexamethyldisilane (Sigma-Aldrich, Dorset, UK) for 5 min. The dehydrated cells on 
scaffolds were coated with Au and examined using a Jeol JSM-840A scanning 
electron microscope as described earlier. 
 
2.7.3. Evaluation of attachment and population size of A549 
cells by measurement of DNA content using Hoechst dye  
The adhesion of A549 cells to the peptide-grafted PDLLA films (Chapter 5) and 
functionalized PDLLA films (Chapter 6) was assessed by measurement of the DNA 
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content using Hoechst 33258 dye. Hoechst 33258 dye can penetrate the cell 
membrane and bind to the minor grove of DNA. The fluorescence emitted by Hoechst 
33258 dye is therefore proportional to the DNA amount. 80000 cells were seeded onto 
24 well plates containing samples fixed to the bottom of each well. After 2 h, the 
culture medium was aspirated followed by one gentle rinse with PBS to remove 
unattached cells. The 2 h period, determined in preliminary tests, was found to be an 
appropriate period for the cell attachment test. 500 μl of proteinase K in K2HPO4 (pH 
8) at a concentration of 50 μg/ml was added to each well and incubated in 5% CO2 
incubator at 37℃ overnight followed by heating at 90℃ for 10 min to inactivate the 
enzyme. Proteinase-treated samples were then pipetted vigorously and centrifuged at 
10000 RPM for 10 min. 100 μl of the supernatant were then transferred to a 24 well 
plate, mixed with 100 μl of Hoechst 33258 dye (2 μg/ml) and vortexed for 2-3 min. 
100 μl of each mixture containing supernatant and Hoechest dye solution was 
transferred to a white 96 well plate and the emission fluorescence was measured at 
458 nm with the excitation wavelength of 365 nm. A standard curve of absorbance 
versus known cell number was also plotted as a reference for the experimental groups. 
(Appendix A4, Figure A-9) 
 
The population of A549 cells cultured on the peptide-grafted PDLLA films (Chapter 5) 
and functionalized PDLLA films (Chapter 6) for 3 and 4 days was also evaluated 
using Hoechst 33258 dye. The protocol used to determine the A549 cell population 
was the same as the protocol used to determine A549 attachment. 
 
2.7.4. Evaluation of cell activity using WST-1 assay 
The viable cell assay, that uses WST-1 reagent (Roche Applied Science, Herts, UK), is 
a colourimetric assay to evaluate metabolic activity, proliferation and viability of the 
cells. Similar to MTT [218], XTT and MTS assays, the tetrazolium salt WST-1 
cleaves into formazan by the action of a cellular enzyme, mitochondrial 
dehydrogenase, causing the colour to change from slightly red to dark red. The level 
of the colour change correlates with the augmentation of the total enzyme activity of 
the tested cells. The colour change can be quantified using a spectrophotometer with a 
measurement wavelength of 420-480 μm and a reference wavelength of over 600 μm. 
Compared with other tetrazolium salts, WST-1 salt offers a wider linear range in 
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response to cell number and cell proliferation. In addition, it also cleaves into soluble 
products like XTT and MTS, thus the addition step of solubilization is not required.  
 
The WST-1 assay was used throughout this thesis (Chapters 3, 5, 6 and 7). In Chapter 
3, in order to test the effect of extracelullar matrix on the proliferation of the 
differentiating mESCs, 400 μl of the homogenized EB suspension was seeded onto 
24-well plates pre-coated with different ECM proteins. On days 11, 12, 16, 20, 24 and 
28 of the differentiation culture, 400 µl of fresh culture medium (serum-free medium 
or SABM) containing 10% (v/v) WST-1 reagent was added to each well and to 4 
blank wells as background controls. The plates were incubated in a humidified 
atmosphere (37oC, 5% (v/v) CO2) for 3 h and shaken gently every 30 min. After 3 h, 
100 µl of the medium was transferred to 96 wells plate and sampled using Dynes 
MRX multi-well plate reader with the test filter at 450 nm and the reference filter at 
650 nm. 
 
For the evaluation of the activity of A549 cells cultured on peptide-grafted PDLLA 
films (Chapter 5) and functionalized PDLLA films (Chapter 6), 5000 A549 cells were 
seeded onto 24 TCP wells, unmodified PDLLA films and modified PDLLA films 
fixed to the bottom of each well containing 500 μl A549 medium changed every other 
day. On days 2 and 4, 500 μl A549 medium containing 5% (v/v) WST-1 solution was 
added to each well. After 1 h, 100 μl of medium was transferred to a transparent 96 
well plate and sampled using the same multi-well plate reader. 
 
For the evaluation of the activity of A549 cells cultured within the scaffolds as 
described in Chapter 7, 500 μl fresh A549 medium containing 5% (v/v) of WST-1 
solution was added to each well containing unmodified or modified scaffolds 4, 8, 12 
and 16 days after A549 cell seeding. After 1 h, 100 μl of medium was transferred to 
96 well plates and sampled using the same multi-well plate reader. 
 
2.8. Statistical analysis 
Statistical analysis of all experimental data was conducted using SPSS16 software 
(SPSS Inc., Chicago, USA). To evaluate whether the average of each independent 
experimental groups are equal, one-way ANOVA (analysis of variance) followed by 
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LSD post-hoc test was performed. The probability value P < 0.05 between two 
samples was considered significantly different. 
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Chapter 3. The effect of culture substratum on the derivation of 
pulmonary epithelial progenitors from murine embryonic stem 
cells 
 
3.1. Introduction  
Respiratory diseases are debilitating and are the leading causes of morbidity and 
mortality worldwide. Pulmonary disease such as pulmonary fibrosis is current 
irreversible and no effective treatment is available. From a tissue engineering point of 
view, restoration of lung function of the above-mentioned pulmonary disease may be 
achieved by implanting pneumocytes on an appropriate scaffold into the gas-exchange 
area of the impaired organ. This area of the lung is comprised of air sacs, or alveoli, 
lined by two types of epithelial cells; gas exchange occurs across type I pneumocytes 
while type II pneumocytes secrete surfactant proteins and act as local progenitors for 
type I cells. At present, it is very difficult to obtain or expand pure populations of 
primary type II pneumocytes and they do not maintain their phenotype for prolonged 
periods in vitro [10]. Thus, stem cells have been explored as a source for potential 
regenerative medicine strategies for the lung. Pulmonary progenitors which can 
express the features of type II pneumocytes, have been differentiated from both 
murine and human embryonic stem cells in a 2D environments using soluble factors 
[16, 203, 219, 220] or cell extract-based reprogramming [17] and, in 3D, using 
coculture [18].  
 
Cell-matrix interactions are well known to affect lung development, including type II 
cell function, surfactant protein synthesis and secretion [221], e.g. laminin is essential 
for alveolar formation and its mRNA increases during lung development [107]. The 
extracellular matrix (ECM) associates with lung development and also plays roles in 
maintaining both the type II pneumocyte phenotype in vitro and lung repair in vivo.  
The morphology of type II pneumocytes and the secretion of surfactant proteins, such 
including surfactant protein C (SPC) and surfactant protein D (SPC), by type II 
pneumocytes retained best on collagen membranes [117], laminin [120] or 
Matrigel-coated plastic [116] with or without growth factors or external forces. 
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Recently, collagen-GAG [196] and Matrigel hydrogel [22] were used as coatings for 
scaffolds seeded with primary pneumocytes. A basic principle of tissue engineering is 
to deliver appropriate cells loaded on scaffolds resembling the in situ tissue both 
mechanically and physiologically [19]. These constructs should fulfil several stringent 
requirements [5]. Poly(D,L-lactide) (PDLLA), a hydrophobic polymer synthesized 
from lactic acid, has been widely used as a scaffold material for different tissue 
engineering applications and is appropriate for lung tissue engineering in particular 
because of its elasticity and its biodegradability when processed into scaffolds. The 
surface properties of a material are known to have significant effects on cell 
attachment, growth and differentiation. As PDLLA is hydrophobic, which may not be 
ideal for cell culture, it is essential to render its surface compatible with cells. In 
addition, in working towards a simplified, easily reproducible system for the 
production of lung tissue constructs an attempt is being made to both differentiate and 
grow ESC-derived pneumocytes on the scaffold. The study was performed in two 
steps. Firstly, the effects were studied of different ECMs coated onto tissue culture 
plastic (TCP) on the differentiation of pulmonary epithelial progenitors from mESCs. 
The pulmonary progenitors, derived using the three-step differentiation protocol [203], 
express the features of the type II pneumocytes. The protocol starts by forming EBs 
from the undifferentiated mESCs. The EBs were then differentiated for 10 days before 
being seeded on to the protein-coated TCP. Day 10 EBs were cryosectioned and 
immunostained to investigate the spatial distribution of the endodermal markers and 
the basement membrane. On day 28, the differentiating culture was analysed for 
expression of type II pneumocyte markers. Based on the results obtained, protein 
coatings that were found to induce higher expression of type II pneumocyte markers 
in the differentiating mESCs were further investigated as coatings on PDLLA films, in 
order to select an appropriate coating for future 3D constructs of distal lung. 
 
Protein coating can change the surface properties of the coated materials dramatically. 
The change in the surface properties can alter cell responses, such as attachment, 
migration, proliferation and even the phenotype. Therefore, the surface properties of 
ECM-coated TCP and PDLLA were also studied using contact angle and ζ-potential 
measurements. The former unveiled the wettability of the protein-coated surfaces and 
the latter was used to evaluate the overall chemistry of the protein-coated surface 
[214].  
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3.2. Methodology  
Five different proteins, including gelatin (GN), collagen (CO), laminin (LN), 
fibronectin (FN) and ECM replacement Matrigel (ML), were coated to TCP (Chapter 
2.5.1.) The water contact angles (Chapter 2.6.2) and the ζ-potential (Chapter 2.6.1) of 
the protein-coated TCP were recorded. For the derivation of pulmonary progenitors, 
embryoid bodies were generated from undifferentiated mESCs for 10 days (Chapter 
2.2.2.2). On day 11, some EBs were cryosectioned and stained for the expression of 
TTF1, laminin and Foxa 2 (Chapter 2.3.3). Other differentiated EBs were seeded on 
protein-coated TCP, and the differentiation progressed for next 18 days (Chapter 
2.2.2.3.1). The preliminary experiments demonstrated that EBs did not attach to 
uncoated-TCP or uncoated PDLLA, so these two surfaces were not further evaluated 
using differentiation culture. Fluorescence microimages were taken on day 21 and 28 
of differentiation (Chapter 2.3.1). On day 28, mRNA expression of SPC, SPD, 
Auqaporin 5, GAPDH and beta-actin were analyzed using RT-PCR (Chapter 2.3.2). 
On the same day, SPC-eGFP positive cells were counted using flow cytometry 
(Chapter 2.3.4). To evaluate the metabolic activity of the differentiation culture, 
WST-1 assay was performed on day 11, 12, 16, 20, 24 and 28 (Chapter 2.7.4). 
 
Basing on the results obtained, LN, ML and the experimental control, GN, were 
further coated to PDLLA (Chapter 2.6.2). The surface properties of protein-coated 
PDLLA films were recorded using water contact angles and the ζ-potential. The same 
differentiation experiments and characterizations were performed on mESCs 
differentiated on protein-coated PDLLA films. 
 
3.3. Results  
3.3.1. Transmitted light and fluorescence microscopy 
To assess the spatial distribution of the endoderm and possible formation of 
pulmonary lineages in day 10 EBs, Foxa2 and TTF-1 were immunostained. Numerous 
Foxa2-immunoreactive cells were found, with the vast majority lying at the periphery 
of the EBs (Figure 3-1A). A smaller population of TTF1-immunoreactive cells was 
also present in the same area (Figure 3-1B). Immunostaining of laminin revealed 
basement membrane formation just beneath the outermost cell layer of the EBs 
(Figure 3-1C), although it did not appear to be contiguous. The discontinuity of 
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basement membrane was also observed by examination of other five sectioned EBs.  
 
At the end of day 21 differentiation culture, SPC-eGFP-expressing cells were 
observed in all experimental groups (Figure 3-1D-K), with their frequency varying 
greatly between different colonies grown under the same experimental conditions, 
therefore, it is not possible to evaluate the percentage of SPC-eGFP positive cells in 
the whole population under fluorescence microscopy. Most SPC-eGFP-positive cells 
lay at the margin of the adherent EB clump and tended to form clusters. In many 
colonies, the SPC-eGFP positive cells lined the characteristic cyst at the core of the 
EB (Figure 3-1H, J). At the end of day 28, cells exhibited some autofluorescence 
which obscured the SPC-eGFP-positive cells and, therefore, these fluorescent images 
were not representive (Figure 3-2). The autofluorescence was the result of SABM, 
which only “selected” the pulmonary progenitors and had chronic toxicity to other 
cells. Those dying cells therefore exhibit strong autofluorescence. 
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Figure 3-1 A-C: left: immunostaining of cryosectioned EBs at the end of day 10, right: the negative 
control of each antibody. (A) Foxa2-immunoreactive cells (red) lying around the border of the cell 
cluster. (B) TTF1-immunoreactive cells (red). Positive cells are also seen at the periphery of the EB but 
in lower numbers than those expressing Foxa2. (C) Immunoreactivity for laminin (red) appears to form 
a layer under the outermost ring of cells. Nuclei (blue) stained with DAPI in all cases. D-K: left: 
SPC-eGFP positive cells at the end of day 21; middle: transmitted light photograph of the same field; 
right: the overlay of fluorescence images and transmitted light photograph. Transcription of the SPC 
gene, and therefore differentiation of pulmonary progenitors, was demonstrated by SPC-eGFP 
fluorescence (green) in differentiating EBs grown on (D) TCP-GN; (E) TCP-CO; (F) TCP-LN; (G) 
TCP-FN; (H) TCP-ML; (I) PDLLA-GN; (J) PDLLA-LN; (K) PDLLA-ML. More than 4 images of 
independent samples from the same conditions were analyzed. 
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Figure 3-2 Microscopic images taken at the end of day 28 differentiation. (A) Left: transmitted light 
photograph of TCP-GN. Right: Green fluorescence channel from the same sample. (B) Left: 
transmitted light photograph of PDLLA-LN. Right: Green fluorescence channel from the same sample. 
Strong autofluorescence was observed from the green fluorescence channel, obscuring the SPC-eGFP 
positive cells. 
 
3.3.2. Evaluation of the mRNA expression of differentiated cells 
using RT-PCR 
Figure 3-3A shows the mRNA expression profiles of differentiated cells cultured on 
protein-coated TCP at the end of day 28. Three independent samples of each condition 
were shown. It appeared that expression of SPC by the cells was influenced by the 
substratum upon which they are cultured, with levels of expression appearing to be 
higher on TCP-LN and TCP-ML than on TCP-GN. Cells grown on TCP-CO or 
TCP-FN expressed less SPC mRNA than those grown on TCP-GN. All other mRNA 
expression levels, except those for GAPDH mRNA which was used as housekeeping 
gene, showed similar trends as those seen for SPC mRNA expression. Cells grown on 
TCP-CO had the lowest levels of each mRNA assayed except for that of GAPDH. 
GAPDH mRNA expression was very consistent in every experimental group 
compared with beta-actin mRNA. On protein-coated PDLLA, the mRNA expression 
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profile was different. Cells grown on PDLLA-LN showed the highest expression of 
each gene tested except housekeeping GAPDH (Figure 3-3B). Cells cultured on 
PDLLA-ML also had mRNA expression levels higher than those obtained for the GN 
control. Beta-actin and SPD mRNA expression showed a similar tendency to that of 
SPC mRNA.  
 
 
Figure 3-3 Results of RT-PCR analysis of mRNA expression profiles of differentiated cells grown on 
coated (A) TCP and (B) PDLLA at the end of day 28 differentiation. Expression of markers for type I 
(aquaporin 5) and type II (SPC, SPD) pneumocytes was seen in EBs grown on TCP coated with GN, 
CO or LN but the strongest expression occurred in EBs grown on LN-coated PDLLA. The symbol – 
stands for negative control. The symbol + stands for positive control, which used cDNA from MLE-12 
cells, an immortalized murine lung epithelial cell line. 
 
3.3.3. EBs attachment, cell activity and cell spreading from EBs  
The effect of different ECM proteins on cell attachments and activities was assessed 
with the WST-1 assay. Initial EB adhesion to TCP-LN, TCP-FN and TCP-ML was 
better than that to TCP-GN and TCP-CO (Figure 3-4A). Clearly, some EBs did not 
attach to TCP-GN and TCP-CO at the end of day 12, resulting in a drop in optical 
density (OD; directly proportional to cell activityies) at 450 nm wavelength. As for 
protein-coated PDLLA, drop in OD was observed on PDLLA-GN and PDLLA-LN 
(Figure 3-4B). Whether or not that EBs can attach to protein coated materials was 
found determined by the cell spreading from the EBs (Figure 3-4C-J). The cell 
spreading on day 12 were in agreement with the OD obtained from WST-1. Cell 
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activities were previously found to increase in this system from day 11 to day 20 
[203]. Similarly, cells in all conditions demonstrated slight increase in overall cell 
activities from day 12 to day 20, which may be the result of increased total cell 
number. On day 21, the serum-free medium was replaced with SABM. From day 
20-24, the overall cell activity in all conditions stayed at a similar level or dropped. It 
was very likely due to the chronic toxicity of SABM to non-pulmonary cells. From 
day 24-28, activities of cells on protein-coated TCP dropped, whereas activities of 
cells on protein-coated PDLLA increased, with ML-PDLLA showed the highest 
increase. The addition of SABM resulted in increased numbers of dying and dead 
cells, as observed under light microscopy (Figure 3-5A). SABM can also be the cause 
of strong autofluorescence of cells differentiated for 28 days (Figure 3-2 and Figure 
3-5B) as mentioned before. 
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Figure 3-4 (A-B) Results of WST-1 assay of cell activity. The activity of cells on ECM-coated TCP or 
PDLLA were found to increase slightly from day 11 to day 20. A different pattern was noted after day 
20 when the overall cell activities on ECM-coated TCP stayed at the same level (day 20-24) then fell 
(day 24-28) while those on ECM-coated PDLLA stayed or fell (day 20-24), and recovered (day 24-28). 
5 independent samples in each condition were evaluated. The WST-1 experiments were repeated for 3 
times. C-J: Light microscopy of cells growing on ECM-coated TCP and PDLLA at the end of day 12. 
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Cells are shown growing on (C) TCP-GN; (D) TCP-CO; (E) TCP-LN; (F) TCP-FN; (G) TCP-ML; (H) 
PDLLA-GN; (I) PDLLA-LN and (J) PDLLA-ML. On PDLLA, cells were seen to extend from EBs to 
the greatest extent when grown on Matrigel-coated PDLLA film (J). Scale bar corresponds to 500µm. 
 
 
Figure 3-5 Light (A) and fluorescence (B) microscopic images of mESCs differentiated on TCP-LN at 
the end of day 28. Many vacuolated cells (arrows) can be observed under light microscopy (A). The 
vacuolated cells are either dying or dead. Strong auto-fluorescence from the cells could be observed on 
fluorescence microscopy. 
 
3.3.4. Determination of eGFP-positive cells by flow cytometry 
Gating of target cells in the differentiating culture was complicated, especially when 
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they comprised only a low percentage of the whole population. As there were many 
dead cells, as well as debris from both cells and the protein coating, after dissociating 
the adherent EBs by trypsin/EDTA, size gating and propidium iodide uptake were 
used for exclusion. The size of the SPC-eGFP-positive population assessed by flow 
cytometry generally in agreement with the SPC mRNA expression profile (Figure 
3-3A-B, and Figure 3-6D-E). The percentage of SPC-eGFP positive cells was ranged 
from 1.2% (TCP-CO) to 5.6% (TCP-ML). TCP-LN and TCP-ML increased the 
frequency of SPC-eGFP positive cells 1.9 and 2.3 fold, respectively, as compared with 
those differentiated on TCP-GN. However, there is no significant difference between 
TCP-LN and TCP-ML. PDLLA-LN and PDLLA-ML increased the frequency of 
SPC-eGFP positive cells 2.7 and 4.3 fold, respectively, as compared with those 
differentiated on PDLLA-GN. Similarly, there was no significant difference between 
PDLLA-LN and PDLLA-ML. 
 
 
 
Figure 3-6 Flow cytometry of SPC-EGFP-expressing cells performed at the end of day 28. (A) Gating 
was done to exclude small cell debris in the low forward scattering region. (B) Propidium iodide was 
used to rule out necrotic cells which have around 100 times higher fluorescence level in the FL3 
channel. Necrotic cells were often found in the terminal differentiation culture, especially in the middle 
of adherent EBs. The peak in the high FL3-H region stood for the PI that binded to the DNA of dead 
cells (C) A threshold was set in the green fluorescence channel FL1 of the negative control of flow 
cytometry (non-SPC-eGFP-transfected mESCs differentiated in parallel with the transfected mESCs). 
(D) The percentage of SPC-eGFP-positive cells cultured on protein-coated TCP was compared with 
cells grown on the control (TCP-GN). (E) The percentage of SPC-eGFP-positive cells cultured on 
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protein-coated PDLLA was compared with cells grown on the control (PDLLA-GN). The numbers 
shown in each column stand for the percentage of SPC-eGFP positive cells of the whole population. 
Asterisks specify statistically significant difference from value of control (TCP-GN and PDLLA-GN) 
(P<0.05). 4 independent samples in each condition were evaluated. The flow cytometry were 
performed for 3 times. 
 
3.3.5. Surface properties of the ECM-coated TCP and PDLLA 
films 
All the protein-coated surfaces except TCP-FN had lower advancing and receding 
contact angles than the uncoated ones, as measured by either the sessile drop or 
captive bubble method (Table 3-1). Some contact angles measured using the two 
methods differed significantly. For example, θA of TCP-ML measured by the sessile 
drop method was comparable to that of TCP-CO. However, θA of TCP-ML measured 
by captive bubble methods was much lower than that of TCP-CO. This difference 
between contact angles obtained by sessile drop and captive bubble was due to the 
intrinsic discrepancy of the measuring principals: contact angles measured using the 
sessile drop method are characteristic of the “dry” polymer surface while contact 
angles measured using the captive bubble method are characteristic of the “wet” or 
hydrated materials surface. Therefore, the positive effects of the coating on enhancing 
the wettability could be observed clearly in the results obtained using captive bubbles, 
especially in the receding contact angles. Despite the enhanced wettability with 
protein coatings, the SPC expression of the differentiated cells did not parallel the 
wettability, suggesting that the SPC expression is independent of the wetting 
behaviour of the substrate. Figure 6A-B shows the ζ-potential courses of the 
protein-coated TCP and PDLLA films as a function of pH (ζ=f(pH)). Both TCP and 
PDLLA films contain mainly Brønsted acidic function groups at the surfaces, which 
resulted in an isoelectric point (iep), where ζ=0, at a low pH and a plateau (ζplateau) in 
the alkaline region. This was understandable because most TCPs were oxygen 
plasma-treated and, thus, contained many acidic functional groups. All the different 
protein-coatings on TCP, except TCP-FN, were found to have a less acidic surface 
than uncoated TCP itself, according to the shift in IEP to a higher pH. Introduction of 
proteins, therefore, increased the numbers of basic groups, such as amines. For 
protein-coated PDLLA, all samples had a higher IEP, also suggesting a less acidic 
surface. TCP and PDLLA coated with the same proteins, except for LN, showed 
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similar values for IEP and ζplateau. PDLLA-LN had a higher IEP and lower ζplateau than 
TCP-LN. The former showed that PDLLA-LN contains fewer acidic functional 
groups and the latter that there were more dissociating acidic functional groups at high 
pH. The difference in the IEP and ζplateau of laminin 332 coating on different materials 
suggested dissimilar unfolding conformations of laminin which subsequently altered 
the mESC responses.
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Table 3-1 Water contact angles of TCP- and PDLLA-coated with/without ECM proteins. 6 independent 
samples in each condition were evaluated. The contact angle measurements were repeated twice. 
 
Contact angle measured by 
sessile drop method (dried 
surface) 
Contact angle measured by 
captive bubble method 
(wet surface) Condition 
Advancing Receding Advancing Receding
TCP 64.3±1.1 13.6±1 88.7±1.2 62.9±3 
TCP-GN 43.3±4.6 14.0±1.3 46.0±4 40.9±2.1 
TCP-CO 50.7±1.5 12.7±0.3 72.4±1.1 46.9±2.0 
TCP-LN 57.1±0.8 14.8±0.6 70.2±2.1 40.3±0.6 
TCP-FN 68.2±2.2 13.8±1.1 71.7±1.2 41.9±0.7 
TCP-ML 51.7±1.4 16.5±0.7 53.2±3.2 40.4±1.6 
PDLLA 73.6±2.3 57.0±1.9 81.8±1.9 63.3±2.5 
PDLLA-GN 62.2±1.2 21.0±1.7 69.7±2 44.6±1.3 
PDLLA-LN 54.3±4.4 13.3±1.8 77.8±2.4 51±1.5 
PDLLA-ML 56.3±2.7 16.3±0.9 47.4±2.6 49±2.1 
 
 
Figure 3-7 ζ-potentials of TCP and protein-coated TCP (A) as well as PDLLA and protein-coated 
PDLLA (B) measured as function of pH in 0.1 mM KCl supporting electrolyte. All protein-coatings on 
both TCP and PDLLA, except TCP-FN, were found to reduce surface acidity as shown by the IEP for 
each (pH at zero potential [0mV]). 2 independent samples in each condition were evaluated. The 
ζ-potential measurements were repeated for 3 times. 
 
3.4. Discussion 
This study aimed to test the effects of different extracellular matrix (ECM) proteins on 
the differentiation of mESCs cells to pulmonary epithelium. A previously published 
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three step differentiation protocol [203] was used to induce the differentiation of 
pulmonary progenitors from mESCs on TCP and PDLLA coated with a range of 
ECMs. Differentiating mESCs appeared to express more pulmonary epithelial 
markers on laminin and Matrigel than on gelatin on day 28. Higher frequency of 
SPC-eGFP positive cells were observed on laminin and Matrigel than the gelatin at 
the end of the differentiation course. As laminin and Matrigel can unfold in different 
conformations which may affect the mESC differentiation into pulmonary progenitors 
when adsorbed to PDLLA, Laminin 332 and Matrigel were further investigated as a 
coating for PDLLA. The results demonstrated that laminin 332 induced higher SPC 
expression than Matrigel and the control (gelatin) did, suggesting that the bioactive 
motifs exposed by laminin 332 adsorpted to the PDLLA films are favoured for the 
differentiation of mESCs into pulmonary progenitors. 
 
When the mESCs formed embryoid bodies (EBs), activin A was added to the culture 
medium to enhance the formation of the endodermal lineage [143, 222]. Collegaues 
have shown previously that expression of the endodermal markers Foxa2 and Sox17 
reaches a peak within EBs on day 10 of differentiation [203]. Therefore, EBs were 
seeded EBs onto protein-coated substrata at this stage. The peak of Foxa2 expression 
at day 10 is consistent with the current observation that Foxa2-immunoreactive cells 
formed a large proportion of the day 10 EBs. The smaller percentage formed by 
TTF1-immunoreactive cells also agrees with the previous finding made by colleagues 
that the expression of TTF1 just becomes detectable from day 11 [203].  
 
ECM proteins were introduced to the culture at the adherent culture stage (day 11-20). 
Serum-free medium was added to induce the random differentiation of mESCs after 
endoderm formation. Thus, if a certain ECM protein plays an important role in 
pneumocyte formation, there would be increased expression of the marker for type II 
pneumocytes, surfactant protein C (SPC), by mESCs differentiating on it. The mESCs 
used in the study were transfected with a 4.8kb murine SPC promoter/EGFP construct 
so that transcription of the SPC gene and, thus, differentiation to the type II 
pneumocyte phenotype, was marked by expression of green fluorescence. SPC-eGFP 
positive cells were observed at the end of the adherent culture stage. Early stage EBs 
have been reported to show endodermal cells on their outer surface and primitive 
ectodermal cells in the middle [223, 224]. The current finding that SPC-EGFP cells 
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located mainly at the borders of the adherent EBs is in agreement with this 
observation. It was also observed that the basement membrane beneath the monolayer 
of the EB surface was discontinuous. The monolayer is likely to be visceral endoderm 
[224], which will not differentiate into the pulmonary lineage. The enhanced 
expression of SPC by mESCs differentiated on LN and ML suggested that either an 
indirect effect was made by ECM on the monolayer cells which further affected the 
definitive endoderm or that some of the definitive endoderm cells had direct contact 
with the ECM coating due to the discontinuity of the basement membrane. 
 
Most SPC-EGFP cells were seen to form clusters, reflecting the necessity of cell-cell 
interactions during ESC differentiation. On day 28 of culture, following the switch to 
small airway basal medium (SABM) (day 21-28), a high level of autofluorescence 
was seen in the cells. SABM has been noted previously to increase cell death in 
differentiating mESC cultures [16] and these cells, in addition to those dying naturally 
during the terminal stages of differentiation, are likely to have contributed to the 
autofluorescence. Coating TCP with LN or ML gave higher levels of SPC expression 
than coating with GN. This corresponds with the recent finding that ML induces high 
endoderm gene expression whereas collagen has lower inductive potential for 
differentiation [225]. As the regulation of SPC expression occurs independently of 
that of other surfactant proteins [226], the fact that increased SPD expression was also 
seen suggests that a higher degree of type II pneumocyte differentiation, through to 
the mature phenotype, occurred on TCP-LN, TCP-ML and PDLLA-LN than on other 
surface-coating combinations. A characteristic feature of type II pneumocytes is their 
transdifferentiation into type I pneumocytes in vitro, so the increased expression of the 
type I cell marker, aquaporin 5, also leads to the same conclusion.  
 
It was recently reported that ECM proteins can induce EB differentiation by seeding 
randomly differentiated 5 day EBs onto collagen gel that incorporated FN and LN. FN 
was reported to induce dose-dependent endothelial differentiation and LN was shown 
to guide the differentiation of the cardiac lineage [227]. Comparing these observations 
with the current finding that LN induces the differentiation of pneumocytes from EBs 
with enhanced endoderm formation suggests that the effect of exogenous ECM 
proteins on stem cells might be stage-specific. The effect of the ECM proteins on 
embryonic development is well known to be stage-specific. For example, expression 
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of LN subunit α1 is limited to the first trimester in human embryos, while LN subunit 
α5 expression is detectable from early fetal lung development and thereafter [228]. 
The LN used in the present study, LN 332, is composed of subunits α3, β3 and γ2. 
Immunoreactivity for LN 332 has been found on the basement membranes of airway 
epithelium and alveolar parenchyma throughout the development of the human lung 
[102, 229]. However, a recent report indicates that LN γ2-deficient mice still showed 
normal branching morphogenesis and epithelial differentiation until the saccular stage 
[230]. Its effect on alveolarization is still unknown because the LN γ2-deficient mice 
died before the alveolarization stage. The increased number of SPC-eGFP-positive 
cells observed differentiating on TCP-LN implied a positive effect of LN 332, either 
on the differentiation of the lung epithelial lineage from endoderm or on type II 
pneumocyte differentiation. In vivo, type I collagen-deficient mice can still develop a 
lung with normal structure [231], suggesting that either type I collagen is crucial to 
the process or its function in lung may be shared by other collagens. This might 
explain why TCP-CO was found in this study not to enhance SPC expression and, 
thus, type II pneumocyte differentiation. In embryonic lung development, FN is more 
involved in branching morphogenesis and airway formation [232]. Its role in type II 
cell differentiation is less obvious. In vitro, FN is unable to maintain the phenotype of 
type II cells [233]. The relative lack of involvement of FN in pulmonary alveolar 
differentiation may explain the lower SPC expression found in cells grown on 
TCP-FN. Matrigel is an EHS sarcoma-derived basement membrane extract. Its main 
component, LN 111 (formerly named LN 1) [95], has a critical role in lung 
development. Antibodies to LN 111 reduce the growth of embryonic lung explants 
and their branching morphogenesis in vitro [234]. Disruption of LN 111 
polymerization causes failure of airway basement membrane formation [235]. The 
increased SPC expression observed in mESC differentiating on TCP-ML agrees with 
this finding. In this research, only a single exogenous ECM protein was applied to the 
differentiation culture after endoderm formation; more tests are needed to determine 
the stage-specific or the synergistic effects of the ECM. 
 
It has been reported previously that beta-tubulin, a cytoskeleton protein, is not an 
appropriate internal control for stem cell differentiation [236]. In this study, results 
were obtained that confirmed this observation. Beta-actin expression was highest in 
cells grown on ML or LN coating on TCP and PDLLA, respectively. As beta-actin is 
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part of the cytoskeleton, its expression is also strongly related to the substratum [237]. 
Beta-actin regulation, which is mediated by integrin and focal adhesion protein 
assemblies, can be activated by ECM [238]. The regulation of beta-actin by the 
substratum is at the transcription level [239]. The integrin signalling pathway and 
ECM work in a positive feedback mechanism which induces the cells themselves to 
produce more ECM [240]. It is also worth noting that the strong correlation between 
the expression of SPC, SPD and beta-actin mRNAs. This is in agreement with the 
literature on primary type II cell culture in vitro [241], which suggests that the 
cytoskeleton can regulate SPC mRNA expression and maintain type II cell 
differentiation. Regulation of SPC mRNA is very likely mediated by polysomes 
which associate with 3’ tail of mRNA and, thus, can transport and stabilize the mRNA 
to a specific location within the cell [242]. Type II cells cultured in vitro on attached 
collagen lost surfactant protein secretion and phenotype, but both characteristics 
recover after detaching the attached gel so that it floated, suggesting the involvement 
of the cytoskeleton in type II differentiation [70, 117].  
 
WST1 cell proliferation assay was used to evaluate the overall cell activities. An 
interesting finding of largest increase in metabolic activity of cells on PDLLA-ML 
from day 24 to day 28 suggesting that ML, when coated on PDLLA, may help the 
differentiating mESCs to recover from the stressed “selecting effect” caused by 
SABM. It may be one of the reasons why the number of SPC-eGFP positive cells 
induced by PDLLA-ML was 4.3 folds higher than by PDLLA-GN. 
 
ECM proteins have been used for decades as coatings to render a material surface 
bioactive [172-174]. Once an ECM protein solution comes into contact with a solid 
surface, a dynamic, non-specific protein adsorption process occurs in which the 
protein changes its conformation to the lowest energy state [176]. This process is 
affected by the chemistry of the solid surface and, therefore, in this report, the overall 
surface chemistry was evaluated by two methods, contact angle measurements using 
sessile drops and the captive bubble technique and ζ-potential measurements. Using 
the sessile drop technique alone to determine the contact angle a cell culture material 
could generate misleading information. For example, θA of “dry” TCP-CO is amongst 
the lowest of all protein-coated surfaces but the θA of “wet” TCP-CO was amongst the 
highest. As PDLLA films were immersed in cell culture medium during 
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differentiation, the captive bubble technique is more representative.  
 
It can be expected that different level of exposure of cell-binding ligands were 
presented on both coatings. This difference may contribute to the fact that SPC 
expression of cells on PDLLA-LN was much higher than PDLLA-ML whereas the 
SPC expression of cells on TCP-ML was slightly higher than that of TCP-LN.  
 
ζ-potential measurements allow determination as to whether two surface are similar 
by measuring the IEP and ζplateau of the materials compared. The IEP shifts to higher 
pH if the surface becomes less acidic after protein coating. ζplateau is governed by two 
factors: the dissociating functional group and the hydrophilicity of a surface. ζplateau 
becomes more negative if the dissociating functional groups are more acidic. In 
addition, ζplateau is less negative in a more hydrophilic surface due to the higher 
interaction between water and materials surface, i.e. the more hydrophilic a surface 
the more water will adsorb removing potential adsorption sites for ions [243]. The 
curves of ζ=f(pH) of TCP-GN and PDLLA-GN are alike, as are TCP-ML and 
PDLLA-ML. This implied similar protein coating on both materials. In contrast, 
TCP-LN and PDLLA-LN have distinct IEPs, ζplateau and the slope of the ζ=f(pH), 
implying rather dissimilar coating properties, despite the same protein were coated. 
This difference may contribute to the higher SPC expression on PDLLA-LN due to 
the different level of exposure of cell-binding ligands. To conclude, IEP and ζplateau do 
not correlate with the SPC expression of the differentiated cells, but both factors were 
good tools to evaluate protein coatings. 
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3.5. Conclusion 
The potential of ECM proteins to affect the differentiation of ESCs into pulmonary 
progenitors was investigated using the three-step differentiation protocol. The current 
differentiation protocol was modified and improved by introducing laminin or 
Matrigel into the differentiation culture. Another important progress for the 
differentiation of pulmonary progenitors was the introduction of degradable PDLLA, 
which was used widespread in the field of tissue engineering. It was also found that 
laminin when coated onto PDLLA films can induce higher pulmonary epithelial 
marker of the differentiating mESCs than gelatin and Matrigel. If the differentiation 
protocol can be further refined, this differentiation system could have widespread 
potential in tissue engineering, developmental studies and the creation of cell-scaffold 
constructs that can be used for pharmacological and toxicological screening. 
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Chapter 4. The effect of fibroblast growth factors on the 
derivation of pulmonary progenitors from murine embryonic 
stem cells 
 
4.1. Introduction 
Stem cells were frequently used as in vitro models to study the embryonic 
development of certain organ [11, 133-135, 244, 245]. In other words, factors that 
play roles in the development of embryonic lung are very likely to affect the 
differentiation of mESCs into pulmonary progenitors. Organogenesis of lung involves 
several forces including transcriptional factors [68, 246], growth factors [87, 247-249], 
cell-cell interactions and cell-matrix interactions [96, 104, 106, 249]. These forces 
also work in vitro, particularly when stem cells were used as a model to recapitulate 
the in vivo organogenesis. In the previous chapter, the importance of extracellular 
matrix proteins in the differentiation of pneumocytes from ESCs was highlighted. 
FGFs play a key role in early lung development and FGF-1, 2, 7 and 10 in particular 
are expressed during epithelial-mesenchymal interactions in the developing lung [247, 
249]. FGFs also participate in alveogenesis and the lungs of transgenic mice with FGF 
receptor knockout lack alveolar formation [82]. FGF is active during the 
pseudoglandular stage of embryonic lung development (formation of the bronchial 
tree between 6-16 weeks in human embryos) and during the crucial time of 
alveolarization [68]. FGF-1 and 2 and 7 appear to play an integral role in the 
transformation of the tracheal epithelium [250]. Acting through the FGFR2 receptor, 
FGF-1 has been detected by immunohistochemistry uniformly throughout the 
embryonic lung mesenchyme of embryonic day 13 rat lungs [83]. FGF-1 has been 
found to increase expression of SPA, SPB and SPD [84] in differentiated culture. In 
addition, FGF-1 induces epithelial budding in early rat embryonic lung cultures [251]. 
In the absence of cardiac mesoderm, ventral foregut endoderm explants have been 
observed to respond to exogenous FGF-1 and FGF-2 in a dose-dependent manner, 
with lower concentrations activating liver specific genes and high concentrations 
activating lung specific genes [85]. FGF-10 was reported to be essential for early lung 
formation; FGF-10 knockout-mice do not generate pulmonary structures [87].  
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In view of the low frequency of target cells obtained using current protocols [203], 
modulating the composition of the culture medium by supplementation with growth 
factors may increase the yield of type II pneumocytes from mESCs. As a result, in this 
report, the effects of FGF-1, 2, 7 and 10 on the efficiency of this in vitro 
differentiation pathway were tested. 
 
4.2. Methodology  
In this chapter, the effects of FGF-1, 2, 7, 10 on the differentiation of mESCs into 
pulmonary progenitors using the 3-step differentiation protocol was studied. High 
concentrations of FGF-1 and FGF-2 were supplemented to mESCs differentiated on 
gelatine-coated TCP from day 11 to day 14 (Chapter 2.2.2.3.2). To evaluate whether 
FGF-1 and FGF-2 can alter the proportion of cells in endoderm and mesoderm 
lineages, the expression endoderm marker Sox17 and Foxa2 as well as mesoderm 
marker Brachyary were evaluated at the end of day 14 differentiation 2.3.2.4). 
Furthermore, to understand whether TTF-1, a transcriptional factor that were 
expressed at the onset of lung development and by thyroid, immunostaining of TTF-1 
and counting positive cells using flow cytometry were performed at the end of day 14 
differentiation (Chapter 2.3.4). The expression of SPC, SPD, CC10, Aquaporin 5 and 
GAPDH were analyzed using RT-PCR at day 28 (Chapter 2.3.2.3). Furthermore, in 
order to know whether the addition of FGF-1 or FGF-2 could guide more endodermal 
cells into hepatic lineage, hepatic marker albumin was also investigated at day 28. 
 
To investigate the effects of FGF10 on the differentiation of mESCs into pulmonary 
progenitors, FGF10 at various concentrations were added to mESCs differentiated on 
gelatin-coated TCP from day 11 to day 14 or from day 15 to day 18. Conventional 
PCR and realtime PCR of SPC expression were performed at day 28. A further 
experiment was performed by supplementing FGF-10 to the mESCs differentiating on 
Matrigel-coated TCP to understand whether there is a synergistic effect between ECM 
and FGF-10. Effects of FGF-7 were investigated preliminarily in a way similar to the 
methodology used to investigate FGF-10, but at fixed concentration of 10 ng/ml of 
FGF-7 was used.  
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4.3. Results 
4.3.1. Conventional and realtime PCR  
The endoderm markers, sox17 and foxa2 RNAs, and the mesoderm marker, brachyury 
RNA, were recorded at the end of day 14 of the differentiation culture, after addition 
of FGF-1 and FGF-2 at high concentrations for 4 days. In general, expression levels 
of sox17, foxa2 and brachyury RNAs were found to be either higher than control (no 
addition of any growth factors) or unchanged for all FGF-1 and/or FGF-2 treated 
samples, except the expression of sox17 RNA which was slightly lower in the culture 
that had received 500 ng/ml FGF-1 (Figure 4-1). 
 
Figure 4-1 Expression of mRNAs of the endoderm markers, SOX17 and Foxa2, as well as the 
mesoderm marker, Brachyury, of differentiating mESCs at the end of day 14. Sample A was 
supplemented with 500 ng/ml FGF-1, B with1000 ng/ml FGF-1, C 100 ng/ml FGF-2, D 500 ng/ml 
FGF-2 and E 500 ng/ml FGF-1+100 ng/ml FGF-2. All of the FGFs were added between days 11-14. 4 
independent samples in each condition were evaluated. The quantitative PCR measurements were 
repeated twice. 
 
SPC is a specific marker for type II pneumocytes and is not present in any other cell 
types. Increased SPC mRNA expression was observed in samples treated with 500 
ng/ml FGF-1 and 1000 ng/ml FGF-1 (Figure 4-2). SPC RNA expression levels similar 
to those of the control were seen for cultures that had been supplemented with FGF-2. 
Supplementation with a combination of FGF-1 and FGF-2 did not yield SPC RNA 
expression above that of control cultures. To quantify the expression of SPC RNA 
more precisely, realtime PCR was performed on control, 500 ng/ml and 1000 ng/ml 
FGF-1 treated samples. Supplementation of the culture medium with 1000 ng/ml 
FGF-1 resulted in SPC RNA expression that was 2.6 times higher than that of the 
control (P < 0.05) (Figure 4-2). Samples supplemented with 500 ng/ml FGF-1 
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presented higher average SPC RNA expression, however, the difference did not reach 
statistical significance due to the large standard deviation. In addition to SPC RNA, 
samples supplemented with 1000 ng/ml FGF-1 also contained higher levels of CC10, 
suggesting the presence of bronchiolar phenotype/s in the cultures. In contrast with 
the FGF-1 treated samples, FGF-2 treated samples, including those treated with both 
500 ng/ml FGF-1 and 100 ng/ml FGF-2, expressed levels of SPD, CC10 and 
aquaporin 5 that were lower than those of the control.  
 
Figure 4-2 (A) Results of conventional PCR of cells in group 1 and (B) quantitative PCR of SPC 
mRNA of sample 1-1 (control), 1-2 (500 ng/ml FGF-1) and 1-3 (1000 ng/ml FGF-1) at the end of day 
28. * Indicates significant difference from control values (P<0.05). More than 3 independent samples in 
each condition were evaluated. The quantitative PCR measurements were repeated 3 times. 
 
To assess the differentiation into another endoderm lineage during early adherent 
culture stage, PCR was performed to detect albumin RNA, present in hepatocytes. No 
increase in albumin RNA expression was seen in samples treated with FGFs. It was 
observed that a slight decrease in albumin RNA occurred in samples treated with 
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FGF-2 and in samples treated with both FGF-1 and FGF-2 compared with the control.  
 
In addition to FGF-1 and FGF-2, the effects of FGF-7 and FGF-10 on SPC RNA 
expression were also evaluated. Low dose FGF-7 (10 ng/ml) and varying doses of 
FGF-10 (20 ng/ml to 200 ng/ml) were added to cells during periods A and B. 
Surprisingly, conventional PCR results indicated that FGF-10 at 20-200 ng/ml had no 
effect on the differentiating cells cultured on gelatin during day 11-18 (Figure 4-3A). 
In order to confirm this result, realtime PCR for SPC RNA was performed and similar 
negative results were obtained (Figure 4-3B). As FGF-10 did not increase SPC RNA 
expression in cells cultured on gelatin, it was interesting to see whether FGF-10 
required additive synergy from an extracellular matrix. Previously, the positive effect 
was reported of extracellular matrix coating, namely laminin 332 and Matrigel, on 
pneumocyte differentiation [252]. In this report, 60 ng/ml of FGF-10 was added to 
cells growing on Matrigel-coated tissue culture plates and the expression of SPC and 
aquaporin 5 RNAs was evaluated. In contrast with cells differentiated on gelatin, cells 
differentiated on Matrigel demonstrated higher levels of SPC RNA when 60 ng/ml of 
FGF-10 was added to the culture during either days 11-14 or days 15-18 (Figure 4-4). 
Slightly higher levels of aquaporin 5 RNA were found in cells grown under the latter 
conditions (Figure 4-4). In contrast to FGF-10, FGF-7 did not induce significantly 
higher SPC expression than FGF-10 in combination with Matrigel coating (Figure 
4-4). 
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Figure 4-3 (A)SPC mRNA expression of FGF-10 treated cells measured by conventional PCR using 
GAPDH as the housekeeping gene (B)Relative SPC mRNA expression of the same cells measured by 
realtime PCR. Both measurements were performed at the end of day 28 differentiation. FGF-10 at 20 
ng/ml to 200 ng/ml was added to the culture medium during either days 11-14 or days 15-18. No 
treated samples demonstrated a SPC expression level different from that of the control. 4 independent 
samples in each condition were evaluated. Both conventional PCR and quantitative PCR measurements 
were repeated twice. 
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Figure 4-4 (A) Conventional PCR measurement of mRNAs in FGF-10 treated cells cultured on 
gelatin-coated or Matrigel-coated tissue culture plates (B) SPC mRNA expression of the FGF-10 
treated cells cultured on gelatin coating measured by realtime PCR (C) SPC expression of the FGF-10 
treated cells cultured on Matrigel coating measured by realtime PCR (D) Relative SPC expression of 
the FGF-7 treated cells cultured on Matrigel coating measured by realtime PCR. All measurements 
were performed at the end of day 28 differentiation. In (B), (C) and (D), 4 independent samples in each 
condition were evaluated. The quantitative PCR measurements were repeated 3 times. 
 
4.3.2. TTF-1-positive cells and SPC-GFP-expressing cells 
Immunostaining of TTF-1 was performed on attached EBs at the end of day 14 of the 
differentiation culture.  
Figure 4-5A demonstrates a representative colony from the day 14 differentiation 
culture. TTF-1-positive cells were found to form clusters in most of the samples, 
suggesting the necessity of cell-cell interaction during their differentiation. 
TTF-1-positive cells were mainly present at the borders of the attached colonies. The 
frequency of TTF-1-positive cells in each colony appeared to vary. As with 
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TTF-1-immunoreactive cells, SPC-eGFP-positive cells formed clusters ( 
Figure 4-5C-E) and some showed thin, neuron-alike cytoplastic processes ( 
Figure 4-5C-E). A similar morphology of SPC-eGFP positive cells were reported 
recently by another group [253]. 
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Figure 4-5 (A1) TTF-1-immunoreactive cells (green) at the end of day 14 differentiation culture. (A2) 
The same field showing the DAPI-stained cell nuclei. The overlay of (A1) and (A2) was shown in (A3). 
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(B) The negative control of TTF-1 staining. (C1) SPC-eGFP positive cells of day 21 differentiation 
culture. (C2) The same field as C1 combined with light microscopy image. (D) SPC-eGFP-positive 
cells of adherent EBs prepared by cryosection at the end of day 21. (E) Confocal laser microscopy 
image of SPC-eGFP cells at the end day 21. 
 
Due to the variability of each colony, the frequencies of TTF-1 positive cells in each 
condition were further evaluated using flow cytometry (Figure 4-6). A single peak, 
with only 0.76% of cells scored TTF-1 positive, was observed in the experimental 
control, in which no FGF-1 and FGF-2 was added during differentiation (Figure 4-6C). 
Because mESCs had already differentiated into various cell types when the flow 
cytometry was performed at the end of the day 14, one has to notice that the single 
peak observed in Figure 4-6C is the addition of many peaks induced by various cell 
types, with barely any TTF-1 positive cells in it. When TTF-1 positive cells were 
presented in the culture, as illustrated in Figure 4-6G-H, we observed a “peak shift”, 
rather than a separate peak. The peak shift suggested that the added FGF-2 altered the 
differentiation profile of the mESCs. Cells that had green fluorescence intensity above 
the threshold in FL1-channel were regarded as TTF-1 positive cells. Cells treated with 
500 μg/ml of FGF-2 had highest TTF-1 positive frequency; cells treated with both 500 
μg/ml of FGF-1 and 100 μg/ml of FGF-2 had second highest frequency of TTF-1 
positive cells. In contrast, 100 μg/ml FGF-2-treated cells had a frequency of TTF-1 
positive cell similar that of the cells with no FGF treatment.  
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Figure 4-6 Flow cytometry of TTF-1-immunoreactive cells performed at the end of day 14. Figures (A) 
and (B) showed negative controls for flow cytometry ( experimental control stained without 1st layer 
antibodies). In (A), a size gate was applied exclude the cell debris. (B) A threshold was defined to score 
0.1% of cells positive. The gating of both (A) and (B) were applied to all other samples. Figures (C) to 
(H) represented samples stained with TTF-1 antibodies. (C) sample 1-1, the experimental control (no 
FGF supplement was added during differentiation). The outline of the histogram of the experimental 
control, as demonstrated in (C), were illustrated in (D-H) for better understanding of the peak shift. (D)  
sample 1-2 (500 ng/ml FGF-1) (E) sample 1-3 (1000 ng/ml FGF-1) (F) sample 1-4 (100 ng/ml FGF-2) 
(G) sample 1-5 (500 ng/ml FGF-2) (H) sample 1-6 (500 ng/ml FGF-1+100 ng/ml FGF-2). Four 
independent samples in each condition were evaluated. 
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4.4. Discussion 
The protocol described in this study was reported to generate differentiated cultures 
that comprised cells expressing the transgene and mRNAs for SPA, SPB, SPC, SPD, 
CC10 and aquaporin 5 from SPC-eGFP-transfected mESCs [201]. In the same report, 
the negative staining of SPC and immature development of the lamellar bodies 
suggested that the SPC-GFP positive cells could be progenitor cells for type II 
pneumocytes [203]. Furthermore, only a low percentage of cells could be directed to 
enter the pulmonary lineage using the protocol. In order to improve the yield, FGF-1, 
2, 7 and 10 were added into the differentiation culture during the cell adhesion stage. 
The concentrations of FGF used for each group were selected on the basis of data 
obtained from in vitro organogenesis or morphogenesis models reported previously 
[83, 85, 92, 254]. 
 
In vivo, ventral foregut endoderm demonstrates multipotent capacity. It can be 
directed to generate pancreas [255], liver [256] and lung [85] by controlling the 
addition of FGF. The expression of TTF-1 in the ventral foregut endoderm was found 
to play a crucial role in early lung development [246, 257, 258]. It has been reported 
that direct contact of the cardiac mesoderm with ventral foregut endoderm is required 
for the initiation of TTF-1 expression in vitro [92]. Initiation of TTF-1 expression can 
also be observed following supplementation with exogenous FGF-1 and FGF-2 in the 
absence of cardiac endoderm [85, 92]. These in vitro embryonic explant models 
provide information on the control of the downstream lineage from endoderm but 
recapitulation of the events in these models using ESCs is complicated because of the 
high degree of variance during the differentiation process. Furthermore, little attention 
had been paid to the effects of high doses of FGF-1 and FGF-2 on the differentiation 
of the downstream endoderm lineage from ESCs. Only low doses of FGF-1, reported 
to induce hepatocyte formation, has ever been investigated [259, 260]. 
 
Growth factor addition does not direct ESC differentiation exclusively into a specific 
cell type, rather it alters the relative proportions of the various phenotypes that emerge 
[142]. In the experiments, we added FGF-1 and FGF-2 to the differentiating mESCs 
on the gelatin-coated TCP, which did not contain any trace amounts of growth factors 
like Matrigel coating. It was found that higher expression of SPC mRNA occurred in 
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samples which received 1000 ng/ml of FGF-1 compared with 500 ng/ml of FGF-1, 
suggesting a dose-dependent effect. FGF-1 has previously been observed to elicit 
immediate endodermal budding of embryonic lung tissue [83] and alter surfactant 
protein gene expression [69]. Consistent with these observations, increased SPC RNA 
expression was observed in FGF1-treated differentiating cultures.  
 
Despite the elevated expression of both endodermal and mesodermal markers induced 
by high doses of FGF-1 and FGF-2, neither type I nor type II pneumocyte markers 
were enriched by FGF-2 or by a combination of FGF-1 and FGF-2, suggesting that 
high doses of FGF-2 were not able to upregulate the pulmonary lineage differentiation. 
FGF-2 has been shown to be a more effective inducer than FGF-1 of surfactant 
protein expression by pulmonary epithelium [86]. Additionally, FGF-2 is abundantly 
expressed and localized in epithelial basement membranes at the late stage of fetal 
lung development, during which time lung epithelial cells undergo major 
morphological changes and cytodifferentiation [86]. Consequently, the ability of the 
“early” adherent culture to be programmed by FGF-2 signalling may be restricted. 
FGF-1, however, appears to act earlier in lung development and increases in SPC 
mRNA expression observed in this experiment may be attributed to the role of FGF-1 
in eliciting lung bud formation necessary for branching morphogenesis [83].  
 
In contrast to the reports that high dosage of FGF-2 can enhance pulmonary lineage 
formation in embryo explants [85], the negative effect of FGF-2 against the 
differentiation into pulmonary lineage, as observed in the current experiments, gave 
rise to a question: does addition of FGF-2 guide the endoderm cells into other 
derivatives, such as the hepatic lineage? In order to answer this question, the presence 
of albumin, a marker of hepatocyte, was assessed. No increase was noted in albumin 
expression following medium supplementation with either FGF-2 or FGF-2 plus 
FGF-1, suggesting that FGF-2 can also not lead the differentiation into hepatic lineage 
under our experimental conditions. 
 
During development, TTF-1 is expressed by distal lung progenitors and thyroid 
follicular cells, another endoderm derivative. It is therefore not specific to lung 
epithelium. However, TTF-1 is a transcriptional factor that serves as a master gene to 
integrate genetic developmental lung morphogenesis and cell lineage determination 
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[246, 251, 258, 261]. In particular, it has also been shown to modulate critically SPC 
expression by type II pneumocytes in conjunction with Erm, a transcription factor 
activated by FGF [262]. Unfortunately, TTF-1 RNA could not be detected using 
conventional PCR at the end of day 14 of the differentiation culture, despite more than 
6 different pairs of TTF-1 primers were tested in the preliminary experiments for this 
study. Previous publication by our group also showed that even realtime PCR was 
employed, only very weak expression of TTF-1 was detected at the end of day 14 
differentiation [203]. Due to the limitation in time, we did not solve this technical 
issue or further evaluate TTF-1 using realtime PCR, instead, we immunostained 
TTF-1 protein using a highly sensitive TTF-1 antibody supplied by Novacastra (New 
castle upon Tyne, UK). The immunostaining demonstrated clusters of TTF-1-positive 
cells located at the borders of the adherent EBs. The TTF-1-positive cells made up a 
large percentage of cells in some colonies. In a small number of colonies, 
TTF-1-positive cells were not detectable. Flow cytometry presented a more complete 
picture of frequency of TTF-1 cells. Higher frequency of TTF-1 positive cells were 
found in sample 1-5 (500 μg/ml FGF-2 supplement, see Table 2) and 1-6 (500 μg/ml 
FGF-1 + 100 μg/ml FGF-2 supplement, see Table 2) at the end of day 14. In contrast, 
SPC expression was found higher in sample 1-2 (500 μg/ml FGF-1 supplement, see 
Table 2) and sample 1-3 (1000 μg/ml FGF-1 supplement, see Table 2) on day 28, 
suggesting that a major proportion of TTF-1-positive cells found on day 14 did not 
turn into pulmonary progenitor cells subsequently during day 15 to day 28.  
 
In addition to FGF-1 and FGF-2, FGF-7 and FGF-10, particularly FGF-10, are the 
most studied growth factors in lung morphogenesis [83, 254, 263, 264]. FGF-10 was 
initially added at various concentrations to the differentiating cells cultured on 
gelatin-coated tissue culture plates, but no change in SPC RNA expression could be 
observed. When the gelatin coating was replaced with Matrigel subsequently, cells 
supplemented with FGF-10 on day 11-14 and day 15-18 demonstrated enhanced SPC 
RNA expression. The necessity of the synergistic effect of FGF-10 and Matrigel in in 
vitro lung explant models was also supported by a previous report [83], which 
demonstrated that FGF-10 did not support endoderm budding on collagen gels, 
though budding occurred on Matrigel. The same report showed that FGF produced no 
response in any tested tissue cultured on collagen. This discrepancy between the 
synergistic effects of Matrigel and collagen may be because the former contains 
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heparin sulphate proteoglycan, which has been shown to potentiate the biological 
activity of FGFs [263, 265]. Matrigel did not work only in the presence of FGF-10, it 
can enhance the expression of pneumocyte markers and increase the number of 
SPC-eGFP positive cells in differentiating mESCs without the help of any growth 
factors (Chapter 3). However, it has to be noticed that even the growth factor-reduced 
Matrigel, as used in the experiments, also contain trace amounts of growth factors, 
including 0-0.1 pg/ml of bFGF, <0.5 ng/ml EGF, 5 ng/ml IGF-1, <5 pg/ml PDGF, 
<0.2 ng/ml NGF, 1.7 ng/ml TGF-beta. Despite these growth factors were at very low 
concentrations, more experiments should be performed to rule out the possibility that 
the observed synergistic effect were actually induced by the FGF-10 and the trace 
amounts of growth factors in the Matrigel coating.  
 
As for FGF-7, 10 ng/ml was chosen as a fact that it is the optimal concentration to 
enhance the type II pneumocyte maturation [89, 90]. 10 ng/ml of FGF-7 was added to 
cells cultured on Matrigel. It did not induce any effect when added on day 11-14. 
When it was added on day 15-18, realtime PCR demonstrated higher average SPC 
RNA expression with large variation precluding statistical significance.  
 
As no single growth factor can recapitulate the complex natural repertoire of 
molecular developmental signalling, only a small part of the natural signalling 
cascade involved in embryonic lung development has been highlighted in this study. 
The overlapping functions and dynamic interactions of the many growth factors 
present during in vivo lung development means that further studies, perhaps 
combining more FGF supplementation on Matrigel-coated tissue culture plates, are 
required to increase sufficiently the differentiation of distal lung epithelial cells from 
ESCs for implantation therapy. The use of FGF can also be applied to hESCs because 
of the similarity of human and murine in terms of development mechanisms. 
 
4.5. Conclusion 
It was demonstrated that fibroblast growth factors play roles in the three-step 
differentiation protocol which we applied to differentiate mESCs toward pulmonary 
progenitors. High concentration of FGF-1 enhanced the expression of the SPC mRNA 
of the differentiated pulmonary progenitors, whereas high concentration of FGF-2 did 
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not show the same effect. A synergistic effect between FGF-10 and the growth 
factor-reduced Matrigel to enhance the SPC expression of the differentiated 
pulmonary progenitors was observed. However, more experiments should be 
performed to investigate whether the observed synergistic effect was caused by the 
trace amounts of growth factor in the Matrigel. 
 
 141
 
Chapter 5. Peptide-grafted poly(D,L-lactide) and its application 
in A549 cell culture and differentiation of murine embryonic 
stem cells into pulmonary epithelial progenitor cells 
 
5.1. Introduction 
Poly(D,L-lactide) (PDLLA) has been used safely in medical applications with FDA 
approval [266] for decades and can be easily processed into various shapes. Thus, it is 
a promising scaffold material for tissue engineering applications. As polylactide is a 
hydrophobic material, efforts have been made to render it more hydrophilic and 
suitable for the maintenance and growth of various cell types [41, 164, 165, 267], 
although few publications can be found for lung tissue applications [22, 195-198]. 
 
The simplest way to enhance cellular responses to a material is to introduce bioactive 
molecules to its surface by direct application of protein solutions. For lung tissue, 
coating with proteins such as laminin was shown to enhance the expression of 
surfactant protein C, a phenotypic marker of type II pneumocyte, by mature type II 
pneumocytes [50, 120, 268]. In addition, laminin can upregulate the differentiation of 
murine embryonic stem cells (mESCs) into pulmonary progenitors [252]. However, 
during the coating process, where laminin adsorption occurs, is it difficult to evaluate 
in which configuration the protein adsorbed and which exposed peptide domain 
confers bioactivity after protein adsorption. In addition, the use of protein coating of 
scaffold surfaces is prohibitively expensive; furthermore, some commonly-used 
proteins to coat biomaterials have been derived from tumour cells, making their 
clinical applications questionable. Small bioactive peptides that can mimic 
extracellular matrix protein functions and be synthesised using automated synthesis 
equipment in large scale, such as RGD (Figure 5-1) and YIGSR (Figure 5-1), and 
therefore, have attracted much attention. RGD and YIGSR have been widely used 
over the past two decades for the modification of biomaterial surfaces [25, 26, 269].  
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Figure 5-1 Structures of RGD and YIGSR peptides. Amines circled by dashed lines are the locations 
where anchoring to PDLLA by EDC occurred. 
 
When cells are seeded onto a solid support, they adhere to the underlying substrate via 
integrin and non-integrin receptors. RGD is the minimum peptide sequence of 
fibronectin that mediates integrin-mediated cell binding. As for non-integrin cell 
adhesion, 67LR, one of the major non-integrin cell adhesion receptors in the plasma 
membrane, can bind to YIGSR and VAPG sequences of elastin [270]. YIGSR is the 
minimum sequence of laminin necessary for cell adhesion and 67LR receptor binding 
of epithelial cells [271]. The YIGSR sequence has been reported to be able to replace 
the function of laminin coating in primary pneumocyte culture [272].  
 
Here peptide mixtures containing various percentages of RGD and YIGSR were 
grafted to the surface of PDLLA films using succinic acid as a spacer using the 
well-established EDC coupling reaction. The prepared peptide-grafted PDLLA films 
were characterised by water contact angle measurements and AFM. The potential use 
of peptide-grafted surfaces for the engineering of pulmonary epithelial tissue was 
investigated in this study using two approaches: firstly, the effects were evaluated of 
peptide-grafted PDLLA surfaces on the attachment, proliferation and the cytoskeleton 
of A549 cells, a widely-used line of distal pulmonary epithelial cells, type II 
pneumocytes. A549 culture was also performed on tissue culture plastic (TCP) and 
unmodified PDLLA films for comparison with the modified PDLLA films. Secondly, 
the effects were investigated of the modified surfaces on the differentiation of mESCs 
into type II pneumocytes and their progenitors. 
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5.2. Methodology  
RGD and YIGSR were dissolved in DD-water at five proportions. The five 
“cocktails” of the peptide solution were grafted to the 4% ethylenediamine-treated 
PDLLA films (Chapter 2.5.2 and 2.5.4). Water contact angle and surface roughness 
using AFM were performed to characterize the peptide-grafted PDLLA films (Chapter 
2.6.2 and 2.6.5) 
 
Two independent cell culture experiments were performed on the peptide-grafted 
surfaces. In the first one, A549 cells were seeded on the peptide-grafted PDLLA films 
and cultured for 4 days. Cell attachment was evaluated 2h after A549 seeding using 
Hoechst dye (Chapter 2.7.3). Formation of focal adhesion points and cytoskeleton of 
A549 cells was determined 24h after cell seeding using immunostaining and 
phalloidin, respectively (Chapter 2.3.3). A549 population and A549 metabolic activity 
was evaluated at day 2 and day 4 using hoechst dye and WST-1 reagent (Chapter 
2.7.4). 
 
The second experiment was to differentiate mESC into pulmonary progenitors on the 
peptide-grafted PDLLA films using the 3-step differentiation protocol (Chapter 
2.2.2.3.3), similar to the experiments described in Chapter 3. The only difference is 
that the protein-coated PDLLA films were replaced by peptide-grafted PDLLA films. 
This experiment is pretty preliminary; therefore only SPC expression of the 
differentiating cells at day 28 was performed using realtime PCR (Chapter 2.3.2.4). 
The SPC-eGFP positive cells were recorded using fluorescence microscopy on day 21 
(Chapter 2.3.1). 
 
5.3. Results 
5.3.1. Surface characterization of peptide-grafted PDLLA  
The water contact angles and surface roughness of the peptide-grafted surfaces were 
evaluated. All peptide-grafted surfaces had lower advancing and receding contact 
angles than unmodified PDLLA (Figure 5-2). The receding contact angles of 
50RGD-50YIGSR, 25RGD-75YIGSR and 0RGD-100YIGSR were even lower than 
those measured on TCP, which is normally treated by the manufacturer in oxygen 
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plasma to enhance the cell responses. A trend of decreasing contact angles could be 
observed as the YIGSR proportion increased. The contact angle hysteresis, the 
difference between the advancing contact angle and receding contact angle, was 
smallest on unmodified PDLLA. Contact angle hysteresis is an index of surface 
hetereogenecity of hydrophilic and hydrophobic domains, but can also be affected by 
the surface roughness. The contact angle hysteresis was largest for 50RGD-50YIGSR, 
followed by 25RGD-75YIGSR and 0RGD-100YIGSR. As the roughness parameter 
Ra of all modified PDLLA was smaller than 1 nm, which is far smaller than the 
roughness scale that can affect contact angles [27, 200, 273, 274], the contact angle 
hysteresis of 50RGD-50YIGSR can only be the result of the inhomogeneous 
distribution of hydrophilic and hydrophobic domains on the surface of modified 
PDLLA films. It was also found that Ra decreased as the YIGSR percentage increased 
(Table 5-1). This finding is interesting because the size of YIGSR is larger than the 
size of RGD. It can be explained by the lower coupling yield of YIGSR as compared 
to the RGD peptide [26] and will be explained in detail in the discussion. 
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Figure 5-2 Dynamic (advancing and receding) captive bubble water contact angles on PDLLA, TCP 
and surface-treated PDLLA films (n=6). The advancing and receding contact angles of all 
surface-modified PDLLA samples were significantly lower than PDLLA (P<0.005). + and ++ stand for 
significant difference between peptide-grafted surfaces and TCP (+ for P<0.05; ++ for P<0.005). The 
water contact angle measurements were repeated 3 times. 
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Table 5-1 Roughness parameter (Ra) of PDLLA and surface-modified samples. All samples have Ra 
larger than PDLLA with P<0.005. 4 independent samples in each condition were probed. The AFM 
probing was repeated 3 times. 
 
Peptide-grafted surface Ra ( nm) 
PDLLA 0.14 ± 0.01 
4% ethylenediamine- treated 
PDLLA 
0.25 ± 0.01 
RGD100-YIGSR0 0.51 ± 0.01 
RGD75-YIGSR25 0.47 ± 0.00 
RGD50-YIGSR50 0.43 ± 0.05 
RGD25-YIGSR75 0.41 ± 0.07 
RGD0-YIGSR100 0.29 ± 0.03 
 
5.3.2. Attachment of A549 cells to peptide-grafted PDLLA 
Cell attachment can be evaluated by determining the DNA content of the cells 
attached to the surface 2 h after cell seeding using Hoechst 33258 dye. All 
peptide-grafted surfaces except 25RGD-100YIGSR and 0RGD-100YIGSR 
demonstrated higher cell attachment than the unmodified PDLLA (Figure 5-3). 
However, A549 attachment on all samples were still significantly lower than TCP. 
Cell adhesion was found to be higher on peptide-grafted PDLLA films with more 
RGD as compared to those containing more YIGSR.  
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Figure 5-3 Cell attachment 2 h after seeding was evaluated by determining the total DNA content of the 
attached cells using Hoechst dye (n = 4~5 for all samples). * and ** stand for significant difference 
between peptide-grafted surfaces and PDLLA (* for P<0.05; ** for P<0.005). + and ++ stand for 
significant difference between peptide-grafted surfaces and TCP (+ for P<0.05; ++ for P<0.005). The 
cell attachment experiments were repeated 3 times. 
 
5.3.3. Cell activity and population of A549 cells on days 2 and 4 
WST-1 and Hoechst assays were performed on both days 2 and 4 of the cell culture. 
The WST-1 assay measured the overall mitochondrial activity of the whole cell 
population and the Hoechst assay measured the total DNA concentration. After day 4, 
the A549 cells reached 100% confluence and died quickly. On day 2, no difference in 
A549 activity was found between all peptide-grafted surfaces and unmodified PDLLA 
(Figure 5-4). A549 cultured on TCP, however, demonstrated higher activity than the 
cells cultured on unmodified PDLLA on day 2. On day 4, TCP, RGD100-YIGSR0, 
RGD75-YIGSR25 and RGD0-YIGSR100 induced higher cell activity levels than 
unmodified PDLLA. On day 4, the A549 activities on all peptide-grafted PDLLA 
films except 75RGD-25YIGSR were significantly lowered than TCP. 
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Figure 5-4 WST-1 assay of A549 cell activity at day 2 and day 4 (n = 4~5 for all samples). * and ** 
stand for significant difference between peptide-grafted surfaces and PDLLA (* for P<0.05; ** for 
P<0.005). + and ++ stand for significant difference between peptide-grafted surfaces and TCP (+ for 
P<0.05; ++ for P<0.005). The WST-1 assay was repeated 3 times. 
 
More A549 cells were found on TCP than on unmodified PDLLA on both day 2 and 
day 4. On day 2 there were fewer A549 cells on all peptide-grafted PDLLA films than 
on unmodified PDLLA films, except 50RGD-50YIGSR (Figure 5-5). On day 4 there 
were more A549 cells on RGD0-YIGSR100 than on unmodified PDLLA. No 
difference in A549 cell population can be found between the other peptide-grafted 
samples and unmodified PDLLA. Comparing to TCP, cell numbers on all 
peptide-grafted surface were significantly lower on both day 2 and day 4. 
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Figure 5-5 Population of A549 cells at day 2 and day 4 was evaluated by the total DNA content using 
Hoechst dye (n = 4~5 for all samples). * and ** stand for significant difference between peptide-grafted 
surfaces and PDLLA (* for P<0.05; ** for P<0.005). + and ++ stand for significant difference between 
peptide-grafted surfaces and TCP (+ for P<0.05; ++ for P<0.005). The evaluation of cell population 
using Hoechst dye was repeated 3 times. 
 
5.3.4. Visualization of cell focal adhesion points and 
cytoskeleton 
The localization of F-actin, a cytoskeletal protein, and vinculin, a focal adhesion 
protein, were visualized 24 h after A549 cells were seeded onto TCP, unmodified 
PDLLA and peptide-grafted PDLLA films. A549 cells seeded on TCP and PDLLA 
demonstrated weak cytoskeleton formation (Figure 5-6A, B). Local distributions of 
the immunoreactive vinculin could be found, nevertheless, no spindle-like structures 
immunoreactive for vinculin, which is indicative of mature focal adhesion point 
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formation, were observed at the junction of F-actin-stained and cytoplasmic processes. 
This pattern suggests immature formation of focal adhesion points. In contrast to cells 
cultured on unmodified PDLLA and TCP, numerous spindle-like 
vinculin-immunoreactive adhesion points and distinct cytoskeleton were observed in 
A549 cells cultured on 100RGD-0YIGSR (Figure 5-6D). Cytoskeleton and adhesion 
point formation decreased with the decreasing percentage of RGD tripeptides. 
Spindle-like vinculin-immunoreactive structures were found not just at the 
cytoplasmic processes of the cells, but also underneath the cytoplasm in 
100RGD-0YIGSR, 75RGD-25YIGSR and 50RGD-50YIGSR (Figure 5-6D-F). For 
cells cultured on 25RGD-75YIGSR and 0RGD-100YIGSR, vinculin 
immunoreactivity could barely be seen (Figure 5-6G, H). 
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Figure 5-6 Immunostaining of vinculin and labelling of F-actin in A549 cells cultured on TCP, PDLLA 
and peptide-grafted surfaces for 24 h. The left panel shows vinculin, and the right column shows 
F-actin. In the left panel, arrows indicate vinculin with “spindle” shape. In the right panel, arrows 
indicated strong F-actin within the cytoplasm. Image (A) to (H) stood for: (A) TCP, (B) PDLLA, (C) 
Negative control for vinculin staining,  (D) 100RGD-0YIGSR, (E) 75RGD-25YIGSR, (F) 
50RGD-50YIGSR, (G) 25RGD-75YIGSR, (H) 0RGD-100YIGSR.  
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5.3.5. Differentiation of pulmonary epithelial progenitors from 
murine embryonic stem cells on peptide-grafted PDLLA 
mESCs were differentiated into pulmonary epithelial progenitors on the 
peptide-grafted PDLLA films and the experimental control, gelatin-coated PDLLA 
films. The pulmonary progenitors were SPC-eGFP positive and could be observed 
under the microscope (Figure 5-7A-D). The pulmonary progenitors differentiated on 
all samples possessed the same morphology, i.e. they were spindle-like and formed 
clusters within the attached EBs. The number of SPC-eGFP cells in different EBs 
varied significantly; therefore, a more appropriate characterization of the pulmonary 
progenitors, expression of SPC mRNA, was performed using quantitative PCR. All 
peptide-grafted surfaces were found to enhance the differentiation of the mESCs into 
pulmonary epithelial progenitors (Figure 5-7E) as compared to the control 
gelatin-coated PDLLA film. Among all the surfaces, RGD0-YIGSR100 enhanced 
SPC mRNA expression 4 fold more than the gelatin-coated PDLLA. The expression 
of SPC mRNA was also found to increase as the percentage of the YIGSR peptide 
increased.  
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Figure 5-7  SPC-eGFP-positive pulmonary epithelial progenitors were differentiated from mESCs for 
28 days on (A) gelatin-coated PDLLA film, (B) 100RGD-0YIGSR, (C) 50RGD-100YIGSR and (D) 
0RGD-100YIGSR. (E) The relative levels of SPC mRNA expression of the mESCs differentiated on 
peptide-grafted PDLLA films compared with the SPC mRNA expression of cells differentiated on the 
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experimental control, gelatin-coated PDLLA films (* P<0.05; ** P<0.005). 4 independent samples in 
each condition were evaluated. The quantitative PCR were repeated twice due to the time limit. 
 
5.4. Discussion 
The development of a synthetic material suitable for pneumocyte culture is still an 
underexplored area of research. In the present context, the water wettability and 
surface roughness of peptide-grafted PDLLA films were investigated and the effect of 
the composition of the grafted peptide layer on the responses of A549 cells and the 
differentiation of mESCs cells evaluated. The results suggested that pulmonary 
epithelial cell behaviour, including cell attachment, focal adhesion point formation, 
activity and population size, is dependent on the type and composition of the grafted 
peptide layer on the PDLLA surface. In addition, this report also showed that 
modification of PDLLA films by peptide-grafting can affect the long-term 
differentiation of mESCs into pulmonary progenitors.  
 
Bioactive peptides were grafted to PDLLA films pretreated with 4% ethylenediamine, 
using a process termed aminolysis where ethylenediamine breaks down the backbone 
of the polyester chains and introduces three types of hydrophilic species to the surface; 
primary amines, alcohols and amides. These hydrophilic species lower the water 
contact angles of the modified polymer surface as demonstrated in the literature [33, 
34, 40]. The introduced primary amines offer sites for peptide grafting using EDC 
coupling reaction, which can couple carboxylic acids and amines in two steps [275, 
276]. Grafting RGD and YIGSR using EDC to surfaces has been described in the 
literature [166] and was achieved by the formation of amide bonds on arginine and 
tyrosine, respectively. The addition of NHS to EDC in the grafting reaction generates 
a semi-stable amine-reactive intermediate. The amine-reactive intermediate has a long 
half-life for up to several hours at pH 8, and thus improves the grafting efficiency 
[276]. The guanidino groups of arginines on both peptides are non-reactive to the 
amine-reactive intermediates because of the eliminated nucleophilicity due to the 
protonation in aqueous solution [26] and the delocalization of the electrons into the Y 
framework of the guanidine group. During the grafting of YIGSR, the grafting 
reaction occurred at the amine of the tyrosine of YIGSR, however, the steric 
hindrance by the hydroxyphenyl groups of tyrosine was reported to give a lower 
grafting yield as compared with RGD [26]. The grafted-peptide layer of 
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75RGD-25YIGSR, 50RGD-50YIGSR and 25RGD-75YIGSR, therefore, comprised 
of less than 25%, 50% and 75% of YIGSR, respectively. The grafted-peptide layer of 
0RGD-100YIGSR is still consisted of 100% of YIGSR, however the number of the 
YIGSR peptides should be less than the number of the RGD peptides of 
100RGD-0YIGSR. This can explain why the roughness parameter Ra of the 
peptide-grafted PDLLA films decreased as the YIGSR percentage increased (Table 
5-1). 
 
Many factors determine (water) contact angles, including surface chemistry and 
roughness of the solid surface. AFM demonstrated that all peptide-grafted samples 
had a Ra < 1 nm. The roughness of all modified films is far smaller than the scale 
which can affect the contact angles as described previously [27, 200, 273, 274]. 
Therefore, the reduced water contact angle is solely the result of functional surface 
groups created by aminolysis and grafted peptides. Despite the fact that the surface 
roughness did not affect the surface wettability, another question arose as to whether 
it affects cell adhesion. Peptides are normally grafted to the material surface using 
spacers [24, 30, 269]. An optimal range for spacer length of 11 - 32 Å has been 
reported, which allows the grafted peptides to reach the integrin or non-integrin cell 
adhesion receptors [269], although spacers have not always been used [30]. It is 
thought that spacers are needed in some cases in order to compensate for the surface 
roughness of the materials [26]. The substrate material used for peptide grafting, 4% 
ethylenediamine-treated PDLLA films, had Ra=0.25 nm, and the spacer, succinic acid, 
had a maximal dimension of 7.8 Å, which could be determined by calculating the 
maximal dimension of all configurations of succinic acid. Despite 7.8 Å being slightly 
smaller than the lower limit of the “optimal spacer range” stated above, 7.8 Å is still 
more than enough to compensate the roughness of the 4% ethylenediamine-treated 
PDLLA films. The results of the vinculin and cytoskeletal staining also confirmed that 
the grafted RGD or YIGSR can reach the A549 cells and, as a result, did affect A549 
cells. 
 
As mentioned, YIGSR was the minimum sequence of laminin necessary for efficient 
cell adhesion and receptor binding of epithelial cells [272]. Its inductive effect on cell 
migration and focal adhesion point formation was reported to be less than RGD for 
fibroblasts [24]. The results showed that higher levels of cell attachment can be 
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observed on RGD-dominant samples despite their higher water contact angles. This 
result is in agreement with a previous report, which suggested that cells have a higher 
affinity to RGD than YIGSR [24]. In addition to cell attachment, the overall activity 
and populations of A549 cells on modified PDLLA films were also evaluated. Both 
WST-1 and Hoechst assays were performed on days 2 and 4 after A549 cell seeding. 
Among five peptide-grafted PDLLA films, only 0RGD-100YIGSR can induce both 
higher A549 activity and more A549 cells than unmodified PDLLA film on day 4. On 
day 2 this positive effect could not be observed, suggesting a time-dependent effect of 
the YIGSR peptide to the A549 cells. The time-dependent effects of the grafted 
peptide layer to the A549 cells were supported by the finding that there were fewer 
A549 cells on all peptide-grafted PDLLA films except 50RGD-50YIGSR than on 
unmodified PDLLA only on day 2 but not on day 4.  
 
A protocol has previously been established by colleagues for the differentiation of 
mESCs into progenitors of distal airway epithelium, specifically type II pneumocytes 
[203, 220]. The pulmonary progenitors obtained in this study had the same 
morphology as the cells obtained in the previous study [203, 220], suggesting that 
peptide-grafted PDLLA did not reroute the differentiation pathway into other lineages. 
Instead, the peptide-grafted PDLLA enhanced the expression of mRNA of surfactant 
protein C (SPC). SPC is the sole marker that is ONLY expressed by type II 
pneumocytes, and thus, SPC mRNA was used in this study to evaluate the effect of 
the peptide-grafted PDLLA films on stem cell differentiation. The fact that SPC 
mRNA expression changed in parallel with the proportion of YIGSR in the grafted 
peptide layer implied a role of surface composition on the differentiation of stem cells. 
This may be explained by the fact that YIGSR peptides can mimic the function of 
laminin whereas RGD mainly mimics the fibronectin function. These results are in 
agreement with those of a previous study, which demonstrated that a laminin coating 
on TCP can enhance the SPC expression several folds more than fibronectin coating 
[252]. Furthermore, the literature also indicated that the phenotype of type II 
pneumocytes can be maintained better on laminin than on fibronectin [91].  
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5.5. Conclusion 
The grafted peptides on PDLLA films result in a reduction of the water contact angles, 
i.e. resulting in an increased hydrophilicity of the modified PDLLA surfaces and 
increase the surface roughness of the PDLLA films. They also influence the response 
of the cultured pulmonary epithelial cell A549, such as attachment, the formation of 
focal adhesion points, cell activities and populations. In another preliminary 
experiment, it appeared that YIGSR-grafted PDLLA films may have the potential to 
serve as the differentiation environment for the differentiation of mESCs towards 
pulmonary epithelial progenitors. However, more investigations should be performed 
to confirm this finding. 
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Chapter 6. Functionalized Poly(D,L-lactide) for pulmonary 
epithelial cell culture 
 
6.1. Introduction 
Pulmonary dieases have long been one of the major causes of death in the world. One 
of the pulmonary disease, pulmonary fibrosis, affects millions of people worldwide 
every year. Pulmonary fibrosis is irreversible and no effective treatment is currently 
available [277]. A promising strategy to conventional medical treatment against 
pulmonary fibrosis, tissue engineering of pulmonary tissue, attracted much attention 
in the last 5 years. The basic principal of tissue engineering is to restore the function 
of a target tissue by implanting cells cultured on appropriate scaffolds to the impaired 
tissue [9, 14]. To restore lung function, type II pulmonary epithelial cells is the choice 
of cells because they were found to proliferate and transdifferentiate into type I 
pulmonary epithelial cells, which are responsible for gas-exchange, when the 
pulmonary epithelium is injured. 
 
The choice of the scaffold material is also important for the culture of pulmonary 
epithelial cells. Poly(D,L-lactide) (PDLLA) has been used safely in medical 
applications for decades and can be processed easily into various structures. It was 
proven biocompatible for the culture of pulmonary epithelial cells [198]. It is 
degraded by hydrolysis of the polyester backbone without the need of enzymes. The 
hydrolysis rate as well as the mechanical properties of the PDLLA can be easily 
modified by changing the ratio of D- and L- isomers of PDLLA. The bulk PDLLA is 
hard, however, when it is processed into scaffolds, the mechanical properties of the 
scaffolds can range from soft to very hard, depending on the preparation conditions of 
the scaffolds [20, 181]. The flexibility in the properties of PDLLA makes it a suitable 
scaffold material for tissue engineering applications. As polylactide is a hydrophobic 
material containing no reactive functional groups in the side chains, efforts have been 
made to modify its surface character in order to make it suitable for the maintenance 
and growth of various cell types [41, 164]. Although publications described surface 
modification of PDLLA scaffolds for cell culture applications [36-39, 146, 165, 
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278-281], none explored pulmonary epithelial cells. In this study, the growth of A549 
cells, a widely-used pulmonary cell line [61], on the functionalized PDLLA films was 
assessed.  
 
The strategy used to modify the surface of PDLLA scaffolds without using costly 
bioactive molecules, such as extracellular matrix proteins, is to introduce functional 
groups into the surface of PDLLA scaffolds [36, 165]. Functional groups such as 
amines and carboxylic acids have been introduced into PDLLA surface to enhance the 
attachment of osteoblasts [282, 283] and both the density and the distribution of the 
functional groups have been shown to affect osteoblast responses [171, 284, 285].  
 
In order to understand the effect of functional groups on pulmonary cell culture, the 
modification of PDLLA films was investigated using two simple techniques. Amines 
were introduced into the surface of PDLLA films by aminolysis (Figure 6-1), a 
transesterification reaction, using different concentrations of ethylenediamine in 
isopropanol. Furthermore, amine-terminated and carboxylic acids-terminated tree-like 
branched architectures were introduced into the surface of PDLLA films. Thus, it is 
called branching modification throughout this study. Because PDLLA lacks reactive 
functional groups, PDLLA films were treated by aminolysis first to obtain free surface 
amines, then branched architectures were prepared by repetitively grafting spacers and 
“trifunctional molecules” to surface amines, generating structures similar to tree 
branching [31]. The “trifunctional molecule” has three functional groups, one of 
which reacted with the spacer of the same generation, and the remaining two 
functional groups are reacted with two spacers of the next generation. This approach 
can enhance the density of local functional groups and alter their distribution in 2D 
environments and 3D scaffolds. Tissue culture plastic, unmodified PDLLA films, 
PDLLA films treated with aminolysis and branch modification were characterized 
with respect to their surface properties. The attachment, proliferation, population and 
focal adhesion point formation of A549 cells were assessed on the all polymer films. 
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Figure 6-1 Schematic diagram showing aminolysis of polyesters by transesterification using 
ethylenediamine 
 
6.2. Methodology 
Functional groups were introduced to the surface of PDLLA films using aminolysis 
and branching modification (Chapter 2.5.2 and 2.5.3). For aminolysis, 1, 2, 4, 8, 15% 
of ethylenediamine in isopropanol were used to treat PDLLA films to generate five 
different kinds of PDLLA films containing amines on the surface (Chapter 2.5.2). 
Branching modification can generate PDLLA containing 1, 2 or 3 generations of 
amine-terminated branched architectures or 1, 2 or 3 generations of carboxylic 
acid-terminated branched architectures on the surface (Chapter 2.5.3)). A total of six 
different samples were prepared using branching modification. 
 
The primary amines on the surface of the aminolyzed PDLLA films were measured 
using fluorescamine assay (Chapter 2.6.4). To evaluate whether the “branching 
modification“ worked, the surface compositions of the PDLLA films treated with 
branching-modification were determined using XPS (Chapter 2.6.6). Their surface 
chemistry was also evaluated using ζ potential measurements (Chapter 2.6.1). Surface 
characterizations, including water contact angle and surface roughness, were 
performed on all functionalized PDLLA films (Chapter 2.6.2 and 2.6.5). 
 
To evaluate the effects of surface functional groups on A549 responses, A549 cells 
were seeded on the functionalized PDLLA films and cultured for 4 days. Cell 
attachments were evaluated 2h after A549 seeding using Hoechst dye (Chapter 2.7.3). 
Formation of focal adhesion points and cytoskeleton of A549 cells was determined 
24h after cell seeding using immunostaining and phalloidin, respectively (Chapter 
2.3.3). A549 population and A549 metabolic activity was evaluated at day 2 and day 4 
using Hoechst dye and WST-1 reagent (Chapter 2.7.3 and 2.7.4). 
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6.3. Results 
The surfaces of PDLLA films modified by aminolysis and branching modification 
were characterized with respect to their surface chemistry, topography and wettability. 
The attachment, focal adhesion point formation, population and activity of pulmonary 
epithelial cells (A549 line) cultured on these functionalized PDLLA films were further 
assessed. 
 
6.3.1. Quantification of primary amine functional groups using 
fluorescamine assay 
The simple fluorescence-based method, fluorescamine, was used to quantify the bulk 
concentration of primary amines of the aminolyzed PDLLA films. The higher the 
concentration of ethylenediamine solution, the higher the concentration of primary 
amines introduced to PDLLA films (Figure 6-2). A sharp increase in primary amines 
was found to be induced by ethylenediamine in isopropanol at ethylenediamine 
concentrations ranging from 6% to 10%. Above 15 % of ethylenediamine, a plateau of 
amine functionalization was reached.  
 
Figure 6-2 Effect of ethylenediamine concentration in isopropanol on fluorescence intensity and the 
corresponding quantity of primary amine introduced to PDLLA films. 4 independent samples in each 
condition were evaluated. The fluorescamine assay was repeated 3 times. 
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6.3.2. Surface composition of modified PDLLA: X-ray 
photoelectron spectroscopy (XPS) 
XPS was used to determine the surface composition of unmodified PDLLA and 
PDLLA films modified by branching modification. As nitrogen is not present in 
PDLLA, it is considered the best candidate to evaluate the surface modification. The 
nitrogen content is expected to increase with each degree of branching. A trend of 
increasing nitrogen and decreasing oxygen content could be observed for all 
generations of bADA and between the 1st and 2nd generations of the bTREN by XPS 
(Table 6-1). There was not significant difference in nitrogen and oxygen content 
between 2nd and 3rd generations of bTREN. 
 
Table 6-1 Surface composition of modified PDLLA as determined by XPS. 5 independent samples in 
each condition were evaluated. The XPS probing was performed only once due to the budget limit. 
Samples C (%) N (%) O (%) 
PDLLA 57.90 ± 0.52 0 42.10 ± 0.52 
bADA1 58.85 ± 0.41 2.49 ± 0.02 37.80 ± 0.54 
bADA2 61.27 ± 3.60 2.89 ± 0.12 34.00 ± 5.91 
bADA3 60.05 ± 0.21 4.19 ± 0.63 33.00 ± 2.16 
bTREN1 59.57 ± 0.04 2.45 ± 0.20 37.68 ± 0.25 
bTREN2 61.53 ± 0.68 3.18 ± 0.31 35.11 ± 0.58 
bTREN3 60.06 ± 0.63 3.02 ± 0.34 36.36 ± 1.23 
 
6.3.3. Wettability of wet PDLLA surfaces: dynamic contact 
angles  
All surface-modified PDLLA films had lower advancing and receding contact angles 
than unmodified PDLLA (Figure 6-3). 15%EDiamine, bTREN1, bTREN2, bADA2 
and  bADA3 had lower advancing and receding contact angles than TCP. PDLLA 
films treated with more concentrated ethylenediamine had lower contact angles, 
particularly 8%EDiamine and 15%EDiamine, than PDLLA films treated with a less 
concentrated ethylenediamine solution. In the bTREN group, it was notable that 
bTREN3 had significantly higher advancing contact angles (P<0.005) than bTREN1 
and bTREN2. In the bADA group, as expected, contact angles decreased as the 
number of branching generations increased.  
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Figure 6-3 Dynamic water contact angles on PDLLA, TCP and modified PDLLA films measured using 
the captive bubble technique. The advancing and receding contact angles of all modified PDLLA were 
significantly lower than PDLLA (P<0.005, n = 4). + and ++ stand for significant difference between 
functionalized surfaces and TCP (+ for P<0.05; ++ for P<0.005). The water contact angle 
measurements were repeated 3 times. 
 
6.3.4. Surface topography and roughness of modified PDLLA: 
Atomic Force Microscopy (AFM)  
Unmodified PDLLA, 1%EDiamine, 2%EDiamine, 4%EDiamine and 8%EDiamine 
had homogeneous surfaces containing no distinct surface features. 15%EDiamine, in 
contrast, had an irregular surface topography with Ra = 1.14 nm. Furthermore, Ra was 
found to increase as the concentration of ethylenediamine increased (Figure 6-4 and 
Table 6-2). For the samples modified with branched architectures, the formation of 
droplet-like structures on the surface of both bTREN and bADA was observed. The 
size of these structures increased as the branching generation increased (Figure 6-4 
and Table 6-2). Compared with bTREN with the same number of generations, bADA 
had higher Ra, i.e. Ra of TREN1 was 0.75 and Ra of ADA1 1.58, Ra of TREN2 0.97 
and Ra of ADA2 3.13, Ra of TREN3 1.38 and Ra of ADA3 3.48. 
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Figure 6-4 AFM scans of unmodified and modified PDLLA films. An area of 1μm x 1μm was imaged. 
(A) unmodified PDLLA film and aminolyzed PDLLA films, (B) PDLLA films grafted with branched 
architectures. 
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Table 6-2 Roughness parameter (Ra) of original PDLLA and modified samples (units: nm). 5 
independent samples in each condition were evaluated. The AFM probing was repeated twice. 
PDLLA and 
aminolyzed surface 
Ra Mean Ra SD Branching 
modification 
Ra Mean Ra SD 
PDLLA 0.14 0.06    
1% 0.16 0.02 TREN1 0.75** 0.03 
2% 0.21 0.04 TREN2 0.97** 0.08 
4% 0.25 0.04 TREN2 1.38** 0.15 
8% 0.28 0.10 ADA1 1.58** 0.12 
15% 1.14** 0.15 ADA2 3.13** 0.48 
   ADA3 3.48** 0.34 
* P<0.05; **P<0.005; SD = standard deviation of the mean. 
 
6.3.5. Surface character of modified PDLLA: ζ-potential 
measurements 
Figure 6-5 shows the ζ-potential of PDLLA, 4%EDiamine, bTREN3 and bADA3 as 
function of pH (ζ=f(pH)). PDLLA contains mainly Brønsted acidic functional groups, 
which resulted in an IEP, where ζ=0, of pH 3.5 and a plateau (ζplateau) of -29 mV in the 
alkaline region [214]. PDLLA is made by ring-opening polymerization of lactide and, 
therefore, it contains carboxylic acid functional groups at one end of each polymer 
chain. Both 4%EDiamine and bADA had IEP values at pH of 3.7, close to the IEP of 
PDLLA. In contrast, bTREN3 has an IEP of 4.5, much higher than the other three 
samples. Among the four samples tested, bTREN3 and bADA3 showed highest and 
lowest ζplateau-value at -25.7 mV and -38.4 mV, respectively, whereas PDLLA and 
4%EDiamne showed no statistically significant difference.  
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Figure 6-5 ζ-potential of PDLLA films, 4%EDiamine, bTREN3 and bADA3 films measured as a 
function of pH in a 1mM KCl supporting electrolyte. 4 independent samples in each condition were 
evaluated. The ζ-potential measurements were repeated 3 times. 
 
6.3.6. Determination of cell attachment using the Hoechst 
33258 dye 
Cell attachment can be evaluated by determining the DNA content of the cells 
attached to the surface 2 h after cell seeding. Among all the experimental samples, 
4%EDdiamine, 8%EDdiamine and 15%EDdiamine induced significantly higher cell 
attachment than the unmodified PDLLA (Figure 6-6). Also both bTREN and bADA 
PDLLA films, which possessed two or three generations, exhibited higher cell 
attachment than unmodified PDLLA. The A549 cell attachment on PDLLA with three 
modified branched architectures was in the following order: bTREN3 > bTREN2 = 
bTREN1 and bADA3 = bADA2 > bADA1. Furthermore, bTREN3 and bADA3 
resulted in cell attachments at comparable level to those on TCP. 
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Figure 6-6 A549 cell attachment was evaluated by measuring the total DNA content of the attached 
cells 2 h after being seeded using Hoechst dye (n = 6 for all samples). * and ** stand for significant 
difference between functionalized surfaces and PDLLA (* for P<0.05; ** for P<0.005). + and ++ stand 
for significant difference between functionalized surfaces and TCP (+ for P<0.05; ++ for P<0.005). The 
cell attachment experiments were repeated 3 times. 
 
6.3.7. Visualization of cell focal adhesion and cytoskeleton 
F-actin, a cytoskeletal protein, and vinculin, a focal adhesion protein, in A549 cells 
were stained 24 h after seeding. A549 cells seeded on TCP, PDLLA and 
aminolysis-treated PDLLA did not demonstrate distinct F-actin formation (Figure 
6-7A-H). Spindle-like structures immunoreactive for vinculin were not observed at 
the junction of the F-actin and the cytoplasmic processes (Figure 6-7A-H). In the 
group of branched architectures, weak spindle-like vinculin-positive structures could 
be found in cells grown on bTREN (Figure 6-8B-D), and spindle-like 
vinculin-positive structures were barely seen in cells on bADA (Figure 6-8E-G). 
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Figure 6-7 Immunostaining of vinculin (left panel) and F-actin (right panel) in A549 cells cultured on 
PDLLA, TCP and aminolyzed PDLLA films after 24 h in culture. Four independent samples of each 
condition were recorded. Vinculin immunoreactivity can be seen at the end of some cell processes, but 
no immunoreactive “spindle-like” structures were seen. F-actins stained by phalloidin were not distinct 
in the most cells cultured on these surfaces for 24h. 
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Figure 6-8 Immunostaining of vinculin (left panel) and F-actin (right panel) in A549 cells cultured on 
PDLLA films with branched architectures after 24 h in culture. In the left panel, arrows indicate 
vinculin-immunostained structures with spindle shape. Weak vinculin-immunoreactive spindle-like 
structures were seen in the cells cultured on bTREN samples. 
 
6.3.8. A549 cell activity and number on days 2 and 4 
WST-1 assay (Figure 6-9) and Hoechst assay for DNA quantification (Figure 6-10) 
were performed only on days 2 and 4 because after day 4, A549 cells reached 100% 
confluence and died quickly. Unmodified PDLLA was found to induce lower cell 
activity than TCP on both day 2 and day 4. All aminolyzed films were found to induce 
similar levels of A549 activity as PDLLA on both days. But no difference was found 
between each condition of the aminolysis group. The cell activity on bTREN was 
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found to be significantly lower than unmodified PDLLA on day 2, but higher than on 
unmodified PDLLA on day 4, suggesting a time-dependent metabolic cell response. 
On day 4, the A549 cell activities on bTREN were comparable to those on TCP. There 
was no significant difference in cell activity between any bADA and unmodified 
PDLLA on either day 2 or day 4.  
 
As far as cell population size was concerned, aminolyzed PDLLA, except for 
15%EDiamine, induced higher cell numbers than unmodified PDLLA on day 4. Cell 
numbers obtained on all branching modified PDLLA samples were significantly lower 
than those on unmodified PDLLA on day 2. On day 4, bTREN2 and bTREN 3 had 
significantly larger cell populations but all bADA samples had lower cell numbers 
than the unmodified PDLLA. Furthermore, the cell numbers on aminolyzed-PDLLA 
films except 15%EDiamine were comparable to those on TCP on day 4. 
 
 
Figure 6-9 Activity of A549 cells on day 2 and day 4 as determined using WST-1 assay (n = 6 for all 
samples). * and ** stand for significant difference between functionalized surfaces and PDLLA (* for 
P<0.05; ** for P<0.005). + and ++ stand for significant difference between functionalized surfaces and 
TCP (+ for P<0.05; ++ for P<0.005). The WST-1 assay was repeated 3 times. 
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Figure 6-10 Population of A549 cells on day 2 and day 4 evaluated by total DNA content using Hoechst 
dye (n = 6 for all samples). * and ** stand for significant difference between functionalized surfaces 
and PDLLA (* for P<0.05; ** for P<0.005). + and ++ stand for significant difference between 
functionalized surfaces and TCP (+ for P<0.05; ++ for P<0.005). The evaluation of cell population 
using Hoechst dye was repeated 3 times. 
 
6.4. Discussion 
In this study, the aim was to modify the surface of PDLLA in order to increase its 
capacity to support the growth of pulmonary epithelium. PDLLA films were modified 
using aminolysis and by attaching branched architectures to the PDLLA surface. 
Aminolysis introduced amines into the surface of PDLLA films. Branching 
modification enhanced the concentration of carboxylic acids and amines in the 
vicinity of the branched architectures. The results suggest that the concentration, type 
and distribution of surface functional groups affect the growth and activity of 
pulmonary epithelial cells on PDLLA.  
 
Aminolysis has long been used in the textile industry to modify the surface of 
synthetic fibres, such PET [168]. Its application for the surface modification of 
biomaterials has only been explored in the past few years [33, 34, 40]. Here,  
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1%-15% ethylenediamine was used in isopropanol to modify the surface of PDLLA 
for 5 min. Aminolysis is a form of trans-esterification reaction where the carbonyl 
carbon is attacked by the nucleophilic nitrogen of the amine to generate amines and 
alcohols (Figure 6-1). Most aminolysis reactions are carried out in either a basic 
aqueous solution or in a solvent with high π-basicity, such as isopropanol. Isopropanol 
was used instead of water as solvent to make up ethylenediamine solutions because, in 
isopropanol, aminolysis is the sole reaction whereas, in water, concurrent hydrolysis 
of PDLLA occurs [33]. 
 
Zhu et al. [34] reported the difficulty of detecting nitrogen using XPS on PCL using a 
similar aminolysis modification. A more sensitive method using fluorescence 
microscopy to quantify rhodamine B isothiocyanate-labelled amines was employed 
instead [34]. Also, a fluorescence assay, fluorescamine, was used to quantify primary 
amines. Fluorescamine can react with primary amines to form a primary amine adduct 
which absorbs light at 390 nm and emits light at 475 nm. It is an extremely sensitive 
reagent, being able to detect amines at sub-picomole (< 10-12 mole) levels [286]. A 
plateau of fluorescence intensity was observed when exceeding 15% of 
ethylenediamine concentration in isopropanol (Figure 6-2). Consequently, 
ethylenediamine concentrations up to 15% were used for subsequent experiments. 
Aminolysis of PDLLA using ethylenediamine generates three hydrophilic species, 
primary amines, alcohols and amides, all of which help to improve the wettability of 
the modified surfaces by water, i.e. result in lower contact angles as measured by the 
captive bubble method.  
 
Surface modification using succinic acid and TREN to form branched architectures 
for fibroblast culture was first reported using solely EDC as the coupling reagent [31]. 
The drawback when using EDC alone is that the unstable intermediate has a very 
short lifetime of only a few minutes [276]. Therefore, the protocol was improved 
firstly by adding NHS to generate amine-reactive NHS esters with a longer lifetime 
and, secondly, by controlling the pH at 5 and 8 during the first and second steps of the 
coupling reactions to improve the coupling efficiency, respectively. EDC was used to 
couple carboxylic acids and amines in two steps of each reaction. In the first step, 
EDC reacted best with carboxylic acid at around pH 5 [275, 276], forming unstable 
amine-reactive O-acylisourea intermediates. NHS then replaced the role of EDC, 
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forming semi-stable, amine-reactive NHS-esters. In the second step, TREN or ADA, 
both containing amine groups, were added to the amine-reactive NHS-esters to 
generate amide bonds. The amine-reactive NHS-esters undergo faster hydrolysis 
when the pH increases, moreover, the reactivity of it to amines also increases with pH 
[213]. Therefore, a suitable pH should be determined to maximize the reaction 
product of the second step of the EDC coupling reaction. In the preliminary test, pH 8 
was found to be a good balance between the reaction rate and the hydrolysis rate of 
the amine-reactive NHS-esters and thus used in the second step of all EDC coupling 
reactions. Despite, the hydrolysis of the amine-reactive NHS-esters still results in a 
coupling efficiency mush less than 100% [275]. Consequently, it is impossible to 
reach 100% branching efficiency, and thus branched architectures with different 
generations might have existed on the same surfaces, e.g. bADA3 can have branched 
architectures with three, two or even only one generation. 
 
During the preparation of branched architectures, unwanted reactions might also have 
occurred during reaction 1 and reaction 2 (Figure 2-12). Succinic acid has two 
carboxylic acids, both of which have the potential to react with amines on 
aminolysis-treated PDLLA (Figure 2-12, dashed circle A). Furthermore, TREN has 3 
amino groups, all of which could react with acid groups introduced by succinic acid in 
reaction 1 (Figure 2-12, dashed circle B and C). Therefore, if more than one coupling 
reaction occurred between one molecule of succinic acid and TREN, the number of 
the available functional groups at the surface decreased rather than increased. As the 
number of the branching generations increased, it could be more likely to see 
unwanted coupling reactions due to the proximity between adjacent branched 
architectures. This might explain why the nitrogen content of bTREN3 was not 
significantly higher than bTREN2 (Table 6-1). The water contact angle of bTREN3 
was also not significantly lower than bTREN2 (Figure 6-3). In contrast, when creating 
bADA the above mentioned problems for bTREN will not be encountered. Except for 
the first generation, bADA used GABA and ADA as the spacers and “trifunctional 
molecules”, respectively. Both GABA and ADA have only one primary amine, 
therefore, in the coupling reaction (Figure 2-12, reaction 3-5), no unwanted coupling 
reactions will occur. The advantage of the design was reflected most significantly in 
the increase of nitrogen content and the reduction of the measured water contact 
angles as the number of branching generations increased (Table 6-1, Figure 6-3), e.g. 
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bADA3 films have a higher nitrogen content and lower water contact angle than 
bADA2. Another problem with the branching modifications of both bTREN and 
bADA is that it was prepared in an aqueous solution. PDLLA is known to be 
susceptible to water [156], i.e. it degrades by hydrolysis. During the modification and 
subsequent washing of the samples, cleavage of the ester backbone by water is prone 
to occur, generating one carboxylic acid at one end of the broken polymer chains. 
Therefore, it is clear that hydrolysis-induced surface carboxylic acids actually 
participated in the branching reactions, especially in step1 of reaction 2 to reaction 5 
(Figure 2-12). 
 
The limitation of XPS is that it only samples a relatively small area of the materials 
surface (approx. 0.04 mm2). To evaluate the entire modified surface, another 
measurement has to be applied. Accordingly, ζ-potential measurements were 
performed on the whole modified surface over a wide pH range. The ζ-potential is 
determined by the formation of the electrochemical double layer, i.e. the dissociation 
of functional groups according to their pKa and the adsorption of ions present the 
background electrolyte (K+, Cl-, H3O+ or OH-). ζ=f(pH) (Figure 6-5) demonstrated 
much higher IEP and ζplateau of bTREN than bADA. The IEP is a measure of the 
surface acidity or basicity. Surfaces that are more acidic, i.e. contain more or stronger 
acidic groups, have lower IEP than a surface that is less acid, and vice versa. The 
presence of the ζplateau is attributed to the dissociation of the charge-determining 
surface groups and the adsorption of the water and ions at the corresponding pH [202]. 
In general, a surface that has more or stronger dissociating acid groups has higher 
ζplateau than a surface that has less or weaker dissociating acid groups. Thus, the 
experimental result that bADA3 had lower IEP and ζplateau than bTREN3 met our 
expectation because bADA3 possessed carboxylic acids at the end of the branched 
architectures while bTREN3 possessed amines at the end of the branched 
architectures. 
 
All modifications used in this study reduced the water contact angle, i.e. improved 
wetting behaviour of the modified PDLLA films. Factors that determined the contact 
angle include the surface chemistry and surface roughness. AFM demonstrated that 
the samples in the aminolysis group had a Ra smaller than 1.2 nm and samples in the 
branching modification group smaller than 3.5 nm. The roughness of all samples is far 
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smaller than a micrometre which is the scale commonly thought to affect contact 
angles [200]. Therefore, the reduced water contact angle is solely the result of 
introduced surface functional groups. Comparing the water contact angle with the 
level of cell attachment, a correlation can be found in the samples modified using the 
same modification technique, i.e. aminolysis, amine-terminated branched 
architectures and carboxylic acid-terminated branched architectures, such that 
substrates exhibiting better cell attachment correspond to lower water contact angles. 
The correlation was also observed by others before [287]. Despite the fact that the 
nanoscale surface roughness did not affect to the contact angle as described, it could 
be argued that the enhanced A549 attachment is attributed to surface roughness. A 
previous publication indicated that surfaces with Ra > 10 nm can enhance cell 
attachment [27]. The positive effect of surface roughness with Ra < 10 nm to 
osteoblast responses was recently demonstrated [288, 289]. However, the effect of 
nanoscale roughness on pulmonary epithelial cells has not yet been investigated. 
Accordingly, it is still not clear whether the enhanced cell attachment to the modified 
surface was solely due to the functional groups introduced. 
 
Another question that arose from the cell attachment experiments was whether the 
cells were in direct contact with the functional groups. Some studies used serum-free 
medium in order to investigate the effect of surface functional groups on the cell 
culture to avoid a secondary surface modification by protein adsorption from the 
serum [290]. Since protein adsorption is always the first event occurring when a 
biomaterial comes in contact with body fluids, using serum-containing medium to 
evaluate the surface modification can be more representative of the in vivo condition. 
It has been suggested that long-term total protein adsorption on 
functional-group-enriched polylactide (PLA) films remain unchanged [291]. However, 
the same study also demonstrated that protein adsorption was faster for functional 
group-enriched polylactide than unmodified PLA and lasted for 800 min as 
determined using a quartz crystal microbalance. In the present case, the cell culture 
medium contained 10% FBS, thus the enhanced cell attachment induced by the 
samples that possessed more functional groups, such as 15%EDiamine, bTREN3 and 
bADA3, might be partly attributed to more serum protein adsorption because the cell 
attachment was measured just 2 h after cell seeding, which is far shorter than the 800 
min period of the serum protein adsorption demonstrated in the literature [291].   
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A previous study reported better cell responses on surfaces possessing 
homogeneously-distributed amines than on surfaces possessing carboxylic acids [171]. 
In this study, bTREN and bADA contained amines and carboxylic acids, respectively. 
The main difference from previous reports is that our branched architectures altered 
the distribution of the functional groups, i.e. functional groups were more 
concentrated where the branched architectures are located. This difference in 
functional group distribution was reflected by the altered A549 cell behaviour: cells 
growing on bTREN exhibited some vinculin-inducing potential, but those on bADA 
did not. In addition to focal adhesion formation, differences in results obtained using 
WST-1 and Hoechst assays were observed. The WST-1 assay measured the overall 
mitochondrial activity of the whole cell population and the Hoechst assay measured 
total DNA concentration. The activity and population size of A549 cells were found to 
be time-dependent. For example, the level of cell activity on the bTREN group was 
slightly lower than that on bADA on day 2, but it was much higher than on bADA on 
day 4. Cell activity and population size can be discussed together to obtain a more 
complete overview of A549 responses. A good example is to compare the results 
obtained for bADA1 with those obtained for unmodified PDLLA. Both of them had a 
similar cell number on day 4, however, the activity of the cells on bADA1 was 
significantly higher than that of cells growing on unmodified PDLLA, which implied 
that cells on bADA1 had a higher average cell activity than those on unmodified 
PDLLA.  
 
6.5. Conclusion 
The development of a synthetic material suitable for pneumocyte cultures is still a 
very new area of research. In this present context, the effect was investigated of the 
amine density and branched architectures on the surface properties of PDLLA, a 
polymer previously shown to be a suitable support for pneumocyte cultures [198]. All 
surface modifications can reduce the water contact angle of PDLLA films 
significantly. PDLLA films modified with branching modifications demonstrated 
droplet-like surface topography. Amine-terminated branched architecture showed 
higher IEP and ζplateau than the carboxylic acid-terminated branched architectures. The 
pulmonary epithelial cell behaviour, such as cell attachment, focal adhesion formation, 
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short-term cell activity and population size, are dependent on the modifications of the 
PDLLA films. PDLLA films modified using 15% ethylenediamine and branched 
architectures with two and three generations can induce better A549 attachment. The 
latter can also induce better focal adhesion point formation, higher A549 activity and 
higher A549 population. Therefore, modification of PDLLA scaffolds with 
amine-terminated branched architectures for two or three generations was 
recommended as the surface modification for the future engineering of pulmonary 
epithelial tissue. 
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Chapter 7. Preparation and modification of Poly(D,L-lactide) 
scaffolds for pulmonary epithelial cell culture 
 
7.1. Introduction 
The aim of this study was to develop a 3D scaffold made of a synthetic material 
suitable for the engineering of pulmonary epithelial tissue. In this study, particular 
focus was placed on the effects of the preparation conditions of scaffolds on the 
resulting pore morphology of the prepared scaffolds and on the subsequent culture of 
pulmonary epithelial cells. The effects of the surface modification of the prepared 3D 
scaffolds on the cell responses were also studied. 
 
The development of the field of tissue engineering has progressed rapidly in the past 
few years. Artificial tissues, such as bone [288, 292, 293] and cartilage [180], have 
been successfully developed in vitro using cells cultured on synthetic scaffolds. For 
the engineering of lung tissue, scaffolds need to be completely different from those 
designed for other tissues, mainly due to a special feature of lung: lung is porous. The 
only other porous tissue in the human body is the cancellous bone. The gas-exchange 
component of the lung is made up of more than three million functional units, called 
alveoli, having an average diameter of 100-200 μm. The total surface area of the 
alveoli is around 70-90 m2 and they are lined by two types of endoderm-derived 
pulmonary epithelial cells. The engineering of lung tissue has progressed much slower 
than that of other tissues. This is due to the difficulty of culturing primary pulmonary 
epithelial cells [10, 78, 268] and also due to the limited number of scaffolds 
specifically designed for lung. In recent years, the lack of primary cells has been 
overcome by the generation of lung epithelial cells and their progenitors from various 
types of stem cells [17, 18, 203, 219, 220]. As for appropriate scaffolds, hydrogels 
made of extracellular matrix proteins, such collagen [196], GAG [196] or Matrigel 
[22] have been tested. Scaffolds made from proteins take advantage of their bioactive 
properties but can be very expensive. Furthermore, many proteins are derived from 
neoplastic tissues and thereby doubtful with respect to their long-term safety in the 
clinical applications.  
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Synthetic polymer scaffolds can be processed into a porous framework which 
facilitates gas and medium diffusion. The porous structures can be optimised to mimic 
the target organ and allow the in-growth of vascular supply and host tissue in vivo. 
Furthermore, synthetic scaffolds can also be used for the in vitro expansion of 
populating cells. Poly(D,L-lactide) (PDLLA), a degradable polyester, was used for the 
scaffold preparation in this study. PDLLA has various biomedical applications due to 
its biodegradability and biocompatibility [146, 294]. The mechanical properties of the 
PDLLA can be tuned by adjusting the ratio of D- or L-isomer [146, 150]. PDLLA can 
also be blended with other polymers for various applications [18-21]. Recently, it was 
found that extracellular matrix protein-coated PDLLA is a suitable scaffold for the 
differentiation of pulmonary epithelial cells from embryonic stem cells [252]. 
 
Thermally Induced Phase Separation (TIPS) is one of many methods to fabricate 
porous scaffolds. This technique was long used in industry to generate porous 
membranes for separation applications [295-297]. The principle of TIPS is based on 
the change in the thermodynamic state of a polymer solution as a function of 
temperature ranges. A polymer solution phase-separates into a polymer-rich phase and 
a polymer-poor phase when the polymer solution is quenched to the temperature 
below the binodal curve of a temperature-composition phase diagram of the polymer 
solution [184]. Interconnectivity of the same phase (polymer-poor or polymer-rich) 
only occurs when the polymer solution is further brought to the unstable zone below 
the spinodal demixing curve. Scaffolds can be obtained by removing the solvent from 
the quenched phase-separated polymer solution using freeze-drying. Factors such as 
solution quenching rate, quenching temperature, solution composition and coarsening 
time and temperature can alter the final morphology of the scaffolds. Among all these 
factors, coarsening, a phenomenon that involves the time-dependent reduction of 
interfacial energy by reducing the interfacial area between the polymer-rich and 
polymer-poor phase, was studied recently for the fabrication of PLLA scaffolds [185, 
189, 190]. During coarsening the tendency of reducing the interfacial energy results in 
the growth of phase-separated droplets over time. These droplets may further coalesce 
to form larger droplets.  
 
When subjected to temperature change, liquid-liquid phase separation occurring in a 
PDLLA-water-dioxane ternary system can generate scaffolds with round porous 
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structures [298, 299]. In this study, the pore size (distribution) of scaffolds created this 
way was manipulated by playing with coarsening temperatures and coarsening time 
periods in order to generate scaffolds with pore sizes similar to the dimension of lung 
alveoli.  
 
In addition to liquid-liquid phase separation, scaffolds were also prepared using 
solid-liquid phase separation. Solid-liquid phase separation using PDLLAdimethyl-
carbonate (DMC) generates scaffolds with anisotropic ladder-like tubular pores [181, 
198]. The pore size of scaffolds prepared in this way is determined by the size of 
DMC crystals [181] The size of DMC crystals can be tuned by controlling the 
temperature at which the PDLLA-DMC solution was frozen.  
 
In order to understand whether the scaffolds prepared by liquid-liquid and/or 
solid-liquid phase separation are suitable culture environments for pulmonary 
epithelial cells, cell culture on manufactured scaffolds was performed using A549 
cells. A549 cells are human pneumocyte-like cells originally derived from an alveolar 
cell carcinoma. A549 has been widely used as a model to study pulmonary epithelial 
cell-biomaterial interactions [195, 300-303]. The metabolic activity of A549 cells and 
their migration into the prepared scaffolds were recorded using WST-1 reagents and 
microscope, respectively. 
 
Not only the porous morphology but also the surface properties of the scaffolds can 
affect the activity of A549 cells cultured on the scaffolds. As PDLLA is known for its 
hydrophobicity, efforts to adjust its surface properties, i.e. make it more hydrophilic, 
have been made [165, 267]. The introduction of functional groups into the surface of 
PDLLA films using aminolysis was recently reported [304], which introduces amines 
to the surface of the PDLLA films. Aminolysis was followed by another treatment 
called branching modification, a technique that can generate amine- or carboxylic 
acid-terminated tree-like branched architectures on the material surface [304]. In this 
study, both surface modifications were applied to 3D scaffolds in order to create 
scaffolds possessing functional groups on the surface. A549 cells were seeded on the 
modified scaffolds and their activity was further examined using WST-1 reagent. 
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7.2. Methodology 
The objective of this chapter is to prepare scaffolds suitable for the culture of 
pulmonary epithelial cells using liquid-liquid phase separation and solid-liquid phase 
separation. The “coarsening” effects on the pore size and porous structure were 
studied using the liquid-liquid phase separation system. The coarsening periods of 10 
min, 20 min, 30min and 60 min as well as coarsening temperatures from 12 to 27℃ 
were used (Chapter 2.4.2.1). Two more scaffolds using solid-liquid phase separation 
were also prepared for comparison (Chapter 2.4.2.2). The pore sizes of the scaffolds 
showing on the SEM microimages were analyzed using image analysis software 
(Chapter 2.6.3). 
 
To study whether the prepared scaffolds are suitable for the culture of pulmonary 
epithelial cells, A549 were seeded onto some scaffolds and cultured for 16 days 
(Chapter 2.7.1). The activities of the cultured A549 cells were evaluated using WST-1 
reagent (Chapter 2.7.4). The penetrations of the A549 into the middle of the scaffolds 
were recorded on day 16 using SEM and fluorescence microscopy (Chapter 2.7.2).  
 
We further modify the surface of some scaffolds using aminolysis and branching 
modification (Chapter 2.5.3), as described in Chapter 6. Similarly, A549 cells were 
seeded into scaffolds, and their metabolic activities were measured using WST-1 
reagent (Chapter 2.7.4). 
 
7.3. Results 
7.3.1. Morphological analysis of the scaffolds  
The pore size of the scaffolds prepared by liquid-liquid phase separation at a 
coarsening temperature of 24℃ was found to increase with the coarsening time 
(Figure 7-1, Figure 7-2). After 60 min coarsening, a solvent-rich layer formed on top 
of the polymer-rich layer, which could be observed on top of the prepared scaffold 
(Figure 7-3). Well-defined macroporous structures were observed for the scaffolds 
LL10M, LL20M and LL30M, however, it is worth noting that many pores were 
poorly-connected or only connected to each other via small (10 - 20 μm) pore throats 
(indicated by arrows in Figure 7-4A, B). These pore throats were smaller than the 
diameter of A549 cells, thereby preventing cell migration into the scaffold from one 
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pore to the next. Pore throats at hundred micrometre scales were also observed 
(Figure 7-4A1, A2), however, their number was much smaller than the number of pore 
throats with diameters ranging from 10 to 20 μm. 
 
Figure 7-1 Scanning electron micrographs of PDLLA scaffolds prepared by liquid-liquid phase 
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separation using a coarsening temperature of 24℃ and increasing coarsening times (group1): (A) no 
coarsening was performed (LL0M); (B) coarsening for 10 min (LL10M); (C) coarsening for 20 min 
(LL20M); (D) coarsening for 30 min (LL30M); (E) coarsening for 60 min (LL60M). All figures are at 
50x magnification. 
 
 
Figure 7-2 The effect of coarsening time on the mean pore size. The error bar indicates the standard 
deviation. The pore sizes of scaffolds prepared using different coarsening time are significantly 
different to each other (In each condition, 6 independent samples were imaged. More than 80 pores in 
each image were measured. SEM probing was repeated twice). 
 
 
Figure 7-3 Scaffolds prepared by liquid-liquid phase separation using a coarsening temperature of 24℃ 
and increasing coarsening times (0 min, 10 min, 20 min and 30 min). From left to right: LL0M, LL10M, 
LL20M, LL30M, LL60M. 
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Figure 7-4 Scanning electron micrographs of scaffolds prepared by liquid-liquid phase separation using 
a temperature of 24℃. A1: LL20M at x200 magnification. A2 is an enlargement of the white square 
shown in A1 at x500 magnification. A3 is an enlargement of the white square in A2 at x1000 
magnification. B: LL30M at x200 magnification. The arrows indicate small pore throats at 10 μm to 20 
μm scale. The dotted line indicates a large pore throat more than 50 μm in diameter. 
 
Seven different scaffolds (Group 2) were prepared using coarsening temperatures 
varying between 12℃ and 27℃ with 30 min coarsening time. Four of the scaffolds 
prepared, LL21C, LL18C, LL15C and LL12C, had average pore sizes exceeding 200 
μm. The pore size of the scaffolds increased from 60 μm to 270 μm with decreasing 
coarsening temperature from 27 ℃ to 18 ℃. The pore size of the scaffolds slightly 
decreased from 270 μm to 220μm when the coarsening temperature was further 
decreased from 18 ℃ to 12 ℃ (Figure 7-5, Figure 7-6). The pore walls of the 
scaffolds were getting rougher when the coarsening temperature was reduced from 27 
℃ to 15 ℃ (Figure 7-5 A-E). When the coarsening temperature was reduced to 12 ℃, 
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scaffolds with smooth pore walls were again observed (Figure 7-5F). Unfortunately, 
the scaffolds LL18C (Figure 7-5 D) and LL12C (Figure 7-5 F) possessed many but 
poorly interconnected pores. The pores are connected to each other only via small 
pore throats. 
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Figure 7-5 Scanning electron micrographs of scaffolds prepared by liquid-liquid phase separation using 
different coarsening temperatures (group 2): (A) coarsening at 27 ℃ for 30 min; (B) coarsening at 24 
℃ for 30 min; (C) coarsening at 21 ℃ for 30 min; (D) coarsening at 18 ℃ for 30 min (E); coarsening 
at 15 ℃ for 30 min; (F) coarsening at 12 ℃ for 30 min..  
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Figure 7-6 The effect of coarsening temperature on pore size. The error bar indicates standard deviation 
from the mean (In each condition, 6 independent samples were imaged. More than 40 pores in each 
image were measured. SEM probing was repeated twice). 
 
In contrast to the isotropic porous architecture of scaffolds prepared by liquid-liquid 
phase separation, scaffolds made by solid-liquid phase separation had an anisotropic 
and ladder-like laminated porous structure (Figure 7-7), similar to that described in 
the literature [38, 181, 305]. The pore dimension of scaffold SL-25 ranged from 150 
to 250 μm (Figure 7-7A, B) and that of scaffold SL-196 ranged from 40 to 50 μm 
(Figure 7-7C, D). The pores of both scaffolds SL-25C and SL-196C had a smoother 
surface than the pores of the scaffolds prepared by liquid-liquid phase separation. 
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Figure 7-7 Scanning electron micrographs of scaffolds prepared by solid-liquid phase separation 
(Group 3): 5% (w/v) PDLLA was dissolved in DMC and frozen at -25℃ (SL-25C) or snap-frozen 
-196℃ (SL-196C) for 2 h (A) scaffold SL-25C sectioned along the direction of the laminated pores (B) 
scaffold SL-25C sectioned transverse to the direction of the laminated pores, (C) scaffold SL-196C, 
sectioned along the direction of the laminated pores, (D) scaffold SL-196C sectioned transverse to the 
direction of the laminated pores. 
 
7.3.2. Penetration of A549 cells cultured on unmodified PDLLA 
scaffolds evaluated using fluorescence microscopy 
Using fluorescence microscopy, not only the cells populating the outermost layer of 
the scaffolds but also those in pores close to the outermost layer could be observed. 
On the last day of culture, day 16, A549 cells transfected with pEGFP-N1 covered the 
outer surface of all scaffolds (Figure 7-8). Cells were seen to penetrate into the 
internal structure of all samples except LL24C, LL27C and SL-196C. It can be 
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observed clearly that in the areas where cells were not populated, scaffolds did not 
emit detectable autofluorescence (Figure 7-8A, B and H). Figure 7-8I showed a 
LL27C scaffold that were not seeded with cells. Similarly, no detectable 
autofluorescence was observed. 
  
Figure 7-8 Fluorescent microscope images of A549 cells cultured on scaffolds prepared using 
liquid-liquid phase separation with coarsening temperature from 27℃ to 12℃ for 30 min (A-F) and 
solid-liquid phase separation with freezing temperature of -196℃ (G) and -25℃ (H), including (A) 
LL27C, (B) LL24C, (C) LL21C, (D) LL18C, (E) LL15C, (F) LL12C, (G) SL-196C and (H) SL-25C, 
after 16 d of culture. The scaffolds were sectioned along the direction of A549 seeding. (A), (B) and (H) 
showed the border of sectioned scaffolds, because cells were not found in the middle area of the 
sections. (C-G) showed the middle area of the sectioned scaffolds. (I) The LL27C without cells did not 
emit detectable fluorescence, but they scattered the fluorescence emitted by the A549 cells as shown in 
(C-G), resulting the obscurity of the some images.  
 
7.3.3. Penetration of A549 cells cultured on unmodified PDLLA 
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scaffolds evaluated using scanning electron microscopy 
(SEM) 
A549 cell migration into the middle of the scaffolds was investigated using SEM. 
SEM images indicated that A549 cells could indeed be observed in the centre of 
scaffolds LL12C, LL15C, LL18C, LL21C and SL-25C (Figure 7-9), confirming 
penetration of the A549 cells. A549 cells were not observed at the centre of scaffolds 
LL24C, LL27C and SL-196C. This finding was in agreement with those obtained 
from fluorescence microscopy (Figure 7-9). 
 
Figure 7-9 Scanning electron micrographs of A549 cells (arrows) cultured for 16 d on the surface of 
scaffolds A: LL27C, B: LL24C, C: LL21C, D: LL18C, E: LL15C, F: LL12C, G: SL-196C, H: SL-25C.  
 
7.3.4. A549 cell activity on the unmodified PDLLA scaffolds 
The WST-1 cell viability assay was performed on days 4, 8, 12 and 16 to measure 
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A549 cell activity on the various scaffolds (Figure 7-10). Cells cultured on scaffold 
SL-25C demonstrated the highest overall levels of A549 cell activity as compared to 
cells cultured on all other scaffolds. In general, scaffolds which possessed larger 
porous structures induced A549 cell activity, except for scaffold LL18C one of the 
samples with the largest pores in the liquid-liquid phase separation group. The overall 
activity of A549 cells cultured on scaffold LL18C, however, was statistically lower to 
that of scaffolds LL12C, LL15C and LL21C. In additional to the A549 culture on 
PDLLA scaffolds, A549 cells were cultured on TCP and PDLLA films in parallel. The 
results were not shown here because it was found that A549 died quickly when they 
reached 100% confluence. It is due to the limited surface area in each well of a 
24-well plate. 
 
Figure 7-10 Activity of A549 cells cultured on scaffolds prepared by liquid-liquid and solid-liquid 
phase separation at day 4, 8, 12, 16. Statistical analysis of A549 cell activity on different scaffolds on 
day 16 was performed (n = 6). The WST-1 assay was repeated 3 times. The absorbance of the WST-1 
reagent presented in this figure was the absorbance of each sample minus the background absorbance 
(WST-1 reagent added to empty wells containing no cells). 
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7.3.5. A549 activity on the modified PDLLA scaffolds 
To study the influences of the surface modification of scaffolds on the pulmonary 
epithelial cells, A549 cells were also cultured on scaffold SL-25C modified using 
aminolysis (4%EDiamine) and by amine-terminated (bTREN3) and carboxylic 
acid-terminated (bADA) branching modifications. Cells grown on 4%EDiamine and 
bTREN3 over 16 days demonstrated higher overall activity than those on the 
unmodified PDLLA scaffolds (Figure 7-11). 
 
Figure 7-11 Activities of A549 cells cultured on surface-modified scaffold SL-25C at day 4, 8, 12 and 
16. Asterisks * indicates for P<0.05 and ** for P<0.005 (n = 6). The WST-1 assay was repeated 3 
times. 
 
7.4. Discussion 
Most previous reports have used the PLLA-dioxane-water tertiary system as a model 
to study the effect of coarsening conditions on the pore structure of the scaffolds [20, 
185, 189, 190, 306]. Instead of PLLA, PDLLA was used in the current study. The 
major difference between the two polymers is that PDLLA is an amorphous polymer 
whereas PLLA is semicrystalline. In the tertiary system using PLLA, a gelation 
temperature can be observed as the result of the partial crystallization in the 
polymer-rich phase [185]. The phenomenon was not observed in the tertiary system in 
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this study using amorphous PDLLA. Scaffolds prepared by liquid-liquid phase 
separation of 5% PDLLA-dioxane solution were reported to have different 
mechanical properties and pore morphology from those made from 5% 
PLLA-dioxane solution [20]. The percentage of water in the tertiary system also 
significantly affected the cloud point (temperature) of PDLLA in solution. A small 
increase of the amount of water, from 13% to 15.5%, added to the system can raise 
the cloud point from of a 5% PLLA-dioxane-water solution 40℃ to 60℃ [185]. 
Rather than a single cloud point, a temperature range in which the clouding of the 
polymer solution occurred was observed for PDLLA between 28℃-32℃ in the 
preliminary test. This temperature range is due to the polydispersity of PDLLA.  
 
The PDLLA-dioxane-water tertiary system has an upper critical solution temperature 
type phase separation behaviour, thus, when the polymer of the solution is brought 
down below the cloud temperature, the thermodynamic tendency of the phase 
separating polymer solution is to reduce the interfacial energy of polymer-rich and 
solvent-rich phases which causes the growth and subsequent coalescence of the 
phase-separated regions [189]. When the coalescence progresses the increasing 
polymer concentration in the polymer-rich phase, leads to an increased viscosity of 
the polymer-rich phase and a decreased number of solvent-rich drops subsequently 
results in a decrease of interconnectivity of the final scaffolds. During coarsening, the 
density, viscosity and solvent flux of both phases create a slow-changing balance of 
solvent-rich droplets distributed within a matrix of polymer-rich phase. When the 
solvent-rich phase grows to the extent that this balance can no longer be maintained, 
the polymer-rich phase sediments and both phases eventually separates so that the 
solvent-rich phase “floats” on top of a polymer-rich phase. This phenomenon was 
observed for scaffold LL60M. Among all other samples in group 1, scaffold LL30M 
possessed the largest pores because of the longest coarsening period. One problem 
with scaffold LL30M was that a large percentage of pores of were only connected to 
other pores only via very small pore throats, far too small for A549 cells to migrate 
into the scaffold. The poor interconnectivity of the scaffold LL30W was the result of 
the coalescence of the solvent-rich droplets and the concurrent increase of the distance 
between coalescencing droplets of the phase-separated polymer solution during 
coarsening as described. 
 199
 
In an attempt to address the issue of pore interconnectivity, the porous structure of 
scaffolds prepared using liquid-liquid phase separation with coarsening period of 30 
min was controlled using different coarsening temperatures ranging from 27℃ to 
12℃. The wide coarsening temperature range is accessible because of the lack of a 
gelation temperature of the tertiary system used due to the amorphous nature of 
PDLLA. The scaffold framework was getting much more irregular when the 
coarsening temperature was decreased from 27℃ to 15℃, which is due to the shift of 
the polymer solution from the poorly-connected metastable region to the unstable 
region of the temperature-composition phase diagram of the PDLLA solution. When 
the coarsening temperature was further reduced to 12℃, sedimentation of 
polymer-rich phase occurred. In the sedimentated polymer-rich phase, phase 
separation still progressed to form both polymer-rich and polymer-poor phases. 
Smaller pores formed in between the already-formed large pores due to a progressing 
phase separation after sedimentation. Scaffold LL18C possessed the largest average 
pore size, 270 μm, among all samples prepared meanwhile scaffold LL18C had many 
poorly-connected pores that were connected to other pores only via small pore throats. 
This is because of the coalescence of the solvent-rich phase, the concurrent decrease 
of the number of solvent-rich droplets and the subsequent reduction in pore 
interconnectivity as described previously. The high number of small pore throats 
restricts the cell migration and nutrition diffusion when the scaffolds were cultured 
with A549 cells, which resulted in the lowest A549 activity among the four samples 
with pore sizes larger than 200 μm. After coarsening, the coarsened-polymer solutions 
were quenched in liquid nitrogen to snap-freeze the coarsened polymer solutions to 
minimize any further phase separation before the solvent was frozen and eventually 
removed by freeze-drying. 
 
When the scaffolds were prepared by solid-liquid phase separation from 5% 
PDLLA-DMC solution, the polymer solution started to solidify before the occurrence 
of liquid-liquid phase separation [181]. In the freezing polymer solution, the PDLLA 
is rejected by the front of the growing DMC crystals. The porous structure of the 
scaffolds is therefore mainly determined by the formation DMC crystals [181]. When 
the polymer solution is frozen at -25℃ in a freezer, the slower cooling rate allows the 
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growth of DMC crystals to continue, which results in larger pores. In contrast, when 
5% PDLLA-DMC solution was quenched in liquid nitrogen, the fast cooling rate did 
not allow the solvent crystals to grow sufficiently large, which resulted in scaffolds 
with small pores. 
 
To elucidate whether scaffolds prepared by liquid-liquid phase separation and 
solid-liquid phase separation are suitable culture environments for pulmonary 
epithelial cells, A549 cells were cultured on these scaffolds. The activity of A549 cells 
was measured using WST-1 reagent, a colourimetric assay similar to the 
commonly-used MTT [218] assay. WST-1 is a terazolium salt, when it is added to the 
cell containing cell culture medium, it is cleaved into formazan dye by 
succinate-tetrazolium reductase in the mitochondria of only metabolically active cells. 
The formazan dye can be quantified by measuring its absorbance using an ELISA 
reader. The measured absorbance is proportional to the metabolic activity of the 
cultured cells. Scaffold SL-25C induced the highest overall A549 activity of all 
prepared scaffolds. The high A549 activity induced by scaffold SL-25C was most 
likely due to the fact that its larger ladder-like pores, which were 150 - 250 μm in 
diameter, allow easy access of cells and exchange of nutrients and waste. In contrast 
to scaffold SL-25C, cells did not migrate into the middle of scaffold SL-196C due to 
its small pores, as demonstrated by SEM and the fluorescence microscope images. 
The overall A549 cell activity on scaffold SL-196C was also much lower than on 
scaffold SL-25C. SEM images demonstrated that A549 cells were not able to migrate 
into the middle of scaffolds LL27C and LL24C prepared by liquid-liquid phase 
separation. The former was prepared at a coarsening temperature of 27℃, which is 
only 1℃ lower than the lower margin of the cloud point, so the state of the PDLLA 
solution at 27℃ was located in the metastable region and close to the bimodal curve 
of the temperature-composition phase diagram, where the initiation of nucleation and 
growth mechanism generated small droplet-like solvent-rich phase dispersed in the 
polymer-rich phase. Even after 30 min coarsening at 27℃, the pores of scaffold 
LL27C were still too small to allow cell migration into its centre. Scaffold LL24C had 
much larger pores than scaffold LL27C, but the pore interconnectivity was poor. 
Other scaffolds, including LL12C, LL15C and LL21C, induced similar levels of cell 
activities over the whole culture period. Scaffold LL18C induced lower cell activities 
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than scaffolds LL12C, LL15C and LL21C, despite its largest average pore size. The 
reason for this was the low pore interconnectivity as the consequence of increasing 
size of and coalescence of polymer-poor phase, as described previously. 
 
Among all the prepared scaffolds, scaffold SL-25C induced the highest A549 cell 
activity. It is interesting to know whether modification of the surface of such scaffolds 
can induce even higher A549 cell activity than the unmodified scaffolds and, therefore, 
it was decided to modify scaffold SL-25C. Ethylenediamine introduces amino groups 
into the polymer backbone by breaking the ester bonds using aminolysis, a 
trans-esterification reaction [33]. For the aminolysis modification of scaffold SL-25C, 
4% ethylenediamine solution in isopropanol was used for 5 min. 4% ethylenediamine 
solution was chosen because the preliminary study demonstrated that PDLLA films 
treated by ethylenediamine solution at a concentration higher than 4% can be too 
fragile for further branching modifications. Amine-terminated or carboxylic 
acid-terminated branched architectures were also prepared by repeatedly introducing 
“spacer” and “tri-functional molecules” to the 4%EDiamie. Branched architectures 
can enhance the concentration of the functional groups in the vicinity of each 
branched architecture and, therefore, the functional groups are not homogeneously 
distributed on the surface of the scaffolds. The effect of these modifications of 
PDLLA films on A549 cell behaviour, including attachment, activity and population 
size, had been tested previously [304]. The major difference between cells cultured on 
films and 3D scaffolds is that cells did reach 100% confluency quickly when they are 
cultured on films, while 3D scaffolds offer sufficient surface area for the cells to 
migrate and proliferate. Therefore, A549 cells cultured on surface-modified 3D 
scaffolds may present different activity levels compared to A549 cells cultured on 
PDLLA films. A549 cells were therefore seeded on surface-modified scaffolds and 
the activity of the A549 cells was investigated. The result demonstrated that both 
4%EDiamine and bTREN3 increased the A549 activity during 16 days in culture 
compared to those cultured on the unmodified SL-25C scaffold, whereas bADA3 did 
not induce higher A549 cell activity compared to the unmodified SL-25C scaffold. As 
4%EDiamine and bTREN3 possessed amines with different distributions on their 
surfaces, it can be inferred that surface amines at certain concentrations can enhance 
the A549 cell activity, regardless of their distribution. A further study should be 
performed to quantify the amine concentration on the surface of both 4%EDiamine 
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and bTREN3. The A549 attachment and their number on scaffolds were not quantified 
in this study because these would require the complete isolation of the DNA of A549 
cells cultured within the scaffolds, and the preliminary test demonstrated that 
erroneous results can be obtained due to any residual DNA trapped within the 
scaffolds. 
 
7.5. Conclusion 
This experiments presented in this chapter provide basic information about the effect 
of the preparation conditions of porous 3D PDLLA scaffolds on their pore structure 
and morphology. The surfaces of these 3D scaffolds were modified and the impact of 
the surface modification on the subsequent culture of pulmonary epithelial cells was 
investigated. It was demonstrated that scaffolds with pores of similar dimensions to 
pulmonary alveoli can be fabricated using liquid-liquid phase separation of the 
PDLLA-dioxane-water tertiary systems. The pore size of these scaffolds can be tuned 
by controlling the coarsening temperatures. Scaffolds prepared using solid-liquid 
phase separation using freezing temperature of -25℃ possessed large ladder-like 
pores with dimension ranging between 150-250 μm. Cell culture of pulmonary 
epithelial cells A549 demonstrated that pore sizes of the scaffolds and surface 
modification on the scaffolds can affect the overall level of the A549 cell activity over 
time. 
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Chapter 8. Conclusions and future work 
8.1. Summary and conclusions  
The overall aims of this project were, firstly, to increase the differentiation 
efficiency of type II pneumocyte progenitors from mESCs by enhancing the 
established differentiation protocol, and secondly, to develop 2D environments 
and 3D scaffolds made of poly(D,L-lactide) (PDLLA) suitable for the culture of 
pulmonary epithelial cells.  
 
To achieve the two aims, the following three questions were proposed at the start of 
this thesis, and investigated in the five experimental chapters; 
  
Question 1: Can the differentiation of murine embryonic stem cells into type II 
pneumocyte progenitors be enhanced by: 
- coating the culture vessel with ECM protein/s?  
- grafting bioactive peptides to the culture vessel?  
- adding fibroblast growth factors to the cell culture medium? 
 
Protein coatings on tissue culture plastic (TCP), specifically with the ECM protein 
laminin and ECM replacement Matrigel, were shown to enhance the expression of the 
mRNAs for markers of pulmonary epithelial progenitors, including surfactant protein 
C and D (SPC and SPD) and aquaporin 5, as compared to the control gelatin, which 
was used in the original “three-step differentiation protocol” for the differentiation of 
pulmonary progenitors from mESCs. Furthermore, coating with either laminin or 
Matrigel was found to increase the number of SPC-eGFP positive cells. 
 
As the conformation of an adsorbed protein is determined by the surface properties of 
the material that the protein is adsorbed to, laminin and Matrigel were further coated 
onto the PDLLA films and the effects of the coatings on the differentiation of mESCs 
tested. It was found that laminin coating on PDLLA films induced the highest levels 
of SPC mRNA expression by the differentiated cells as compared to Matrigel or 
gelatin coating. The adsorption of the proteins on TCP and PDLLA films was 
confirmed by the change in the IEP, where the ζ potential ζ=f(pH) = 0, and the ζplateau, 
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of the protein-coated surfaces. Moreover, all protein-coated TCP and PDLLA films 
had lower water contact angles as compared to non-coated counterparts. The water 
contact angles of the protein-coated surfaces, however, did not correlate to the SPC 
expression of the differentiated pulmonary progenitors. 
 
The SPC mRNA expression of the differentiated pulmonary progenitors can also be 
enhanced by adding fibroblast growth factor (FGF) into the differentiation medium. 
High concentrations (500 ng/ml and 1000 ng/ml) of FGF-1 were found to enhance the 
expression of SPC mRNA of the differentiated cells compared to the control culture of 
cells fed with no growth factors. Interesting results were found using cells fed with the 
differentiation medium containing FGF-10. FGF-10 at 60 ng/ml did not induce a 
change in the expression of SPC mRNA when the mESCs were differentiated on a 
gelatin coating, but, in contrast, FGF-10 enhanced the SPC mRNA expression of the 
differentiated pulmonary progenitors when the gelatin was replaced with Matrigel, 
suggesting synergic effects between the growth factors and ECM proteins. 
 
It was further demonstrated that the positive effects of laminin coating of PDLLA 
films on the differentiation of pulmonary progenitors from mESCs can also be 
observed on cells differentiated on YIGSR-grafted PDLLA films. YIGSR is the 
peptide that mimics the cell adhesion function of laminin. YIGSR-grafted PDLLA 
films induced greater SPC mRNA expression of the differentiated cells than was 
observed with cells cultured on the gelatin-coated PDLLA control. When RGD 
peptides were co-grafted with YIGSR onto PDLLA, the expression of SPC decreased, 
suggesting a concentration-dependent effect of grafted YIGSR on the expression of 
SPC mRNA. 
 
Question 2: How do the pulmonary epithelial cells respond to the surface of PDLLA 
scaffolds grafted with RGD and YIGSR peptides or modified with amines or 
carboxylic acids and how do the surface-modified PDLLA scaffolds differ from 
unmodified PDLLA scaffolds? 
Pulmonary epithelial A549 cells do attach better to RGD-grafted than YIGSR-grafted 
PDLLA surfaces. Focal adhesion points formed within A549 cells cultured on 
RGD-grafted PDLLA films outnumbered the focal adhesion points formed within the 
A549 cells cultured on YIGSR-grafted PDLLA films. The number of focal adhesion 
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points in A549 cells was positively related to the amount of the grafted RGD. All 
peptide-grafted PDLLA films demonstrated lower water contact angles and rougher 
surfaces than the unmodified PDLLA surface. YIGSR-grafted surfaces, on the other 
hand, possessed only slightly lower water contact angles but rougher surfaces than 
RGD-grafted surfaces. 
 
Functional groups were introduced to the surface of PDLLA films using aminolysis 
and branching modifications. Aminolysis introduced amines onto the surfaces of 
PDLLA films, while the branching modification created amine-terminated and 
carboxylic acid-terminated tree-like branched architectures on the amine-funct-
ionalized PDLLA. All of the functionalized PDLLA films possessed lower water 
contact angles than unmodified PDLLA films. The attachment of A549 cells was 
better on PDLLA films possessing more functional groups. PDLLA films 
functionalised with amine-terminated branched architectures can induce higher 
metabolic activity of the cultured cells than unmodified PDLLA film and PDLLA 
films functionalised with carboxylic acid-terminated branched architectures. 
 
Question 3: What are the parameters needed to prepare 3D synthetic scaffolds with 
a pore structure suitable for the culture of pulmonary epithelial cells?  
Experimental results demonstrated that, when scaffolds possessed pores with 
diameters exceeding 150 μm and with good interconnectivity between these pores, 
pulmonary epithelial cells can penetrate into the scaffolds and be active within them 
for at least 16 days, as evaluated using the WST-1 assay.  This is because large pores 
allow nutrition diffusion in and waste diffusion out of the scaffolds. Consequently, 
pulmonary epithelial cells can penetrate into and survive within the interior of such 
scaffolds. 
 
Liquid-liquid phase separation using 5% PDLLA in 13% water and 87% dioxane 
generates porous scaffolds with round pores. The “coarsening”phenomenon, a 
tendency of the decreasing interfacial area and the reducing interfacial energy of the 
separated phases over time, was used to control the pore structure and pore sizes 
within the scaffolds. Longer coarsening times generated scaffolds with large pores 
because of the thermodynamic tendency to reduce interfacial energy between the 
polymer-rich and polymer-poor phases and the subsequent coalescence of the 
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polymer-poor phases in the polymer solution. When a coarsening time of 30 min and 
coarsening temperature between 21℃ to 15℃ was used, scaffolds possessing pores 
with diameters exceeding 150 μm were obtained. These scaffolds possessed structures 
similar to the pulmonary alveolus and allowed the penetration and the culture of 
pulmonary epithelial cells as mentioned, thus, they may be good candidates for the 
implantation purposes.  
 
Solid-liquid phase separation using 5% PDLLA in 100% dimethylcarbonate generates 
scaffolds with ladder-like porous structures. The pore dimensions are determined 
mainly by the growth of solvent crystals, which is controlled by the freezing 
temperature and rate of the polymer solution. Using a freezing temperature of -25℃ 
prior to freeze-drying, the size of the ladder-like pores can be as large as 300 μm. 
A549 cells proliferate better on these scaffolds than on all other scaffolds studied. 
This is because of the much larger pores which facilitated nutrition and waste 
exchange. This scaffold, therefore, can be considered suitable for the in vitro 
expansion of the pulmonary epithelial cells. 
 
In conclusion, the differentiation of pulmonary progenitors from murine embryonic 
stem cells can be influenced by the external signals from the culture system, including 
extracellular matrix, fibroblast growth factors and bioactive peptides. Furthermore, 
PDLLA films modified using bioactive peptide grafting, aminolysis and branching 
modification and 3D PDLLA scaffolds can be applied as cell culture environments for 
pulmonary epithelial cells. 
 
8.2. Suggestions for future work 
The results obtained in this project provide a basis for the engineering of pulmonary 
epithelial tissue. For example, the differentiation protocols of pulmonary progenitors 
from mESCs established in this study can be further applied to the differentiation of 
human pulmonary progenitors from hESCs. However, a number of issues encountered 
during these studies will need to be resolved and more research performed. These 
issues and possible solutions are summarised below. 
 
The differentiated cell cultures derived from ESCs in this study only expressed the 
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mRNA for pulmonary epithelial markers, specifically surfactant proteins. The 
RT-PCR method used appeared to be reliable and had appropriate controls, so there 
was no reason to suggest the data were erroneous. However, the corresponding 
surfactant proteins could not be detected using immunocytochemistry, despite 
extensive tests using different antibodies. This has long been a problem of the 
three-step differentiation protocol [203]. This may have been due to the technical 
difficulties encountered during sectioning of the attached embryoid bodies (EBs) on 
the protein-coated TCP or PDLLA. It may also have been a result of surfactant protein 
synthesis been restricted to the mRNA level and consequent immaturity of the type II 
pneumocyte progenitors. If the latter is the case, more studies should be performed to 
find the missing key, which can guide the pulmonary progenitors to differentiate into 
mature pulmonary epithelial cells.  
 
The positive effects of laminin and Matrigel on mESC differentiation to distal airway 
epithelium were demonstrated in this study. The molecular mechanisms by which 
laminin and Matrigel exerted their effects are still unknown. Investigations of the 
expression of the integrins and proteins in the downstream cascades of the cells in the 
attached EBs should be performed. Furthermore, it needs to be understood whether 
the future pulmonary progenitors are influenced by laminin and Matrigel in a direct or 
indirect manner.  
 
Laminin was found to affect the expression of SPC of the differentiated cells at 
varying levels when it was adsorbed to the surface of different materials. This might 
have been due to the fact that, when laminin is adsorbed to different materials 
conformational change and may affect the exposure of its bioactive moieties [175]. To 
establish this, further investigations could be performed aiming to quantify the 
conformation of the adsorbed laminin and the exposure of its bioactive moieties. 
 
FGFs were shown to be effective in increasing the SPC expression levels of 
differentiating mESCs. The FGF concentrations used in the experiments were based 
on those reported in the literature for the maintenance of the type II pneumocytes or 
for the study of the FGFs effect on the excised embryonic lung in vitro. A broader 
range of FGF concentrations, more FGF combinations and different feeding regimes 
could be tested to further improve the differentiation protocol. As with the positive 
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effects of the ECM coatings on the derivation of pulmonary progenitors, the 
mechanisms by which FGF influence on differentiation of mESCs are still unknown. 
All FGFs used in this project, i.e. FGF-1, 2 ,7 and 10, can bind to FGF receptors, then 
the signals pass through a series of downstream protein cascade to MAPK/ERK 
pathway, that can regulate the activities of several transcriptional factors, such as 
c-Myc, Sap1a, Elk-1 and CREB [2-8]. Some of these transcriptional factors controlled 
by FGF can affect the organogenesis and the branching morphogenesis of the 
embryonic lung [87, 88, 247, 251, 307-309], especially via mesenchymal-epithelial 
interaction [309]. Thus, it would be interesting to find out how the FGFs affect the 
differentiation of pulmonary progenitors via the regulation of the above-mentioned 
transcriptional factors. 
 
YIGSR-grafting to PDLLA can replace the role of intact laminin and induce the 
expression of SPC, indicating differentiation of pneumocytes. Unfortunately, these 
experiments took place towards the end of the study and, thus, the results are only 
preliminary and there was not time to evaluate the expression of other pulmonary 
epithelial markers. Factors such as the concentration of the grafted peptide, the linker 
length between the grafted YIGSR and PDLLA surface, could be optimized to 
increase the SPC expression of the differentiated mESCs on the surface-modified 
PDLLA films. Recently, nanofibrous scaffolds made of self-assembly YIGSR peptides 
were reported [310, 311]. The nanofibrous scaffolds provide environments similar to 
the extracellular spaces of most tissues. These nanofibrous scaffolds may be used to 
culture mature pulmonary epithelial cells or to differentiate mESCs into type II 
pneumocyte progenitors. Had more time been available, this is something that would 
have been tested. 
 
Using aminolysis and branching modifications, it was possible to demonstrate that 
functional groups on a PDLLA surface can alter the responses of a line of airway 
epithelium-like (A549) cells. However, it is still not known whether the effect of the 
functional groups on A549 responses is due to the groups themselves or the adsorbed 
serum proteins. To answer this question, it would be necessary to investigate the 
amount of the adsorbed protein and structure of the protein layer adsorbed from the 
A549 culture medium onto the functionalized PDLLA. 
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PDLLA scaffolds designed to mimic the structure of the distal lung were prepared and 
seeded with A549 cells as a first step to attempt a 3D culture of pulmonary epithelial 
cells. The mechanical properties of the scaffold should match its target tissue so that 
the implanted scaffolds should keep its structural stability in an in vivo physiological 
environment. The investigation of the mechanical properties, such as elastic modulus 
and tensile strength, of the manufactured scaffolds specifically under physiological 
conditions, i.e. in the tissue fluid and at 37℃, and the degradation profile of these 
scaffolds are needed as well as in vivo studies to evaluate the vessel in-growth.  
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Appendix A  Step by step experimental protocol 
A1. Protocols for immunostaining 
1. Cells that formed a monolayer were fixed using 4% PFA (4% w/v 
paraformaldehyde in PBS) for 30 min after medium aspiration and several rinses 
of PBS. Aspire the PFA then rinse samples several times using PBS. 
 
2. To fix unseeded EBs as described in Chapter 3, EBs were harvested, washed with 
PBS and fixed with 4% (w/v) PFA overnight, allowing PFA to penetrate the whole 
EB. Wash the fixed EBs with PBS for several times and cryoprotect the fixed EBs 
using 30% (w/v) sucrose in PBS at 4˚C overnight. Cryoprotected samples were 
then immersed in O.C.T. embedding medium (Miles, Elkhart, IN) in a mould 
made of aluminum foil for 30 min at room temperature. The mould that contained 
samples was rapidly immersed into isopentane pre-cooled with liquid nitrogen. 
The frozen samples were either stored in -80˚C for further use or cryosectioned to 
15 μm thickness at -20˚C immediately. 
 
3. Use 3% (v/v) normal serum derived from the same species from which the 
secondary antibodies were derived to block the background antigens for 30 min. 
 
4. Shake off the blocking solution, add primary antibodies in diluent comprising 
0.05% (w/v) bovine serum albumin (BSA; Sigma-Aldrich, Dorset, UK) and 
0.01% (w/v) NaN3 (Sigma-Aldrich, Dorset, UK) in PBS at predetermined dilution 
ratios (Table 2-5) to samples overnight at 4˚C followed by several rinses of PBS 
on the second day. 
 
5. Appropriate secondary antibodies, raised against the donor species of the primary 
antibodies and conjugated with fluorophore, were diluted at predetermined ratios 
in azide-free diluent consisting of only 0.05% (w/v) BSA in PBS and were added 
to the samples for 1 h in the dark at room temperature. 
 
6. Rinsed samples several times with PBS and mounted samples in Vectashield 
containing 1.5 μg/mL 4',6 diamidino- 2 – phenylindole (DAPI) (Vector 
Laboratories, Burlingame, CA). 
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Appendix B  Supplementary results 
B1. Determination of optimal cycle number for conventional PCR 
It is necessary to find the optimal cycle number for each PCR primer in order to 
obtain semi-quantitative information of the mRNA expression. The RNA was 
extracted from the cells differentiated from mESCs using the original three-step 
differentiation protocol, reverse-transcribed the extracted RNA into cDNA, and 
determined the optimal cycle number of the primer pairs as showed from Figure B-1 
to Figure B-7. The density of each band on the left of Figure B-1 to Figure B-7 was 
measured by the Quantity One software. The density of the each band was plotted 
using a random logarithmic scale against the cycle number. The optimal cycle number 
was determined by choosing the cycle number that is corresponding to the middle 
point of the linear region of each plot. 
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Figure B-1 Saturation curve of albumin primer 
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Figure B-2 Saturation curve of aquaporin 5 primer 
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Figure B-3 Saturation curve of β-actin primer 
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Figure B-4 Saturation curve of CC10 primer 
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Figure B-5 Saturation curve of GAPDH primer 
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Figure B-6 Saturation curve of SPC primer 
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Figure B-7 Saturation curve of SPD primer 
 
B2. Optimization of reaction concentration of murine SPC primers for real-time 
PCR 
Optimization of primer concentration was performed according to the supplier’s 
protocol. Primer pairs that have the best amplification efficient generate the lowest Ct 
when sample amount of the sample is added to each reaction.  
 
As Table B-1 shows, three pairs of SPC primers, forward primer and reverse primer at 
50 nM, 300 nM or 900 nM, were compared using MLE-12 cDNA. MLE-12 is a 
murine pulmonary epithelial cell line. SPC primer 3 with forward primer at 900 nM 
and reverse primer at 900 nM had the lowest Ct compared with the other primers at all 
concentrations and the primers in other combinations, thus, it was chosen for this 
study. The details of the primer sequences are listed in Table B-2. 
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Table B-1 Optimation of the reaction concentration of four different pairs of murine SPC primer 
SPC primer 1 SPC primer 2 SPC primer 3 
Forward primer 
concentration
Forward primer 
concentration 
Forward primer concentration 
 
50 nM 300 nM 900 nM 50 nM 300 nM 900 nM 50 nM 300 nM 900 nM 
50 nM UD UD 30.38 UD 39.66 37.91 UD 34.03 33.83 
300 nM UD 32.1 28.47 39.34 32.7 31.27 35.72 29.21 28.45 
Reverse 
primer 
Concentration 900 nM 38.86 33.12 29.6 36.28 32.34 30.73 35.19 29.02 28.14 
UD stands for undetermined Ct, which is larger than 40 cycles 
 
Table B-2 Four pairs of primers designed using primer 3 software 
Primers Primer sequence  
SPC primer 1 ACCCTGTGTGGAGAGCTACCA Forward 
 TTTGCGGAGGGTCTTTCCT Reverse 
SPC primer 2 CTTTCCTAGGCCTTGCTGTG Forward 
 GTTTCTACCGACCCTGTGGA Reverse 
SPC primer 3 CAGCTCCAGGAACCTACTGC Forward 
 GCGAAAGCCTCAAGACTAGG Reverse 
 
B3. Standard curve for fluorescamine assay 
The standard curve, obtained using Sigmaplot software (Systat Software Inc., San 
Jose, CA), can be described by
1
- 0 ln 2
-
0 {1- }
C
C
x x b
by y a e
+ ×
⎛ ⎞⎜ ⎟⎜ ⎟⎝ ⎠= + , where a = 794.167, 
b=2.435-7, c = 1.288, x0 = 1.8371-7 and y0 = 6.739. It was used as a reference to 
evaluate the numbers of surface amine groups in other figures. Black circles indicate 
the serial diluted ethylenediamine and the curve indicates the fitted nonlinear 
regression curve using Weibull 5 parameter formula. 
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Figure B-8 Standard curve of ethylenediamine solution diluted in acetone at different concentrations.  
 
B4. Standard curve for DNA quantity determination using Hoechst 33258 
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Figure B-9 Standard curve of DNA quantity determination using Hoechst 33258 
 
